AET,RPT-U.S. healthcare executives say Obamacare is not going anywhereUPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers. SAN FRANCISCO/WASHINGTON Jan 15 U.S. healthcare executives say Obamacare is likely here to stay, despite repeated calls from Republican lawmakers for repeal of the 2010 law aimed at providing health coverage for millions of uninsured Americans.UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  
AMZN,EU regulators said had doubts over Amazon's Luxembourg tax dealUPDATE 1-EU says part of Amazon's Luxembourg tax deal "cosmetic" * Tax ruling in place for more than 10 years   (Adds details from document)  UPDATE 1-EU says part of Amazon's Luxembourg tax deal "cosmetic" * Tax ruling in place for more than 10 years   (Adds details from document) BRUSSELS, Jan 16 European antitrust regulators believed Amazon's arrangement with Luxembourg to minimise its tax bill did constitute state aid and expressed doubt that such aid was lawful, according to a document released on Friday.UPDATE 1-EU says part of Amazon's Luxembourg tax deal "cosmetic" * Tax ruling in place for more than 10 years   (Adds details from document)  
T,AT&T; appoints Arroyo as Iusacell CEO in MexicoAT&T; appoints Arroyo as Iusacell CEO in MexicoSprint says Obama net neutrality plan wouldn't curb investmentsAT&T; estimates charges of $10 bln in fourth quarter Jan 16 AT&T; Inc said it expected to record charges of about $10 billion for the fourth quarter but the non-cash losses would not affect operating results.  AT&T; estimates charges of $10 bln in fourth quarter Jan 16 AT&T; Inc said it expected to record charges of about $10 billion for the fourth quarter but the non-cash losses would not affect operating results. WASHINGTON Sprint Corp will keep investing in its networks even if U.S. regulators adopt stricter "net neutrality" rules as long as they are applied with a "light touch," the company said in a letter to the FCC released on Friday. | AT&T; estimates charges of $10 bln in fourth quarter Jan 16 AT&T; Inc said it expected to record charges of about $10 billion for the fourth quarter but the non-cash losses would not affect operating results. VideoAT&T; estimates charges of $10 bln in fourth quarter Jan 16 AT&T; Inc said it expected to record charges of about $10 billion for the fourth quarter but the non-cash losses would not affect operating results.  AT&T; estimates charges of $10 bln in fourth quarter Jan 16 AT&T; Inc said it expected to record charges of about $10 billion for the fourth quarter but the non-cash losses would not affect operating results.   Sprint says Obama net neutrality plan wouldn't curb investmentsAT&T; estimates charges of $10 bln in fourth quarter Jan 16 AT&T; Inc said it expected to record charges of about $10 billion for the fourth quarter but the non-cash losses would not affect operating results.  AT&T; estimates charges of $10 bln in fourth quarter Jan 16 AT&T; Inc said it expected to record charges of about $10 billion for the fourth quarter but the non-cash losses would not affect operating results. WASHINGTON Sprint Corp will keep investing in its networks even if U.S. regulators adopt stricter "net neutrality" rules as long as they are applied with a "light touch," the company said in a letter to the FCC released on Friday. | AT&T; estimates charges of $10 bln in fourth quarter Jan 16 AT&T; Inc said it expected to record charges of about $10 billion for the fourth quarter but the non-cash losses would not affect operating results. VideoAT&T; estimates charges of $10 bln in fourth quarter Jan 16 AT&T; Inc said it expected to record charges of about $10 billion for the fourth quarter but the non-cash losses would not affect operating results.  AT&T; estimates charges of $10 bln in fourth quarter Jan 16 AT&T; Inc said it expected to record charges of about $10 billion for the fourth quarter but the non-cash losses would not affect operating results.  MEXICO CITY AT&T; said on Friday it had appointed company veteran F. Thaddeus Arroyo as the chief executive of Iusacell, Mexico's No.3 wireless carrier which it recently bought.Sprint says Obama net neutrality plan wouldn't curb investmentsAT&T; estimates charges of $10 bln in fourth quarter Jan 16 AT&T; Inc said it expected to record charges of about $10 billion for the fourth quarter but the non-cash losses would not affect operating results.  AT&T; estimates charges of $10 bln in fourth quarter Jan 16 AT&T; Inc said it expected to record charges of about $10 billion for the fourth quarter but the non-cash losses would not affect operating results. WASHINGTON Sprint Corp will keep investing in its networks even if U.S. regulators adopt stricter "net neutrality" rules as long as they are applied with a "light touch," the company said in a letter to the FCC released on Friday. | AT&T; estimates charges of $10 bln in fourth quarter Jan 16 AT&T; Inc said it expected to record charges of about $10 billion for the fourth quarter but the non-cash losses would not affect operating results. VideoAT&T; estimates charges of $10 bln in fourth quarter Jan 16 AT&T; Inc said it expected to record charges of about $10 billion for the fourth quarter but the non-cash losses would not affect operating results.  AT&T; estimates charges of $10 bln in fourth quarter Jan 16 AT&T; Inc said it expected to record charges of about $10 billion for the fourth quarter but the non-cash losses would not affect operating results.    AT&T; appoints Arroyo as Iusacell CEO in MexicoSprint says Obama net neutrality plan wouldn't curb investmentsAT&T; estimates charges of $10 bln in fourth quarter Jan 16 AT&T; Inc said it expected to record charges of about $10 billion for the fourth quarter but the non-cash losses would not affect operating results.  AT&T; estimates charges of $10 bln in fourth quarter Jan 16 AT&T; Inc said it expected to record charges of about $10 billion for the fourth quarter but the non-cash losses would not affect operating results. WASHINGTON Sprint Corp will keep investing in its networks even if U.S. regulators adopt stricter "net neutrality" rules as long as they are applied with a "light touch," the company said in a letter to the FCC released on Friday. | AT&T; estimates charges of $10 bln in fourth quarter Jan 16 AT&T; Inc said it expected to record charges of about $10 billion for the fourth quarter but the non-cash losses would not affect operating results. VideoAT&T; estimates charges of $10 bln in fourth quarter Jan 16 AT&T; Inc said it expected to record charges of about $10 billion for the fourth quarter but the non-cash losses would not affect operating results.  AT&T; estimates charges of $10 bln in fourth quarter Jan 16 AT&T; Inc said it expected to record charges of about $10 billion for the fourth quarter but the non-cash losses would not affect operating results.   Sprint says Obama net neutrality plan wouldn't curb investmentsAT&T; estimates charges of $10 bln in fourth quarter Jan 16 AT&T; Inc said it expected to record charges of about $10 billion for the fourth quarter but the non-cash losses would not affect operating results.  AT&T; estimates charges of $10 bln in fourth quarter Jan 16 AT&T; Inc said it expected to record charges of about $10 billion for the fourth quarter but the non-cash losses would not affect operating results. WASHINGTON Sprint Corp will keep investing in its networks even if U.S. regulators adopt stricter "net neutrality" rules as long as they are applied with a "light touch," the company said in a letter to the FCC released on Friday. | AT&T; estimates charges of $10 bln in fourth quarter Jan 16 AT&T; Inc said it expected to record charges of about $10 billion for the fourth quarter but the non-cash losses would not affect operating results. VideoAT&T; estimates charges of $10 bln in fourth quarter Jan 16 AT&T; Inc said it expected to record charges of about $10 billion for the fourth quarter but the non-cash losses would not affect operating results.  AT&T; estimates charges of $10 bln in fourth quarter Jan 16 AT&T; Inc said it expected to record charges of about $10 billion for the fourth quarter but the non-cash losses would not affect operating results.  MEXICO CITY AT&T; said on Friday it had appointed company veteran F. Thaddeus Arroyo as the chief executive of Iusacell, Mexico's No.3 wireless carrier which it recently bought.Sprint says Obama net neutrality plan wouldn't curb investmentsAT&T; estimates charges of $10 bln in fourth quarter Jan 16 AT&T; Inc said it expected to record charges of about $10 billion for the fourth quarter but the non-cash losses would not affect operating results.  AT&T; estimates charges of $10 bln in fourth quarter Jan 16 AT&T; Inc said it expected to record charges of about $10 billion for the fourth quarter but the non-cash losses would not affect operating results. WASHINGTON Sprint Corp will keep investing in its networks even if U.S. regulators adopt stricter "net neutrality" rules as long as they are applied with a "light touch," the company said in a letter to the FCC released on Friday. | AT&T; estimates charges of $10 bln in fourth quarter Jan 16 AT&T; Inc said it expected to record charges of about $10 billion for the fourth quarter but the non-cash losses would not affect operating results. VideoAT&T; estimates charges of $10 bln in fourth quarter Jan 16 AT&T; Inc said it expected to record charges of about $10 billion for the fourth quarter but the non-cash losses would not affect operating results.  AT&T; estimates charges of $10 bln in fourth quarter Jan 16 AT&T; Inc said it expected to record charges of about $10 billion for the fourth quarter but the non-cash losses would not affect operating results.   MEXICO CITY, Jan 16 AT&T; said on Friday it had appointed company veteran F. Thaddeus Arroyo as the chief executive of Iusacell, Mexico's No.3 wireless carrier which it recently bought.AT&T; appoints Arroyo as Iusacell CEO in MexicoSprint says Obama net neutrality plan wouldn't curb investmentsAT&T; estimates charges of $10 bln in fourth quarter Jan 16 AT&T; Inc said it expected to record charges of about $10 billion for the fourth quarter but the non-cash losses would not affect operating results.  AT&T; estimates charges of $10 bln in fourth quarter Jan 16 AT&T; Inc said it expected to record charges of about $10 billion for the fourth quarter but the non-cash losses would not affect operating results. WASHINGTON Sprint Corp will keep investing in its networks even if U.S. regulators adopt stricter "net neutrality" rules as long as they are applied with a "light touch," the company said in a letter to the FCC released on Friday. | AT&T; estimates charges of $10 bln in fourth quarter Jan 16 AT&T; Inc said it expected to record charges of about $10 billion for the fourth quarter but the non-cash losses would not affect operating results. VideoAT&T; estimates charges of $10 bln in fourth quarter Jan 16 AT&T; Inc said it expected to record charges of about $10 billion for the fourth quarter but the non-cash losses would not affect operating results.  AT&T; estimates charges of $10 bln in fourth quarter Jan 16 AT&T; Inc said it expected to record charges of about $10 billion for the fourth quarter but the non-cash losses would not affect operating results.   Sprint says Obama net neutrality plan wouldn't curb investmentsAT&T; estimates charges of $10 bln in fourth quarter Jan 16 AT&T; Inc said it expected to record charges of about $10 billion for the fourth quarter but the non-cash losses would not affect operating results.  AT&T; estimates charges of $10 bln in fourth quarter Jan 16 AT&T; Inc said it expected to record charges of about $10 billion for the fourth quarter but the non-cash losses would not affect operating results. WASHINGTON Sprint Corp will keep investing in its networks even if U.S. regulators adopt stricter "net neutrality" rules as long as they are applied with a "light touch," the company said in a letter to the FCC released on Friday. | AT&T; estimates charges of $10 bln in fourth quarter Jan 16 AT&T; Inc said it expected to record charges of about $10 billion for the fourth quarter but the non-cash losses would not affect operating results. VideoAT&T; estimates charges of $10 bln in fourth quarter Jan 16 AT&T; Inc said it expected to record charges of about $10 billion for the fourth quarter but the non-cash losses would not affect operating results.  AT&T; estimates charges of $10 bln in fourth quarter Jan 16 AT&T; Inc said it expected to record charges of about $10 billion for the fourth quarter but the non-cash losses would not affect operating results.  MEXICO CITY AT&T; said on Friday it had appointed company veteran F. Thaddeus Arroyo as the chief executive of Iusacell, Mexico's No.3 wireless carrier which it recently bought.Sprint says Obama net neutrality plan wouldn't curb investmentsAT&T; estimates charges of $10 bln in fourth quarter Jan 16 AT&T; Inc said it expected to record charges of about $10 billion for the fourth quarter but the non-cash losses would not affect operating results.  AT&T; estimates charges of $10 bln in fourth quarter Jan 16 AT&T; Inc said it expected to record charges of about $10 billion for the fourth quarter but the non-cash losses would not affect operating results. WASHINGTON Sprint Corp will keep investing in its networks even if U.S. regulators adopt stricter "net neutrality" rules as long as they are applied with a "light touch," the company said in a letter to the FCC released on Friday. | AT&T; estimates charges of $10 bln in fourth quarter Jan 16 AT&T; Inc said it expected to record charges of about $10 billion for the fourth quarter but the non-cash losses would not affect operating results. VideoAT&T; estimates charges of $10 bln in fourth quarter Jan 16 AT&T; Inc said it expected to record charges of about $10 billion for the fourth quarter but the non-cash losses would not affect operating results.  AT&T; estimates charges of $10 bln in fourth quarter Jan 16 AT&T; Inc said it expected to record charges of about $10 billion for the fourth quarter but the non-cash losses would not affect operating results.    
BHI,ValueAct buys 5.1 pct stake in Baker Hughes Jan 16 Activist hedge fund ValueAct Capital disclosed a 5.1 percent stake in Baker Hughes Inc, the world's No. 3 oilfield services company that has agreed to be bought by bigger rival Halliburton Co for $35 billion in cash and stock. 
BBY,UPDATE 3-Best Buy expects no same-store sales growth in next six months * Stock falls as much as 16 pct   (Adds analyst's comment, details on RadioShack bankruptcy, updates shares) 
CBS,UPDATE 2-Dish reaches deal that brings back Fox news, business channels LOS ANGELES, Jan 15 The Fox News and Fox Business channels returned on Thursday to satellite TV provider Dish Network Corp's lineup after both sides agreed to a multiyear deal. 
SCHW,UPDATE 1-Schwab quarterly profit grows on higher interest revenue Jan 16 Charles Schwab Corp reported earnings of $350 million in the last quarter of 2014 as higher interest income and $33 billion of new client assets supplemented modest gains in client trading revenue during a bullish quarter for stocks. 
CVX,REFILE-Indonesia scraps land tax on oil and gas exploration JAKARTA, Jan 16 Indonesia has scrapped a land tax that companies pay while exploring for oil and gas, a move that might encourage exploration at a time of concern that it could fall sharply due to tumbling oil prices. 
C,Fitch: Citi's 4Q'14 Results Cap Off a Disappointing YearCiti lost more than $150 mln on currency swings - Bloomberg Jan 16 Citigroup Inc, the world's biggest currencies dealer, lost more than $150 million after the Swiss central bank decided to let the franc trade freely against the euro, Bloomberg reported.  Citi lost more than $150 mln on currency swings - Bloomberg Jan 16 Citigroup Inc, the world's biggest currencies dealer, lost more than $150 million after the Swiss central bank decided to let the franc trade freely against the euro, Bloomberg reported. (The following statement was released by the rating agency) CHICAGO, January 16 (Fitch) Citigroup's (Citi) fourth quarter 2014 (4Q'14)  results reflect the ongoing drag of legal-related charges on the company, and  the difficult operating environment. Excluding the impact of CVA/DVA during all  periods, Citi's adjusted return on assets (ROA) was just 7 basis points (bps) in  4Q'14, and 40bps for the year, well below next year's targets of 90bps to  110bps. The full-year ROA improves to 59bps wheCiti lost more than $150 mln on currency swings - Bloomberg Jan 16 Citigroup Inc, the world's biggest currencies dealer, lost more than $150 million after the Swiss central bank decided to let the franc trade freely against the euro, Bloomberg reported.  
XOM,REFILE-Indonesia scraps land tax on oil and gas exploration JAKARTA, Jan 16 Indonesia has scrapped a land tax that companies pay while exploring for oil and gas, a move that might encourage exploration at a time of concern that it could fall sharply due to tumbling oil prices. 
GE,REFILE-EXCLUSIVE-GE finances first A350 powered by rival Rolls-Royce PARIS, Jan 16 When the Airbus A350 jet made its commercial debut with Qatar Airways this week, the event marked a milestone for engine supplier Rolls-Royce, but slipping unnoticed under the radar with financing was its arch-rival General Electric. 
GILD,Gilead to appeal India patent ruling on hepatitis C drugGilead to appeal India patent ruling on hepatitis C drugAetna backs Gilead's hepatitis C treatment and gets discountCORRECTED (OFFICIAL)-Aetna backs Gilead's hepatitis C treatment, gets discountCORRECTED (OFFICIAL)-Aetna backs Gilead's hepatitis C treatment, gets discountREFILE-Aetna backs Gilead's hepatitis C treatment, gets discountUPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers. Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.   REFILE-Aetna backs Gilead's hepatitis C treatment, gets discountUPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers. Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to its nearly 11 million commercial customers.REFILE-Aetna backs Gilead's hepatitis C treatment, gets discountUPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers. Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.    CORRECTED (OFFICIAL)-Aetna backs Gilead's hepatitis C treatment, gets discountREFILE-Aetna backs Gilead's hepatitis C treatment, gets discountUPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers. Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.   REFILE-Aetna backs Gilead's hepatitis C treatment, gets discountUPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers. Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to its nearly 11 million commercial customers.REFILE-Aetna backs Gilead's hepatitis C treatment, gets discountUPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers. Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.   Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to its nearly 11 million commercial customers.CORRECTED (OFFICIAL)-Aetna backs Gilead's hepatitis C treatment, gets discountREFILE-Aetna backs Gilead's hepatitis C treatment, gets discountUPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers. Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.   REFILE-Aetna backs Gilead's hepatitis C treatment, gets discountUPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers. Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to its nearly 11 million commercial customers.REFILE-Aetna backs Gilead's hepatitis C treatment, gets discountUPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers. Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.     CORRECTED (OFFICIAL)-Aetna backs Gilead's hepatitis C treatment, gets discountCORRECTED (OFFICIAL)-Aetna backs Gilead's hepatitis C treatment, gets discountREFILE-Aetna backs Gilead's hepatitis C treatment, gets discountUPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers. Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.   REFILE-Aetna backs Gilead's hepatitis C treatment, gets discountUPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers. Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to its nearly 11 million commercial customers.REFILE-Aetna backs Gilead's hepatitis C treatment, gets discountUPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers. Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.    CORRECTED (OFFICIAL)-Aetna backs Gilead's hepatitis C treatment, gets discountREFILE-Aetna backs Gilead's hepatitis C treatment, gets discountUPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers. Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.   REFILE-Aetna backs Gilead's hepatitis C treatment, gets discountUPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers. Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to its nearly 11 million commercial customers.REFILE-Aetna backs Gilead's hepatitis C treatment, gets discountUPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers. Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.   Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to its nearly 11 million commercial customers.CORRECTED (OFFICIAL)-Aetna backs Gilead's hepatitis C treatment, gets discountREFILE-Aetna backs Gilead's hepatitis C treatment, gets discountUPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers. Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.   REFILE-Aetna backs Gilead's hepatitis C treatment, gets discountUPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers. Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to its nearly 11 million commercial customers.REFILE-Aetna backs Gilead's hepatitis C treatment, gets discountUPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers. Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.    Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to its nearly 20 million commercial customers.CORRECTED (OFFICIAL)-Aetna backs Gilead's hepatitis C treatment, gets discountCORRECTED (OFFICIAL)-Aetna backs Gilead's hepatitis C treatment, gets discountREFILE-Aetna backs Gilead's hepatitis C treatment, gets discountUPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers. Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.   REFILE-Aetna backs Gilead's hepatitis C treatment, gets discountUPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers. Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to its nearly 11 million commercial customers.REFILE-Aetna backs Gilead's hepatitis C treatment, gets discountUPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers. Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.    CORRECTED (OFFICIAL)-Aetna backs Gilead's hepatitis C treatment, gets discountREFILE-Aetna backs Gilead's hepatitis C treatment, gets discountUPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers. Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.   REFILE-Aetna backs Gilead's hepatitis C treatment, gets discountUPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers. Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to its nearly 11 million commercial customers.REFILE-Aetna backs Gilead's hepatitis C treatment, gets discountUPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers. Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.   Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to its nearly 11 million commercial customers.CORRECTED (OFFICIAL)-Aetna backs Gilead's hepatitis C treatment, gets discountREFILE-Aetna backs Gilead's hepatitis C treatment, gets discountUPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers. Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.   REFILE-Aetna backs Gilead's hepatitis C treatment, gets discountUPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers. Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to its nearly 11 million commercial customers.REFILE-Aetna backs Gilead's hepatitis C treatment, gets discountUPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers. Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.      Aetna backs Gilead's hepatitis C treatment and gets discountCORRECTED (OFFICIAL)-Aetna backs Gilead's hepatitis C treatment, gets discountCORRECTED (OFFICIAL)-Aetna backs Gilead's hepatitis C treatment, gets discountREFILE-Aetna backs Gilead's hepatitis C treatment, gets discountUPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers. Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.   REFILE-Aetna backs Gilead's hepatitis C treatment, gets discountUPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers. Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to its nearly 11 million commercial customers.REFILE-Aetna backs Gilead's hepatitis C treatment, gets discountUPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers. Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.    CORRECTED (OFFICIAL)-Aetna backs Gilead's hepatitis C treatment, gets discountREFILE-Aetna backs Gilead's hepatitis C treatment, gets discountUPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers. Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.   REFILE-Aetna backs Gilead's hepatitis C treatment, gets discountUPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers. Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to its nearly 11 million commercial customers.REFILE-Aetna backs Gilead's hepatitis C treatment, gets discountUPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers. Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.   Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to its nearly 11 million commercial customers.CORRECTED (OFFICIAL)-Aetna backs Gilead's hepatitis C treatment, gets discountREFILE-Aetna backs Gilead's hepatitis C treatment, gets discountUPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers. Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.   REFILE-Aetna backs Gilead's hepatitis C treatment, gets discountUPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers. Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to its nearly 11 million commercial customers.REFILE-Aetna backs Gilead's hepatitis C treatment, gets discountUPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers. Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.     CORRECTED (OFFICIAL)-Aetna backs Gilead's hepatitis C treatment, gets discountCORRECTED (OFFICIAL)-Aetna backs Gilead's hepatitis C treatment, gets discountREFILE-Aetna backs Gilead's hepatitis C treatment, gets discountUPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers. Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.   REFILE-Aetna backs Gilead's hepatitis C treatment, gets discountUPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers. Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to its nearly 11 million commercial customers.REFILE-Aetna backs Gilead's hepatitis C treatment, gets discountUPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers. Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.    CORRECTED (OFFICIAL)-Aetna backs Gilead's hepatitis C treatment, gets discountREFILE-Aetna backs Gilead's hepatitis C treatment, gets discountUPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers. Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.   REFILE-Aetna backs Gilead's hepatitis C treatment, gets discountUPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers. Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to its nearly 11 million commercial customers.REFILE-Aetna backs Gilead's hepatitis C treatment, gets discountUPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers. Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.   Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to its nearly 11 million commercial customers.CORRECTED (OFFICIAL)-Aetna backs Gilead's hepatitis C treatment, gets discountREFILE-Aetna backs Gilead's hepatitis C treatment, gets discountUPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers. Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.   REFILE-Aetna backs Gilead's hepatitis C treatment, gets discountUPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers. Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to its nearly 11 million commercial customers.REFILE-Aetna backs Gilead's hepatitis C treatment, gets discountUPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers. Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.    Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to its nearly 20 million commercial customers.CORRECTED (OFFICIAL)-Aetna backs Gilead's hepatitis C treatment, gets discountCORRECTED (OFFICIAL)-Aetna backs Gilead's hepatitis C treatment, gets discountREFILE-Aetna backs Gilead's hepatitis C treatment, gets discountUPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers. Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.   REFILE-Aetna backs Gilead's hepatitis C treatment, gets discountUPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers. Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to its nearly 11 million commercial customers.REFILE-Aetna backs Gilead's hepatitis C treatment, gets discountUPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers. Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.    CORRECTED (OFFICIAL)-Aetna backs Gilead's hepatitis C treatment, gets discountREFILE-Aetna backs Gilead's hepatitis C treatment, gets discountUPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers. Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.   REFILE-Aetna backs Gilead's hepatitis C treatment, gets discountUPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers. Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to its nearly 11 million commercial customers.REFILE-Aetna backs Gilead's hepatitis C treatment, gets discountUPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers. Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.   Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to its nearly 11 million commercial customers.CORRECTED (OFFICIAL)-Aetna backs Gilead's hepatitis C treatment, gets discountREFILE-Aetna backs Gilead's hepatitis C treatment, gets discountUPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers. Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.   REFILE-Aetna backs Gilead's hepatitis C treatment, gets discountUPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers. Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to its nearly 11 million commercial customers.REFILE-Aetna backs Gilead's hepatitis C treatment, gets discountUPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers. Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.     MUMBAI U.S.-based Gilead Sciences Inc  will appeal the Indian patent office's rejection of its application for hepatitis C drug Sovaldi, a move that could allow local drugmakers to launch cheaper generic versions of the $1,000-a-pill medicine.Aetna backs Gilead's hepatitis C treatment and gets discountCORRECTED (OFFICIAL)-Aetna backs Gilead's hepatitis C treatment, gets discountCORRECTED (OFFICIAL)-Aetna backs Gilead's hepatitis C treatment, gets discountREFILE-Aetna backs Gilead's hepatitis C treatment, gets discountUPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers. Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.   REFILE-Aetna backs Gilead's hepatitis C treatment, gets discountUPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers. Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to its nearly 11 million commercial customers.REFILE-Aetna backs Gilead's hepatitis C treatment, gets discountUPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers. Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.    CORRECTED (OFFICIAL)-Aetna backs Gilead's hepatitis C treatment, gets discountREFILE-Aetna backs Gilead's hepatitis C treatment, gets discountUPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers. Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.   REFILE-Aetna backs Gilead's hepatitis C treatment, gets discountUPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers. Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to its nearly 11 million commercial customers.REFILE-Aetna backs Gilead's hepatitis C treatment, gets discountUPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers. Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.   Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to its nearly 11 million commercial customers.CORRECTED (OFFICIAL)-Aetna backs Gilead's hepatitis C treatment, gets discountREFILE-Aetna backs Gilead's hepatitis C treatment, gets discountUPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers. Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.   REFILE-Aetna backs Gilead's hepatitis C treatment, gets discountUPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers. Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to its nearly 11 million commercial customers.REFILE-Aetna backs Gilead's hepatitis C treatment, gets discountUPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers. Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.     CORRECTED (OFFICIAL)-Aetna backs Gilead's hepatitis C treatment, gets discountCORRECTED (OFFICIAL)-Aetna backs Gilead's hepatitis C treatment, gets discountREFILE-Aetna backs Gilead's hepatitis C treatment, gets discountUPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers. Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.   REFILE-Aetna backs Gilead's hepatitis C treatment, gets discountUPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers. Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to its nearly 11 million commercial customers.REFILE-Aetna backs Gilead's hepatitis C treatment, gets discountUPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers. Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.    CORRECTED (OFFICIAL)-Aetna backs Gilead's hepatitis C treatment, gets discountREFILE-Aetna backs Gilead's hepatitis C treatment, gets discountUPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers. Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.   REFILE-Aetna backs Gilead's hepatitis C treatment, gets discountUPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers. Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to its nearly 11 million commercial customers.REFILE-Aetna backs Gilead's hepatitis C treatment, gets discountUPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers. Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.   Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to its nearly 11 million commercial customers.CORRECTED (OFFICIAL)-Aetna backs Gilead's hepatitis C treatment, gets discountREFILE-Aetna backs Gilead's hepatitis C treatment, gets discountUPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers. Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.   REFILE-Aetna backs Gilead's hepatitis C treatment, gets discountUPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers. Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to its nearly 11 million commercial customers.REFILE-Aetna backs Gilead's hepatitis C treatment, gets discountUPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers. Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.    Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to its nearly 20 million commercial customers.CORRECTED (OFFICIAL)-Aetna backs Gilead's hepatitis C treatment, gets discountCORRECTED (OFFICIAL)-Aetna backs Gilead's hepatitis C treatment, gets discountREFILE-Aetna backs Gilead's hepatitis C treatment, gets discountUPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers. Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.   REFILE-Aetna backs Gilead's hepatitis C treatment, gets discountUPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers. Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to its nearly 11 million commercial customers.REFILE-Aetna backs Gilead's hepatitis C treatment, gets discountUPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers. Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.    CORRECTED (OFFICIAL)-Aetna backs Gilead's hepatitis C treatment, gets discountREFILE-Aetna backs Gilead's hepatitis C treatment, gets discountUPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers. Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.   REFILE-Aetna backs Gilead's hepatitis C treatment, gets discountUPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers. Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to its nearly 11 million commercial customers.REFILE-Aetna backs Gilead's hepatitis C treatment, gets discountUPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers. Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.   Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to its nearly 11 million commercial customers.CORRECTED (OFFICIAL)-Aetna backs Gilead's hepatitis C treatment, gets discountREFILE-Aetna backs Gilead's hepatitis C treatment, gets discountUPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers. Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.   REFILE-Aetna backs Gilead's hepatitis C treatment, gets discountUPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers. Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to its nearly 11 million commercial customers.REFILE-Aetna backs Gilead's hepatitis C treatment, gets discountUPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers. Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.       Gilead to appeal India patent ruling on hepatitis C drugAetna backs Gilead's hepatitis C treatment and gets discountCORRECTED (OFFICIAL)-Aetna backs Gilead's hepatitis C treatment, gets discountCORRECTED (OFFICIAL)-Aetna backs Gilead's hepatitis C treatment, gets discountREFILE-Aetna backs Gilead's hepatitis C treatment, gets discountUPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers. Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.   REFILE-Aetna backs Gilead's hepatitis C treatment, gets discountUPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers. Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to its nearly 11 million commercial customers.REFILE-Aetna backs Gilead's hepatitis C treatment, gets discountUPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers. Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.    CORRECTED (OFFICIAL)-Aetna backs Gilead's hepatitis C treatment, gets discountREFILE-Aetna backs Gilead's hepatitis C treatment, gets discountUPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers. Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.   REFILE-Aetna backs Gilead's hepatitis C treatment, gets discountUPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers. Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to its nearly 11 million commercial customers.REFILE-Aetna backs Gilead's hepatitis C treatment, gets discountUPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers. Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.   Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to its nearly 11 million commercial customers.CORRECTED (OFFICIAL)-Aetna backs Gilead's hepatitis C treatment, gets discountREFILE-Aetna backs Gilead's hepatitis C treatment, gets discountUPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers. Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.   REFILE-Aetna backs Gilead's hepatitis C treatment, gets discountUPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers. Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to its nearly 11 million commercial customers.REFILE-Aetna backs Gilead's hepatitis C treatment, gets discountUPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers. Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.     CORRECTED (OFFICIAL)-Aetna backs Gilead's hepatitis C treatment, gets discountCORRECTED (OFFICIAL)-Aetna backs Gilead's hepatitis C treatment, gets discountREFILE-Aetna backs Gilead's hepatitis C treatment, gets discountUPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers. Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.   REFILE-Aetna backs Gilead's hepatitis C treatment, gets discountUPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers. Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to its nearly 11 million commercial customers.REFILE-Aetna backs Gilead's hepatitis C treatment, gets discountUPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers. Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.    CORRECTED (OFFICIAL)-Aetna backs Gilead's hepatitis C treatment, gets discountREFILE-Aetna backs Gilead's hepatitis C treatment, gets discountUPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers. Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.   REFILE-Aetna backs Gilead's hepatitis C treatment, gets discountUPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers. Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to its nearly 11 million commercial customers.REFILE-Aetna backs Gilead's hepatitis C treatment, gets discountUPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers. Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.   Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to its nearly 11 million commercial customers.CORRECTED (OFFICIAL)-Aetna backs Gilead's hepatitis C treatment, gets discountREFILE-Aetna backs Gilead's hepatitis C treatment, gets discountUPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers. Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.   REFILE-Aetna backs Gilead's hepatitis C treatment, gets discountUPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers. Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to its nearly 11 million commercial customers.REFILE-Aetna backs Gilead's hepatitis C treatment, gets discountUPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers. Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.    Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to its nearly 20 million commercial customers.CORRECTED (OFFICIAL)-Aetna backs Gilead's hepatitis C treatment, gets discountCORRECTED (OFFICIAL)-Aetna backs Gilead's hepatitis C treatment, gets discountREFILE-Aetna backs Gilead's hepatitis C treatment, gets discountUPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers. Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.   REFILE-Aetna backs Gilead's hepatitis C treatment, gets discountUPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers. Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to its nearly 11 million commercial customers.REFILE-Aetna backs Gilead's hepatitis C treatment, gets discountUPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers. Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.    CORRECTED (OFFICIAL)-Aetna backs Gilead's hepatitis C treatment, gets discountREFILE-Aetna backs Gilead's hepatitis C treatment, gets discountUPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers. Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.   REFILE-Aetna backs Gilead's hepatitis C treatment, gets discountUPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers. Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to its nearly 11 million commercial customers.REFILE-Aetna backs Gilead's hepatitis C treatment, gets discountUPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers. Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.   Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to its nearly 11 million commercial customers.CORRECTED (OFFICIAL)-Aetna backs Gilead's hepatitis C treatment, gets discountREFILE-Aetna backs Gilead's hepatitis C treatment, gets discountUPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers. Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.   REFILE-Aetna backs Gilead's hepatitis C treatment, gets discountUPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers. Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to its nearly 11 million commercial customers.REFILE-Aetna backs Gilead's hepatitis C treatment, gets discountUPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers. Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.      Aetna backs Gilead's hepatitis C treatment and gets discountCORRECTED (OFFICIAL)-Aetna backs Gilead's hepatitis C treatment, gets discountCORRECTED (OFFICIAL)-Aetna backs Gilead's hepatitis C treatment, gets discountREFILE-Aetna backs Gilead's hepatitis C treatment, gets discountUPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers. Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.   REFILE-Aetna backs Gilead's hepatitis C treatment, gets discountUPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers. Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to its nearly 11 million commercial customers.REFILE-Aetna backs Gilead's hepatitis C treatment, gets discountUPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers. Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.    CORRECTED (OFFICIAL)-Aetna backs Gilead's hepatitis C treatment, gets discountREFILE-Aetna backs Gilead's hepatitis C treatment, gets discountUPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers. Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.   REFILE-Aetna backs Gilead's hepatitis C treatment, gets discountUPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers. Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to its nearly 11 million commercial customers.REFILE-Aetna backs Gilead's hepatitis C treatment, gets discountUPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers. Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.   Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to its nearly 11 million commercial customers.CORRECTED (OFFICIAL)-Aetna backs Gilead's hepatitis C treatment, gets discountREFILE-Aetna backs Gilead's hepatitis C treatment, gets discountUPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers. Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.   REFILE-Aetna backs Gilead's hepatitis C treatment, gets discountUPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers. Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to its nearly 11 million commercial customers.REFILE-Aetna backs Gilead's hepatitis C treatment, gets discountUPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers. Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.     CORRECTED (OFFICIAL)-Aetna backs Gilead's hepatitis C treatment, gets discountCORRECTED (OFFICIAL)-Aetna backs Gilead's hepatitis C treatment, gets discountREFILE-Aetna backs Gilead's hepatitis C treatment, gets discountUPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers. Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.   REFILE-Aetna backs Gilead's hepatitis C treatment, gets discountUPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers. Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to its nearly 11 million commercial customers.REFILE-Aetna backs Gilead's hepatitis C treatment, gets discountUPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers. Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.    CORRECTED (OFFICIAL)-Aetna backs Gilead's hepatitis C treatment, gets discountREFILE-Aetna backs Gilead's hepatitis C treatment, gets discountUPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers. Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.   REFILE-Aetna backs Gilead's hepatitis C treatment, gets discountUPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers. Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to its nearly 11 million commercial customers.REFILE-Aetna backs Gilead's hepatitis C treatment, gets discountUPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers. Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.   Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to its nearly 11 million commercial customers.CORRECTED (OFFICIAL)-Aetna backs Gilead's hepatitis C treatment, gets discountREFILE-Aetna backs Gilead's hepatitis C treatment, gets discountUPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers. Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.   REFILE-Aetna backs Gilead's hepatitis C treatment, gets discountUPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers. Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to its nearly 11 million commercial customers.REFILE-Aetna backs Gilead's hepatitis C treatment, gets discountUPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers. Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.    Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to its nearly 20 million commercial customers.CORRECTED (OFFICIAL)-Aetna backs Gilead's hepatitis C treatment, gets discountCORRECTED (OFFICIAL)-Aetna backs Gilead's hepatitis C treatment, gets discountREFILE-Aetna backs Gilead's hepatitis C treatment, gets discountUPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers. Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.   REFILE-Aetna backs Gilead's hepatitis C treatment, gets discountUPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers. Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to its nearly 11 million commercial customers.REFILE-Aetna backs Gilead's hepatitis C treatment, gets discountUPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers. Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.    CORRECTED (OFFICIAL)-Aetna backs Gilead's hepatitis C treatment, gets discountREFILE-Aetna backs Gilead's hepatitis C treatment, gets discountUPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers. Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.   REFILE-Aetna backs Gilead's hepatitis C treatment, gets discountUPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers. Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to its nearly 11 million commercial customers.REFILE-Aetna backs Gilead's hepatitis C treatment, gets discountUPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers. Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.   Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to its nearly 11 million commercial customers.CORRECTED (OFFICIAL)-Aetna backs Gilead's hepatitis C treatment, gets discountREFILE-Aetna backs Gilead's hepatitis C treatment, gets discountUPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers. Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.   REFILE-Aetna backs Gilead's hepatitis C treatment, gets discountUPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers. Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to its nearly 11 million commercial customers.REFILE-Aetna backs Gilead's hepatitis C treatment, gets discountUPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers. Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.     MUMBAI U.S.-based Gilead Sciences Inc  will appeal the Indian patent office's rejection of its application for hepatitis C drug Sovaldi, a move that could allow local drugmakers to launch cheaper generic versions of the $1,000-a-pill medicine.Aetna backs Gilead's hepatitis C treatment and gets discountCORRECTED (OFFICIAL)-Aetna backs Gilead's hepatitis C treatment, gets discountCORRECTED (OFFICIAL)-Aetna backs Gilead's hepatitis C treatment, gets discountREFILE-Aetna backs Gilead's hepatitis C treatment, gets discountUPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers. Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.   REFILE-Aetna backs Gilead's hepatitis C treatment, gets discountUPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers. Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to its nearly 11 million commercial customers.REFILE-Aetna backs Gilead's hepatitis C treatment, gets discountUPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers. Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.    CORRECTED (OFFICIAL)-Aetna backs Gilead's hepatitis C treatment, gets discountREFILE-Aetna backs Gilead's hepatitis C treatment, gets discountUPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers. Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.   REFILE-Aetna backs Gilead's hepatitis C treatment, gets discountUPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers. Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to its nearly 11 million commercial customers.REFILE-Aetna backs Gilead's hepatitis C treatment, gets discountUPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers. Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.   Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to its nearly 11 million commercial customers.CORRECTED (OFFICIAL)-Aetna backs Gilead's hepatitis C treatment, gets discountREFILE-Aetna backs Gilead's hepatitis C treatment, gets discountUPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers. Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.   REFILE-Aetna backs Gilead's hepatitis C treatment, gets discountUPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers. Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to its nearly 11 million commercial customers.REFILE-Aetna backs Gilead's hepatitis C treatment, gets discountUPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers. Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.     CORRECTED (OFFICIAL)-Aetna backs Gilead's hepatitis C treatment, gets discountCORRECTED (OFFICIAL)-Aetna backs Gilead's hepatitis C treatment, gets discountREFILE-Aetna backs Gilead's hepatitis C treatment, gets discountUPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers. Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.   REFILE-Aetna backs Gilead's hepatitis C treatment, gets discountUPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers. Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to its nearly 11 million commercial customers.REFILE-Aetna backs Gilead's hepatitis C treatment, gets discountUPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers. Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.    CORRECTED (OFFICIAL)-Aetna backs Gilead's hepatitis C treatment, gets discountREFILE-Aetna backs Gilead's hepatitis C treatment, gets discountUPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers. Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.   REFILE-Aetna backs Gilead's hepatitis C treatment, gets discountUPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers. Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to its nearly 11 million commercial customers.REFILE-Aetna backs Gilead's hepatitis C treatment, gets discountUPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers. Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.   Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to its nearly 11 million commercial customers.CORRECTED (OFFICIAL)-Aetna backs Gilead's hepatitis C treatment, gets discountREFILE-Aetna backs Gilead's hepatitis C treatment, gets discountUPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers. Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.   REFILE-Aetna backs Gilead's hepatitis C treatment, gets discountUPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers. Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to its nearly 11 million commercial customers.REFILE-Aetna backs Gilead's hepatitis C treatment, gets discountUPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers. Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.    Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to its nearly 20 million commercial customers.CORRECTED (OFFICIAL)-Aetna backs Gilead's hepatitis C treatment, gets discountCORRECTED (OFFICIAL)-Aetna backs Gilead's hepatitis C treatment, gets discountREFILE-Aetna backs Gilead's hepatitis C treatment, gets discountUPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers. Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.   REFILE-Aetna backs Gilead's hepatitis C treatment, gets discountUPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers. Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to its nearly 11 million commercial customers.REFILE-Aetna backs Gilead's hepatitis C treatment, gets discountUPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers. Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.    CORRECTED (OFFICIAL)-Aetna backs Gilead's hepatitis C treatment, gets discountREFILE-Aetna backs Gilead's hepatitis C treatment, gets discountUPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers. Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.   REFILE-Aetna backs Gilead's hepatitis C treatment, gets discountUPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers. Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to its nearly 11 million commercial customers.REFILE-Aetna backs Gilead's hepatitis C treatment, gets discountUPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers. Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.   Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to its nearly 11 million commercial customers.CORRECTED (OFFICIAL)-Aetna backs Gilead's hepatitis C treatment, gets discountREFILE-Aetna backs Gilead's hepatitis C treatment, gets discountUPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers. Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.   REFILE-Aetna backs Gilead's hepatitis C treatment, gets discountUPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers. Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to its nearly 11 million commercial customers.REFILE-Aetna backs Gilead's hepatitis C treatment, gets discountUPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers. Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.      MUMBAI, Jan 16 U.S.-based Gilead Sciences Inc  will appeal the Indian patent office's rejection of its application for hepatitis C drug Sovaldi, a move that could allow local drugmakers to launch cheaper generic versions of the $1,000-a-pill medicine.Gilead to appeal India patent ruling on hepatitis C drugAetna backs Gilead's hepatitis C treatment and gets discountCORRECTED (OFFICIAL)-Aetna backs Gilead's hepatitis C treatment, gets discountCORRECTED (OFFICIAL)-Aetna backs Gilead's hepatitis C treatment, gets discountREFILE-Aetna backs Gilead's hepatitis C treatment, gets discountUPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers. Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.   REFILE-Aetna backs Gilead's hepatitis C treatment, gets discountUPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers. Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to its nearly 11 million commercial customers.REFILE-Aetna backs Gilead's hepatitis C treatment, gets discountUPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers. Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.    CORRECTED (OFFICIAL)-Aetna backs Gilead's hepatitis C treatment, gets discountREFILE-Aetna backs Gilead's hepatitis C treatment, gets discountUPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers. Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.   REFILE-Aetna backs Gilead's hepatitis C treatment, gets discountUPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers. Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to its nearly 11 million commercial customers.REFILE-Aetna backs Gilead's hepatitis C treatment, gets discountUPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers. Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.   Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to its nearly 11 million commercial customers.CORRECTED (OFFICIAL)-Aetna backs Gilead's hepatitis C treatment, gets discountREFILE-Aetna backs Gilead's hepatitis C treatment, gets discountUPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers. Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.   REFILE-Aetna backs Gilead's hepatitis C treatment, gets discountUPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers. Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to its nearly 11 million commercial customers.REFILE-Aetna backs Gilead's hepatitis C treatment, gets discountUPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers. Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.     CORRECTED (OFFICIAL)-Aetna backs Gilead's hepatitis C treatment, gets discountCORRECTED (OFFICIAL)-Aetna backs Gilead's hepatitis C treatment, gets discountREFILE-Aetna backs Gilead's hepatitis C treatment, gets discountUPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers. Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.   REFILE-Aetna backs Gilead's hepatitis C treatment, gets discountUPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers. Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to its nearly 11 million commercial customers.REFILE-Aetna backs Gilead's hepatitis C treatment, gets discountUPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers. Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.    CORRECTED (OFFICIAL)-Aetna backs Gilead's hepatitis C treatment, gets discountREFILE-Aetna backs Gilead's hepatitis C treatment, gets discountUPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers. Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.   REFILE-Aetna backs Gilead's hepatitis C treatment, gets discountUPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers. Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to its nearly 11 million commercial customers.REFILE-Aetna backs Gilead's hepatitis C treatment, gets discountUPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers. Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.   Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to its nearly 11 million commercial customers.CORRECTED (OFFICIAL)-Aetna backs Gilead's hepatitis C treatment, gets discountREFILE-Aetna backs Gilead's hepatitis C treatment, gets discountUPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers. Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.   REFILE-Aetna backs Gilead's hepatitis C treatment, gets discountUPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers. Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to its nearly 11 million commercial customers.REFILE-Aetna backs Gilead's hepatitis C treatment, gets discountUPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers. Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.    Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to its nearly 20 million commercial customers.CORRECTED (OFFICIAL)-Aetna backs Gilead's hepatitis C treatment, gets discountCORRECTED (OFFICIAL)-Aetna backs Gilead's hepatitis C treatment, gets discountREFILE-Aetna backs Gilead's hepatitis C treatment, gets discountUPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers. Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.   REFILE-Aetna backs Gilead's hepatitis C treatment, gets discountUPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers. Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to its nearly 11 million commercial customers.REFILE-Aetna backs Gilead's hepatitis C treatment, gets discountUPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers. Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.    CORRECTED (OFFICIAL)-Aetna backs Gilead's hepatitis C treatment, gets discountREFILE-Aetna backs Gilead's hepatitis C treatment, gets discountUPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers. Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.   REFILE-Aetna backs Gilead's hepatitis C treatment, gets discountUPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers. Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to its nearly 11 million commercial customers.REFILE-Aetna backs Gilead's hepatitis C treatment, gets discountUPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers. Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.   Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to its nearly 11 million commercial customers.CORRECTED (OFFICIAL)-Aetna backs Gilead's hepatitis C treatment, gets discountREFILE-Aetna backs Gilead's hepatitis C treatment, gets discountUPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers. Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.   REFILE-Aetna backs Gilead's hepatitis C treatment, gets discountUPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers. Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to its nearly 11 million commercial customers.REFILE-Aetna backs Gilead's hepatitis C treatment, gets discountUPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers. Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.      Aetna backs Gilead's hepatitis C treatment and gets discountCORRECTED (OFFICIAL)-Aetna backs Gilead's hepatitis C treatment, gets discountCORRECTED (OFFICIAL)-Aetna backs Gilead's hepatitis C treatment, gets discountREFILE-Aetna backs Gilead's hepatitis C treatment, gets discountUPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers. Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.   REFILE-Aetna backs Gilead's hepatitis C treatment, gets discountUPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers. Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to its nearly 11 million commercial customers.REFILE-Aetna backs Gilead's hepatitis C treatment, gets discountUPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers. Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.    CORRECTED (OFFICIAL)-Aetna backs Gilead's hepatitis C treatment, gets discountREFILE-Aetna backs Gilead's hepatitis C treatment, gets discountUPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers. Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.   REFILE-Aetna backs Gilead's hepatitis C treatment, gets discountUPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers. Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to its nearly 11 million commercial customers.REFILE-Aetna backs Gilead's hepatitis C treatment, gets discountUPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers. Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.   Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to its nearly 11 million commercial customers.CORRECTED (OFFICIAL)-Aetna backs Gilead's hepatitis C treatment, gets discountREFILE-Aetna backs Gilead's hepatitis C treatment, gets discountUPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers. Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.   REFILE-Aetna backs Gilead's hepatitis C treatment, gets discountUPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers. Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to its nearly 11 million commercial customers.REFILE-Aetna backs Gilead's hepatitis C treatment, gets discountUPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers. Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.     CORRECTED (OFFICIAL)-Aetna backs Gilead's hepatitis C treatment, gets discountCORRECTED (OFFICIAL)-Aetna backs Gilead's hepatitis C treatment, gets discountREFILE-Aetna backs Gilead's hepatitis C treatment, gets discountUPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers. Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.   REFILE-Aetna backs Gilead's hepatitis C treatment, gets discountUPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers. Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to its nearly 11 million commercial customers.REFILE-Aetna backs Gilead's hepatitis C treatment, gets discountUPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers. Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.    CORRECTED (OFFICIAL)-Aetna backs Gilead's hepatitis C treatment, gets discountREFILE-Aetna backs Gilead's hepatitis C treatment, gets discountUPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers. Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.   REFILE-Aetna backs Gilead's hepatitis C treatment, gets discountUPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers. Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to its nearly 11 million commercial customers.REFILE-Aetna backs Gilead's hepatitis C treatment, gets discountUPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers. Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.   Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to its nearly 11 million commercial customers.CORRECTED (OFFICIAL)-Aetna backs Gilead's hepatitis C treatment, gets discountREFILE-Aetna backs Gilead's hepatitis C treatment, gets discountUPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers. Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.   REFILE-Aetna backs Gilead's hepatitis C treatment, gets discountUPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers. Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to its nearly 11 million commercial customers.REFILE-Aetna backs Gilead's hepatitis C treatment, gets discountUPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers. Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.    Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to its nearly 20 million commercial customers.CORRECTED (OFFICIAL)-Aetna backs Gilead's hepatitis C treatment, gets discountCORRECTED (OFFICIAL)-Aetna backs Gilead's hepatitis C treatment, gets discountREFILE-Aetna backs Gilead's hepatitis C treatment, gets discountUPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers. Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.   REFILE-Aetna backs Gilead's hepatitis C treatment, gets discountUPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers. Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to its nearly 11 million commercial customers.REFILE-Aetna backs Gilead's hepatitis C treatment, gets discountUPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers. Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.    CORRECTED (OFFICIAL)-Aetna backs Gilead's hepatitis C treatment, gets discountREFILE-Aetna backs Gilead's hepatitis C treatment, gets discountUPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers. Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.   REFILE-Aetna backs Gilead's hepatitis C treatment, gets discountUPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers. Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to its nearly 11 million commercial customers.REFILE-Aetna backs Gilead's hepatitis C treatment, gets discountUPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers. Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.   Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to its nearly 11 million commercial customers.CORRECTED (OFFICIAL)-Aetna backs Gilead's hepatitis C treatment, gets discountREFILE-Aetna backs Gilead's hepatitis C treatment, gets discountUPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers. Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.   REFILE-Aetna backs Gilead's hepatitis C treatment, gets discountUPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers. Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to its nearly 11 million commercial customers.REFILE-Aetna backs Gilead's hepatitis C treatment, gets discountUPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers. Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.     MUMBAI U.S.-based Gilead Sciences Inc  will appeal the Indian patent office's rejection of its application for hepatitis C drug Sovaldi, a move that could allow local drugmakers to launch cheaper generic versions of the $1,000-a-pill medicine.Aetna backs Gilead's hepatitis C treatment and gets discountCORRECTED (OFFICIAL)-Aetna backs Gilead's hepatitis C treatment, gets discountCORRECTED (OFFICIAL)-Aetna backs Gilead's hepatitis C treatment, gets discountREFILE-Aetna backs Gilead's hepatitis C treatment, gets discountUPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers. Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.   REFILE-Aetna backs Gilead's hepatitis C treatment, gets discountUPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers. Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to its nearly 11 million commercial customers.REFILE-Aetna backs Gilead's hepatitis C treatment, gets discountUPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers. Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.    CORRECTED (OFFICIAL)-Aetna backs Gilead's hepatitis C treatment, gets discountREFILE-Aetna backs Gilead's hepatitis C treatment, gets discountUPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers. Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.   REFILE-Aetna backs Gilead's hepatitis C treatment, gets discountUPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers. Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to its nearly 11 million commercial customers.REFILE-Aetna backs Gilead's hepatitis C treatment, gets discountUPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers. Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.   Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to its nearly 11 million commercial customers.CORRECTED (OFFICIAL)-Aetna backs Gilead's hepatitis C treatment, gets discountREFILE-Aetna backs Gilead's hepatitis C treatment, gets discountUPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers. Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.   REFILE-Aetna backs Gilead's hepatitis C treatment, gets discountUPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers. Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to its nearly 11 million commercial customers.REFILE-Aetna backs Gilead's hepatitis C treatment, gets discountUPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers. Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.     CORRECTED (OFFICIAL)-Aetna backs Gilead's hepatitis C treatment, gets discountCORRECTED (OFFICIAL)-Aetna backs Gilead's hepatitis C treatment, gets discountREFILE-Aetna backs Gilead's hepatitis C treatment, gets discountUPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers. Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.   REFILE-Aetna backs Gilead's hepatitis C treatment, gets discountUPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers. Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to its nearly 11 million commercial customers.REFILE-Aetna backs Gilead's hepatitis C treatment, gets discountUPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers. Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.    CORRECTED (OFFICIAL)-Aetna backs Gilead's hepatitis C treatment, gets discountREFILE-Aetna backs Gilead's hepatitis C treatment, gets discountUPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers. Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.   REFILE-Aetna backs Gilead's hepatitis C treatment, gets discountUPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers. Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to its nearly 11 million commercial customers.REFILE-Aetna backs Gilead's hepatitis C treatment, gets discountUPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers. Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.   Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to its nearly 11 million commercial customers.CORRECTED (OFFICIAL)-Aetna backs Gilead's hepatitis C treatment, gets discountREFILE-Aetna backs Gilead's hepatitis C treatment, gets discountUPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers. Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.   REFILE-Aetna backs Gilead's hepatitis C treatment, gets discountUPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers. Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to its nearly 11 million commercial customers.REFILE-Aetna backs Gilead's hepatitis C treatment, gets discountUPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers. Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.    Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to its nearly 20 million commercial customers.CORRECTED (OFFICIAL)-Aetna backs Gilead's hepatitis C treatment, gets discountCORRECTED (OFFICIAL)-Aetna backs Gilead's hepatitis C treatment, gets discountREFILE-Aetna backs Gilead's hepatitis C treatment, gets discountUPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers. Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.   REFILE-Aetna backs Gilead's hepatitis C treatment, gets discountUPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers. Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to its nearly 11 million commercial customers.REFILE-Aetna backs Gilead's hepatitis C treatment, gets discountUPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers. Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.    CORRECTED (OFFICIAL)-Aetna backs Gilead's hepatitis C treatment, gets discountREFILE-Aetna backs Gilead's hepatitis C treatment, gets discountUPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers. Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.   REFILE-Aetna backs Gilead's hepatitis C treatment, gets discountUPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers. Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to its nearly 11 million commercial customers.REFILE-Aetna backs Gilead's hepatitis C treatment, gets discountUPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers. Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.   Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to its nearly 11 million commercial customers.CORRECTED (OFFICIAL)-Aetna backs Gilead's hepatitis C treatment, gets discountREFILE-Aetna backs Gilead's hepatitis C treatment, gets discountUPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers. Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.   REFILE-Aetna backs Gilead's hepatitis C treatment, gets discountUPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers. Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to its nearly 11 million commercial customers.REFILE-Aetna backs Gilead's hepatitis C treatment, gets discountUPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.  UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers. Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it has negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.UPDATE 2-Aetna backs Gilead's hepatitis C treatment, gets discount Jan 16 Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.       
GS,Goldman profit hit by weaker bond trading, investment bankingUPDATE 5-Goldman Sachs profit hit by weak fixed-income tradingGoldman need not advance ex-programmer's legal fees - U.S. judgeGoldman need not advance ex-programmer's legal fees - U.S. judgeGoldman need not advance ex-programmer's legal fees - U.S. judgeFitch: FICC, Underwriting Weigh on Goldman's 4Q'14 ResultsGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   Goldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  (The following statement was released by the rating agency) NEW YORK, January 16 (Fitch) The Goldman Sachs Group, Inc. (Goldman) reported  relatively weaker net revenue in 4Q'14, with declines in fixed income,  currencies and commodities (FICC) and underwriting outpacing strong performance  in financial advisory and equity sales and trading, according to Fitch Ratings.  While Goldman's overall financial performance was down quarter-over-quarter  (QoQ), consistent with its U.S. global trading andGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.    Fitch: FICC, Underwriting Weigh on Goldman's 4Q'14 ResultsGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   Goldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  (The following statement was released by the rating agency) NEW YORK, January 16 (Fitch) The Goldman Sachs Group, Inc. (Goldman) reported  relatively weaker net revenue in 4Q'14, with declines in fixed income,  currencies and commodities (FICC) and underwriting outpacing strong performance  in financial advisory and equity sales and trading, according to Fitch Ratings.  While Goldman's overall financial performance was down quarter-over-quarter  (QoQ), consistent with its U.S. global trading andGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   A U.S. federal judge on Friday said computer programmer Sergey Aleynikov is not entitled to have former employer Goldman Sachs Group Inc cover his legal fees to defend against criminal charges that he stole secret code from the bank's computers.Fitch: FICC, Underwriting Weigh on Goldman's 4Q'14 ResultsGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   Goldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  (The following statement was released by the rating agency) NEW YORK, January 16 (Fitch) The Goldman Sachs Group, Inc. (Goldman) reported  relatively weaker net revenue in 4Q'14, with declines in fixed income,  currencies and commodities (FICC) and underwriting outpacing strong performance  in financial advisory and equity sales and trading, according to Fitch Ratings.  While Goldman's overall financial performance was down quarter-over-quarter  (QoQ), consistent with its U.S. global trading andGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.     Goldman need not advance ex-programmer's legal fees - U.S. judgeFitch: FICC, Underwriting Weigh on Goldman's 4Q'14 ResultsGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   Goldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  (The following statement was released by the rating agency) NEW YORK, January 16 (Fitch) The Goldman Sachs Group, Inc. (Goldman) reported  relatively weaker net revenue in 4Q'14, with declines in fixed income,  currencies and commodities (FICC) and underwriting outpacing strong performance  in financial advisory and equity sales and trading, according to Fitch Ratings.  While Goldman's overall financial performance was down quarter-over-quarter  (QoQ), consistent with its U.S. global trading andGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.    Fitch: FICC, Underwriting Weigh on Goldman's 4Q'14 ResultsGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   Goldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  (The following statement was released by the rating agency) NEW YORK, January 16 (Fitch) The Goldman Sachs Group, Inc. (Goldman) reported  relatively weaker net revenue in 4Q'14, with declines in fixed income,  currencies and commodities (FICC) and underwriting outpacing strong performance  in financial advisory and equity sales and trading, according to Fitch Ratings.  While Goldman's overall financial performance was down quarter-over-quarter  (QoQ), consistent with its U.S. global trading andGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   A U.S. federal judge on Friday said computer programmer Sergey Aleynikov is not entitled to have former employer Goldman Sachs Group Inc cover his legal fees to defend against criminal charges that he stole secret code from the bank's computers.Fitch: FICC, Underwriting Weigh on Goldman's 4Q'14 ResultsGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   Goldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  (The following statement was released by the rating agency) NEW YORK, January 16 (Fitch) The Goldman Sachs Group, Inc. (Goldman) reported  relatively weaker net revenue in 4Q'14, with declines in fixed income,  currencies and commodities (FICC) and underwriting outpacing strong performance  in financial advisory and equity sales and trading, according to Fitch Ratings.  While Goldman's overall financial performance was down quarter-over-quarter  (QoQ), consistent with its U.S. global trading andGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.    A U.S. federal judge on Friday said computer programmer Sergey Aleynikov is not entitled to have former employer Goldman Sachs Group Inc cover his legal fees to defend against criminal charges that he stole secret code from the bank's computers.Goldman need not advance ex-programmer's legal fees - U.S. judgeFitch: FICC, Underwriting Weigh on Goldman's 4Q'14 ResultsGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   Goldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  (The following statement was released by the rating agency) NEW YORK, January 16 (Fitch) The Goldman Sachs Group, Inc. (Goldman) reported  relatively weaker net revenue in 4Q'14, with declines in fixed income,  currencies and commodities (FICC) and underwriting outpacing strong performance  in financial advisory and equity sales and trading, according to Fitch Ratings.  While Goldman's overall financial performance was down quarter-over-quarter  (QoQ), consistent with its U.S. global trading andGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.    Fitch: FICC, Underwriting Weigh on Goldman's 4Q'14 ResultsGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   Goldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  (The following statement was released by the rating agency) NEW YORK, January 16 (Fitch) The Goldman Sachs Group, Inc. (Goldman) reported  relatively weaker net revenue in 4Q'14, with declines in fixed income,  currencies and commodities (FICC) and underwriting outpacing strong performance  in financial advisory and equity sales and trading, according to Fitch Ratings.  While Goldman's overall financial performance was down quarter-over-quarter  (QoQ), consistent with its U.S. global trading andGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   A U.S. federal judge on Friday said computer programmer Sergey Aleynikov is not entitled to have former employer Goldman Sachs Group Inc cover his legal fees to defend against criminal charges that he stole secret code from the bank's computers.Fitch: FICC, Underwriting Weigh on Goldman's 4Q'14 ResultsGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   Goldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  (The following statement was released by the rating agency) NEW YORK, January 16 (Fitch) The Goldman Sachs Group, Inc. (Goldman) reported  relatively weaker net revenue in 4Q'14, with declines in fixed income,  currencies and commodities (FICC) and underwriting outpacing strong performance  in financial advisory and equity sales and trading, according to Fitch Ratings.  While Goldman's overall financial performance was down quarter-over-quarter  (QoQ), consistent with its U.S. global trading andGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.      Goldman need not advance ex-programmer's legal fees - U.S. judgeGoldman need not advance ex-programmer's legal fees - U.S. judgeFitch: FICC, Underwriting Weigh on Goldman's 4Q'14 ResultsGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   Goldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  (The following statement was released by the rating agency) NEW YORK, January 16 (Fitch) The Goldman Sachs Group, Inc. (Goldman) reported  relatively weaker net revenue in 4Q'14, with declines in fixed income,  currencies and commodities (FICC) and underwriting outpacing strong performance  in financial advisory and equity sales and trading, according to Fitch Ratings.  While Goldman's overall financial performance was down quarter-over-quarter  (QoQ), consistent with its U.S. global trading andGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.    Fitch: FICC, Underwriting Weigh on Goldman's 4Q'14 ResultsGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   Goldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  (The following statement was released by the rating agency) NEW YORK, January 16 (Fitch) The Goldman Sachs Group, Inc. (Goldman) reported  relatively weaker net revenue in 4Q'14, with declines in fixed income,  currencies and commodities (FICC) and underwriting outpacing strong performance  in financial advisory and equity sales and trading, according to Fitch Ratings.  While Goldman's overall financial performance was down quarter-over-quarter  (QoQ), consistent with its U.S. global trading andGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   A U.S. federal judge on Friday said computer programmer Sergey Aleynikov is not entitled to have former employer Goldman Sachs Group Inc cover his legal fees to defend against criminal charges that he stole secret code from the bank's computers.Fitch: FICC, Underwriting Weigh on Goldman's 4Q'14 ResultsGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   Goldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  (The following statement was released by the rating agency) NEW YORK, January 16 (Fitch) The Goldman Sachs Group, Inc. (Goldman) reported  relatively weaker net revenue in 4Q'14, with declines in fixed income,  currencies and commodities (FICC) and underwriting outpacing strong performance  in financial advisory and equity sales and trading, according to Fitch Ratings.  While Goldman's overall financial performance was down quarter-over-quarter  (QoQ), consistent with its U.S. global trading andGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.     Goldman need not advance ex-programmer's legal fees - U.S. judgeFitch: FICC, Underwriting Weigh on Goldman's 4Q'14 ResultsGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   Goldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  (The following statement was released by the rating agency) NEW YORK, January 16 (Fitch) The Goldman Sachs Group, Inc. (Goldman) reported  relatively weaker net revenue in 4Q'14, with declines in fixed income,  currencies and commodities (FICC) and underwriting outpacing strong performance  in financial advisory and equity sales and trading, according to Fitch Ratings.  While Goldman's overall financial performance was down quarter-over-quarter  (QoQ), consistent with its U.S. global trading andGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.    Fitch: FICC, Underwriting Weigh on Goldman's 4Q'14 ResultsGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   Goldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  (The following statement was released by the rating agency) NEW YORK, January 16 (Fitch) The Goldman Sachs Group, Inc. (Goldman) reported  relatively weaker net revenue in 4Q'14, with declines in fixed income,  currencies and commodities (FICC) and underwriting outpacing strong performance  in financial advisory and equity sales and trading, according to Fitch Ratings.  While Goldman's overall financial performance was down quarter-over-quarter  (QoQ), consistent with its U.S. global trading andGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   A U.S. federal judge on Friday said computer programmer Sergey Aleynikov is not entitled to have former employer Goldman Sachs Group Inc cover his legal fees to defend against criminal charges that he stole secret code from the bank's computers.Fitch: FICC, Underwriting Weigh on Goldman's 4Q'14 ResultsGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   Goldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  (The following statement was released by the rating agency) NEW YORK, January 16 (Fitch) The Goldman Sachs Group, Inc. (Goldman) reported  relatively weaker net revenue in 4Q'14, with declines in fixed income,  currencies and commodities (FICC) and underwriting outpacing strong performance  in financial advisory and equity sales and trading, according to Fitch Ratings.  While Goldman's overall financial performance was down quarter-over-quarter  (QoQ), consistent with its U.S. global trading andGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.    A U.S. federal judge on Friday said computer programmer Sergey Aleynikov is not entitled to have former employer Goldman Sachs Group Inc cover his legal fees to defend against criminal charges that he stole secret code from the bank's computers.Goldman need not advance ex-programmer's legal fees - U.S. judgeFitch: FICC, Underwriting Weigh on Goldman's 4Q'14 ResultsGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   Goldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  (The following statement was released by the rating agency) NEW YORK, January 16 (Fitch) The Goldman Sachs Group, Inc. (Goldman) reported  relatively weaker net revenue in 4Q'14, with declines in fixed income,  currencies and commodities (FICC) and underwriting outpacing strong performance  in financial advisory and equity sales and trading, according to Fitch Ratings.  While Goldman's overall financial performance was down quarter-over-quarter  (QoQ), consistent with its U.S. global trading andGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.    Fitch: FICC, Underwriting Weigh on Goldman's 4Q'14 ResultsGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   Goldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  (The following statement was released by the rating agency) NEW YORK, January 16 (Fitch) The Goldman Sachs Group, Inc. (Goldman) reported  relatively weaker net revenue in 4Q'14, with declines in fixed income,  currencies and commodities (FICC) and underwriting outpacing strong performance  in financial advisory and equity sales and trading, according to Fitch Ratings.  While Goldman's overall financial performance was down quarter-over-quarter  (QoQ), consistent with its U.S. global trading andGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   A U.S. federal judge on Friday said computer programmer Sergey Aleynikov is not entitled to have former employer Goldman Sachs Group Inc cover his legal fees to defend against criminal charges that he stole secret code from the bank's computers.Fitch: FICC, Underwriting Weigh on Goldman's 4Q'14 ResultsGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   Goldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  (The following statement was released by the rating agency) NEW YORK, January 16 (Fitch) The Goldman Sachs Group, Inc. (Goldman) reported  relatively weaker net revenue in 4Q'14, with declines in fixed income,  currencies and commodities (FICC) and underwriting outpacing strong performance  in financial advisory and equity sales and trading, according to Fitch Ratings.  While Goldman's overall financial performance was down quarter-over-quarter  (QoQ), consistent with its U.S. global trading andGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.     Jan 16 A U.S. federal judge on Friday said computer programmer Sergey Aleynikov is not entitled to have former employer Goldman Sachs Group Inc cover his legal fees to defend against criminal charges that he stole secret code from the bank's computers.Goldman need not advance ex-programmer's legal fees - U.S. judgeGoldman need not advance ex-programmer's legal fees - U.S. judgeFitch: FICC, Underwriting Weigh on Goldman's 4Q'14 ResultsGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   Goldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  (The following statement was released by the rating agency) NEW YORK, January 16 (Fitch) The Goldman Sachs Group, Inc. (Goldman) reported  relatively weaker net revenue in 4Q'14, with declines in fixed income,  currencies and commodities (FICC) and underwriting outpacing strong performance  in financial advisory and equity sales and trading, according to Fitch Ratings.  While Goldman's overall financial performance was down quarter-over-quarter  (QoQ), consistent with its U.S. global trading andGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.    Fitch: FICC, Underwriting Weigh on Goldman's 4Q'14 ResultsGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   Goldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  (The following statement was released by the rating agency) NEW YORK, January 16 (Fitch) The Goldman Sachs Group, Inc. (Goldman) reported  relatively weaker net revenue in 4Q'14, with declines in fixed income,  currencies and commodities (FICC) and underwriting outpacing strong performance  in financial advisory and equity sales and trading, according to Fitch Ratings.  While Goldman's overall financial performance was down quarter-over-quarter  (QoQ), consistent with its U.S. global trading andGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   A U.S. federal judge on Friday said computer programmer Sergey Aleynikov is not entitled to have former employer Goldman Sachs Group Inc cover his legal fees to defend against criminal charges that he stole secret code from the bank's computers.Fitch: FICC, Underwriting Weigh on Goldman's 4Q'14 ResultsGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   Goldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  (The following statement was released by the rating agency) NEW YORK, January 16 (Fitch) The Goldman Sachs Group, Inc. (Goldman) reported  relatively weaker net revenue in 4Q'14, with declines in fixed income,  currencies and commodities (FICC) and underwriting outpacing strong performance  in financial advisory and equity sales and trading, according to Fitch Ratings.  While Goldman's overall financial performance was down quarter-over-quarter  (QoQ), consistent with its U.S. global trading andGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.     Goldman need not advance ex-programmer's legal fees - U.S. judgeFitch: FICC, Underwriting Weigh on Goldman's 4Q'14 ResultsGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   Goldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  (The following statement was released by the rating agency) NEW YORK, January 16 (Fitch) The Goldman Sachs Group, Inc. (Goldman) reported  relatively weaker net revenue in 4Q'14, with declines in fixed income,  currencies and commodities (FICC) and underwriting outpacing strong performance  in financial advisory and equity sales and trading, according to Fitch Ratings.  While Goldman's overall financial performance was down quarter-over-quarter  (QoQ), consistent with its U.S. global trading andGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.    Fitch: FICC, Underwriting Weigh on Goldman's 4Q'14 ResultsGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   Goldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  (The following statement was released by the rating agency) NEW YORK, January 16 (Fitch) The Goldman Sachs Group, Inc. (Goldman) reported  relatively weaker net revenue in 4Q'14, with declines in fixed income,  currencies and commodities (FICC) and underwriting outpacing strong performance  in financial advisory and equity sales and trading, according to Fitch Ratings.  While Goldman's overall financial performance was down quarter-over-quarter  (QoQ), consistent with its U.S. global trading andGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   A U.S. federal judge on Friday said computer programmer Sergey Aleynikov is not entitled to have former employer Goldman Sachs Group Inc cover his legal fees to defend against criminal charges that he stole secret code from the bank's computers.Fitch: FICC, Underwriting Weigh on Goldman's 4Q'14 ResultsGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   Goldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  (The following statement was released by the rating agency) NEW YORK, January 16 (Fitch) The Goldman Sachs Group, Inc. (Goldman) reported  relatively weaker net revenue in 4Q'14, with declines in fixed income,  currencies and commodities (FICC) and underwriting outpacing strong performance  in financial advisory and equity sales and trading, according to Fitch Ratings.  While Goldman's overall financial performance was down quarter-over-quarter  (QoQ), consistent with its U.S. global trading andGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.    A U.S. federal judge on Friday said computer programmer Sergey Aleynikov is not entitled to have former employer Goldman Sachs Group Inc cover his legal fees to defend against criminal charges that he stole secret code from the bank's computers.Goldman need not advance ex-programmer's legal fees - U.S. judgeFitch: FICC, Underwriting Weigh on Goldman's 4Q'14 ResultsGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   Goldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  (The following statement was released by the rating agency) NEW YORK, January 16 (Fitch) The Goldman Sachs Group, Inc. (Goldman) reported  relatively weaker net revenue in 4Q'14, with declines in fixed income,  currencies and commodities (FICC) and underwriting outpacing strong performance  in financial advisory and equity sales and trading, according to Fitch Ratings.  While Goldman's overall financial performance was down quarter-over-quarter  (QoQ), consistent with its U.S. global trading andGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.    Fitch: FICC, Underwriting Weigh on Goldman's 4Q'14 ResultsGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   Goldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  (The following statement was released by the rating agency) NEW YORK, January 16 (Fitch) The Goldman Sachs Group, Inc. (Goldman) reported  relatively weaker net revenue in 4Q'14, with declines in fixed income,  currencies and commodities (FICC) and underwriting outpacing strong performance  in financial advisory and equity sales and trading, according to Fitch Ratings.  While Goldman's overall financial performance was down quarter-over-quarter  (QoQ), consistent with its U.S. global trading andGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   A U.S. federal judge on Friday said computer programmer Sergey Aleynikov is not entitled to have former employer Goldman Sachs Group Inc cover his legal fees to defend against criminal charges that he stole secret code from the bank's computers.Fitch: FICC, Underwriting Weigh on Goldman's 4Q'14 ResultsGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   Goldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  (The following statement was released by the rating agency) NEW YORK, January 16 (Fitch) The Goldman Sachs Group, Inc. (Goldman) reported  relatively weaker net revenue in 4Q'14, with declines in fixed income,  currencies and commodities (FICC) and underwriting outpacing strong performance  in financial advisory and equity sales and trading, according to Fitch Ratings.  While Goldman's overall financial performance was down quarter-over-quarter  (QoQ), consistent with its U.S. global trading andGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.       Goldman need not advance ex-programmer's legal fees - U.S. judgeGoldman need not advance ex-programmer's legal fees - U.S. judgeGoldman need not advance ex-programmer's legal fees - U.S. judgeFitch: FICC, Underwriting Weigh on Goldman's 4Q'14 ResultsGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   Goldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  (The following statement was released by the rating agency) NEW YORK, January 16 (Fitch) The Goldman Sachs Group, Inc. (Goldman) reported  relatively weaker net revenue in 4Q'14, with declines in fixed income,  currencies and commodities (FICC) and underwriting outpacing strong performance  in financial advisory and equity sales and trading, according to Fitch Ratings.  While Goldman's overall financial performance was down quarter-over-quarter  (QoQ), consistent with its U.S. global trading andGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.    Fitch: FICC, Underwriting Weigh on Goldman's 4Q'14 ResultsGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   Goldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  (The following statement was released by the rating agency) NEW YORK, January 16 (Fitch) The Goldman Sachs Group, Inc. (Goldman) reported  relatively weaker net revenue in 4Q'14, with declines in fixed income,  currencies and commodities (FICC) and underwriting outpacing strong performance  in financial advisory and equity sales and trading, according to Fitch Ratings.  While Goldman's overall financial performance was down quarter-over-quarter  (QoQ), consistent with its U.S. global trading andGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   A U.S. federal judge on Friday said computer programmer Sergey Aleynikov is not entitled to have former employer Goldman Sachs Group Inc cover his legal fees to defend against criminal charges that he stole secret code from the bank's computers.Fitch: FICC, Underwriting Weigh on Goldman's 4Q'14 ResultsGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   Goldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  (The following statement was released by the rating agency) NEW YORK, January 16 (Fitch) The Goldman Sachs Group, Inc. (Goldman) reported  relatively weaker net revenue in 4Q'14, with declines in fixed income,  currencies and commodities (FICC) and underwriting outpacing strong performance  in financial advisory and equity sales and trading, according to Fitch Ratings.  While Goldman's overall financial performance was down quarter-over-quarter  (QoQ), consistent with its U.S. global trading andGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.     Goldman need not advance ex-programmer's legal fees - U.S. judgeFitch: FICC, Underwriting Weigh on Goldman's 4Q'14 ResultsGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   Goldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  (The following statement was released by the rating agency) NEW YORK, January 16 (Fitch) The Goldman Sachs Group, Inc. (Goldman) reported  relatively weaker net revenue in 4Q'14, with declines in fixed income,  currencies and commodities (FICC) and underwriting outpacing strong performance  in financial advisory and equity sales and trading, according to Fitch Ratings.  While Goldman's overall financial performance was down quarter-over-quarter  (QoQ), consistent with its U.S. global trading andGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.    Fitch: FICC, Underwriting Weigh on Goldman's 4Q'14 ResultsGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   Goldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  (The following statement was released by the rating agency) NEW YORK, January 16 (Fitch) The Goldman Sachs Group, Inc. (Goldman) reported  relatively weaker net revenue in 4Q'14, with declines in fixed income,  currencies and commodities (FICC) and underwriting outpacing strong performance  in financial advisory and equity sales and trading, according to Fitch Ratings.  While Goldman's overall financial performance was down quarter-over-quarter  (QoQ), consistent with its U.S. global trading andGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   A U.S. federal judge on Friday said computer programmer Sergey Aleynikov is not entitled to have former employer Goldman Sachs Group Inc cover his legal fees to defend against criminal charges that he stole secret code from the bank's computers.Fitch: FICC, Underwriting Weigh on Goldman's 4Q'14 ResultsGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   Goldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  (The following statement was released by the rating agency) NEW YORK, January 16 (Fitch) The Goldman Sachs Group, Inc. (Goldman) reported  relatively weaker net revenue in 4Q'14, with declines in fixed income,  currencies and commodities (FICC) and underwriting outpacing strong performance  in financial advisory and equity sales and trading, according to Fitch Ratings.  While Goldman's overall financial performance was down quarter-over-quarter  (QoQ), consistent with its U.S. global trading andGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.    A U.S. federal judge on Friday said computer programmer Sergey Aleynikov is not entitled to have former employer Goldman Sachs Group Inc cover his legal fees to defend against criminal charges that he stole secret code from the bank's computers.Goldman need not advance ex-programmer's legal fees - U.S. judgeFitch: FICC, Underwriting Weigh on Goldman's 4Q'14 ResultsGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   Goldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  (The following statement was released by the rating agency) NEW YORK, January 16 (Fitch) The Goldman Sachs Group, Inc. (Goldman) reported  relatively weaker net revenue in 4Q'14, with declines in fixed income,  currencies and commodities (FICC) and underwriting outpacing strong performance  in financial advisory and equity sales and trading, according to Fitch Ratings.  While Goldman's overall financial performance was down quarter-over-quarter  (QoQ), consistent with its U.S. global trading andGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.    Fitch: FICC, Underwriting Weigh on Goldman's 4Q'14 ResultsGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   Goldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  (The following statement was released by the rating agency) NEW YORK, January 16 (Fitch) The Goldman Sachs Group, Inc. (Goldman) reported  relatively weaker net revenue in 4Q'14, with declines in fixed income,  currencies and commodities (FICC) and underwriting outpacing strong performance  in financial advisory and equity sales and trading, according to Fitch Ratings.  While Goldman's overall financial performance was down quarter-over-quarter  (QoQ), consistent with its U.S. global trading andGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   A U.S. federal judge on Friday said computer programmer Sergey Aleynikov is not entitled to have former employer Goldman Sachs Group Inc cover his legal fees to defend against criminal charges that he stole secret code from the bank's computers.Fitch: FICC, Underwriting Weigh on Goldman's 4Q'14 ResultsGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   Goldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  (The following statement was released by the rating agency) NEW YORK, January 16 (Fitch) The Goldman Sachs Group, Inc. (Goldman) reported  relatively weaker net revenue in 4Q'14, with declines in fixed income,  currencies and commodities (FICC) and underwriting outpacing strong performance  in financial advisory and equity sales and trading, according to Fitch Ratings.  While Goldman's overall financial performance was down quarter-over-quarter  (QoQ), consistent with its U.S. global trading andGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.      Goldman need not advance ex-programmer's legal fees - U.S. judgeGoldman need not advance ex-programmer's legal fees - U.S. judgeFitch: FICC, Underwriting Weigh on Goldman's 4Q'14 ResultsGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   Goldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  (The following statement was released by the rating agency) NEW YORK, January 16 (Fitch) The Goldman Sachs Group, Inc. (Goldman) reported  relatively weaker net revenue in 4Q'14, with declines in fixed income,  currencies and commodities (FICC) and underwriting outpacing strong performance  in financial advisory and equity sales and trading, according to Fitch Ratings.  While Goldman's overall financial performance was down quarter-over-quarter  (QoQ), consistent with its U.S. global trading andGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.    Fitch: FICC, Underwriting Weigh on Goldman's 4Q'14 ResultsGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   Goldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  (The following statement was released by the rating agency) NEW YORK, January 16 (Fitch) The Goldman Sachs Group, Inc. (Goldman) reported  relatively weaker net revenue in 4Q'14, with declines in fixed income,  currencies and commodities (FICC) and underwriting outpacing strong performance  in financial advisory and equity sales and trading, according to Fitch Ratings.  While Goldman's overall financial performance was down quarter-over-quarter  (QoQ), consistent with its U.S. global trading andGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   A U.S. federal judge on Friday said computer programmer Sergey Aleynikov is not entitled to have former employer Goldman Sachs Group Inc cover his legal fees to defend against criminal charges that he stole secret code from the bank's computers.Fitch: FICC, Underwriting Weigh on Goldman's 4Q'14 ResultsGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   Goldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  (The following statement was released by the rating agency) NEW YORK, January 16 (Fitch) The Goldman Sachs Group, Inc. (Goldman) reported  relatively weaker net revenue in 4Q'14, with declines in fixed income,  currencies and commodities (FICC) and underwriting outpacing strong performance  in financial advisory and equity sales and trading, according to Fitch Ratings.  While Goldman's overall financial performance was down quarter-over-quarter  (QoQ), consistent with its U.S. global trading andGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.     Goldman need not advance ex-programmer's legal fees - U.S. judgeFitch: FICC, Underwriting Weigh on Goldman's 4Q'14 ResultsGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   Goldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  (The following statement was released by the rating agency) NEW YORK, January 16 (Fitch) The Goldman Sachs Group, Inc. (Goldman) reported  relatively weaker net revenue in 4Q'14, with declines in fixed income,  currencies and commodities (FICC) and underwriting outpacing strong performance  in financial advisory and equity sales and trading, according to Fitch Ratings.  While Goldman's overall financial performance was down quarter-over-quarter  (QoQ), consistent with its U.S. global trading andGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.    Fitch: FICC, Underwriting Weigh on Goldman's 4Q'14 ResultsGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   Goldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  (The following statement was released by the rating agency) NEW YORK, January 16 (Fitch) The Goldman Sachs Group, Inc. (Goldman) reported  relatively weaker net revenue in 4Q'14, with declines in fixed income,  currencies and commodities (FICC) and underwriting outpacing strong performance  in financial advisory and equity sales and trading, according to Fitch Ratings.  While Goldman's overall financial performance was down quarter-over-quarter  (QoQ), consistent with its U.S. global trading andGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   A U.S. federal judge on Friday said computer programmer Sergey Aleynikov is not entitled to have former employer Goldman Sachs Group Inc cover his legal fees to defend against criminal charges that he stole secret code from the bank's computers.Fitch: FICC, Underwriting Weigh on Goldman's 4Q'14 ResultsGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   Goldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  (The following statement was released by the rating agency) NEW YORK, January 16 (Fitch) The Goldman Sachs Group, Inc. (Goldman) reported  relatively weaker net revenue in 4Q'14, with declines in fixed income,  currencies and commodities (FICC) and underwriting outpacing strong performance  in financial advisory and equity sales and trading, according to Fitch Ratings.  While Goldman's overall financial performance was down quarter-over-quarter  (QoQ), consistent with its U.S. global trading andGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.    A U.S. federal judge on Friday said computer programmer Sergey Aleynikov is not entitled to have former employer Goldman Sachs Group Inc cover his legal fees to defend against criminal charges that he stole secret code from the bank's computers.Goldman need not advance ex-programmer's legal fees - U.S. judgeFitch: FICC, Underwriting Weigh on Goldman's 4Q'14 ResultsGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   Goldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  (The following statement was released by the rating agency) NEW YORK, January 16 (Fitch) The Goldman Sachs Group, Inc. (Goldman) reported  relatively weaker net revenue in 4Q'14, with declines in fixed income,  currencies and commodities (FICC) and underwriting outpacing strong performance  in financial advisory and equity sales and trading, according to Fitch Ratings.  While Goldman's overall financial performance was down quarter-over-quarter  (QoQ), consistent with its U.S. global trading andGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.    Fitch: FICC, Underwriting Weigh on Goldman's 4Q'14 ResultsGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   Goldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  (The following statement was released by the rating agency) NEW YORK, January 16 (Fitch) The Goldman Sachs Group, Inc. (Goldman) reported  relatively weaker net revenue in 4Q'14, with declines in fixed income,  currencies and commodities (FICC) and underwriting outpacing strong performance  in financial advisory and equity sales and trading, according to Fitch Ratings.  While Goldman's overall financial performance was down quarter-over-quarter  (QoQ), consistent with its U.S. global trading andGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   A U.S. federal judge on Friday said computer programmer Sergey Aleynikov is not entitled to have former employer Goldman Sachs Group Inc cover his legal fees to defend against criminal charges that he stole secret code from the bank's computers.Fitch: FICC, Underwriting Weigh on Goldman's 4Q'14 ResultsGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   Goldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  (The following statement was released by the rating agency) NEW YORK, January 16 (Fitch) The Goldman Sachs Group, Inc. (Goldman) reported  relatively weaker net revenue in 4Q'14, with declines in fixed income,  currencies and commodities (FICC) and underwriting outpacing strong performance  in financial advisory and equity sales and trading, according to Fitch Ratings.  While Goldman's overall financial performance was down quarter-over-quarter  (QoQ), consistent with its U.S. global trading andGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.     Jan 16 A U.S. federal judge on Friday said computer programmer Sergey Aleynikov is not entitled to have former employer Goldman Sachs Group Inc cover his legal fees to defend against criminal charges that he stole secret code from the bank's computers.Goldman need not advance ex-programmer's legal fees - U.S. judgeGoldman need not advance ex-programmer's legal fees - U.S. judgeFitch: FICC, Underwriting Weigh on Goldman's 4Q'14 ResultsGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   Goldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  (The following statement was released by the rating agency) NEW YORK, January 16 (Fitch) The Goldman Sachs Group, Inc. (Goldman) reported  relatively weaker net revenue in 4Q'14, with declines in fixed income,  currencies and commodities (FICC) and underwriting outpacing strong performance  in financial advisory and equity sales and trading, according to Fitch Ratings.  While Goldman's overall financial performance was down quarter-over-quarter  (QoQ), consistent with its U.S. global trading andGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.    Fitch: FICC, Underwriting Weigh on Goldman's 4Q'14 ResultsGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   Goldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  (The following statement was released by the rating agency) NEW YORK, January 16 (Fitch) The Goldman Sachs Group, Inc. (Goldman) reported  relatively weaker net revenue in 4Q'14, with declines in fixed income,  currencies and commodities (FICC) and underwriting outpacing strong performance  in financial advisory and equity sales and trading, according to Fitch Ratings.  While Goldman's overall financial performance was down quarter-over-quarter  (QoQ), consistent with its U.S. global trading andGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   A U.S. federal judge on Friday said computer programmer Sergey Aleynikov is not entitled to have former employer Goldman Sachs Group Inc cover his legal fees to defend against criminal charges that he stole secret code from the bank's computers.Fitch: FICC, Underwriting Weigh on Goldman's 4Q'14 ResultsGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   Goldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  (The following statement was released by the rating agency) NEW YORK, January 16 (Fitch) The Goldman Sachs Group, Inc. (Goldman) reported  relatively weaker net revenue in 4Q'14, with declines in fixed income,  currencies and commodities (FICC) and underwriting outpacing strong performance  in financial advisory and equity sales and trading, according to Fitch Ratings.  While Goldman's overall financial performance was down quarter-over-quarter  (QoQ), consistent with its U.S. global trading andGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.     Goldman need not advance ex-programmer's legal fees - U.S. judgeFitch: FICC, Underwriting Weigh on Goldman's 4Q'14 ResultsGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   Goldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  (The following statement was released by the rating agency) NEW YORK, January 16 (Fitch) The Goldman Sachs Group, Inc. (Goldman) reported  relatively weaker net revenue in 4Q'14, with declines in fixed income,  currencies and commodities (FICC) and underwriting outpacing strong performance  in financial advisory and equity sales and trading, according to Fitch Ratings.  While Goldman's overall financial performance was down quarter-over-quarter  (QoQ), consistent with its U.S. global trading andGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.    Fitch: FICC, Underwriting Weigh on Goldman's 4Q'14 ResultsGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   Goldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  (The following statement was released by the rating agency) NEW YORK, January 16 (Fitch) The Goldman Sachs Group, Inc. (Goldman) reported  relatively weaker net revenue in 4Q'14, with declines in fixed income,  currencies and commodities (FICC) and underwriting outpacing strong performance  in financial advisory and equity sales and trading, according to Fitch Ratings.  While Goldman's overall financial performance was down quarter-over-quarter  (QoQ), consistent with its U.S. global trading andGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   A U.S. federal judge on Friday said computer programmer Sergey Aleynikov is not entitled to have former employer Goldman Sachs Group Inc cover his legal fees to defend against criminal charges that he stole secret code from the bank's computers.Fitch: FICC, Underwriting Weigh on Goldman's 4Q'14 ResultsGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   Goldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  (The following statement was released by the rating agency) NEW YORK, January 16 (Fitch) The Goldman Sachs Group, Inc. (Goldman) reported  relatively weaker net revenue in 4Q'14, with declines in fixed income,  currencies and commodities (FICC) and underwriting outpacing strong performance  in financial advisory and equity sales and trading, according to Fitch Ratings.  While Goldman's overall financial performance was down quarter-over-quarter  (QoQ), consistent with its U.S. global trading andGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.    A U.S. federal judge on Friday said computer programmer Sergey Aleynikov is not entitled to have former employer Goldman Sachs Group Inc cover his legal fees to defend against criminal charges that he stole secret code from the bank's computers.Goldman need not advance ex-programmer's legal fees - U.S. judgeFitch: FICC, Underwriting Weigh on Goldman's 4Q'14 ResultsGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   Goldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  (The following statement was released by the rating agency) NEW YORK, January 16 (Fitch) The Goldman Sachs Group, Inc. (Goldman) reported  relatively weaker net revenue in 4Q'14, with declines in fixed income,  currencies and commodities (FICC) and underwriting outpacing strong performance  in financial advisory and equity sales and trading, according to Fitch Ratings.  While Goldman's overall financial performance was down quarter-over-quarter  (QoQ), consistent with its U.S. global trading andGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.    Fitch: FICC, Underwriting Weigh on Goldman's 4Q'14 ResultsGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   Goldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  (The following statement was released by the rating agency) NEW YORK, January 16 (Fitch) The Goldman Sachs Group, Inc. (Goldman) reported  relatively weaker net revenue in 4Q'14, with declines in fixed income,  currencies and commodities (FICC) and underwriting outpacing strong performance  in financial advisory and equity sales and trading, according to Fitch Ratings.  While Goldman's overall financial performance was down quarter-over-quarter  (QoQ), consistent with its U.S. global trading andGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   A U.S. federal judge on Friday said computer programmer Sergey Aleynikov is not entitled to have former employer Goldman Sachs Group Inc cover his legal fees to defend against criminal charges that he stole secret code from the bank's computers.Fitch: FICC, Underwriting Weigh on Goldman's 4Q'14 ResultsGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   Goldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  (The following statement was released by the rating agency) NEW YORK, January 16 (Fitch) The Goldman Sachs Group, Inc. (Goldman) reported  relatively weaker net revenue in 4Q'14, with declines in fixed income,  currencies and commodities (FICC) and underwriting outpacing strong performance  in financial advisory and equity sales and trading, according to Fitch Ratings.  While Goldman's overall financial performance was down quarter-over-quarter  (QoQ), consistent with its U.S. global trading andGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.      * Shares down less than 1 pct in midday trading   (Adds details from conference call; updates share move)Goldman need not advance ex-programmer's legal fees - U.S. judgeGoldman need not advance ex-programmer's legal fees - U.S. judgeGoldman need not advance ex-programmer's legal fees - U.S. judgeFitch: FICC, Underwriting Weigh on Goldman's 4Q'14 ResultsGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   Goldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  (The following statement was released by the rating agency) NEW YORK, January 16 (Fitch) The Goldman Sachs Group, Inc. (Goldman) reported  relatively weaker net revenue in 4Q'14, with declines in fixed income,  currencies and commodities (FICC) and underwriting outpacing strong performance  in financial advisory and equity sales and trading, according to Fitch Ratings.  While Goldman's overall financial performance was down quarter-over-quarter  (QoQ), consistent with its U.S. global trading andGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.    Fitch: FICC, Underwriting Weigh on Goldman's 4Q'14 ResultsGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   Goldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  (The following statement was released by the rating agency) NEW YORK, January 16 (Fitch) The Goldman Sachs Group, Inc. (Goldman) reported  relatively weaker net revenue in 4Q'14, with declines in fixed income,  currencies and commodities (FICC) and underwriting outpacing strong performance  in financial advisory and equity sales and trading, according to Fitch Ratings.  While Goldman's overall financial performance was down quarter-over-quarter  (QoQ), consistent with its U.S. global trading andGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   A U.S. federal judge on Friday said computer programmer Sergey Aleynikov is not entitled to have former employer Goldman Sachs Group Inc cover his legal fees to defend against criminal charges that he stole secret code from the bank's computers.Fitch: FICC, Underwriting Weigh on Goldman's 4Q'14 ResultsGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   Goldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  (The following statement was released by the rating agency) NEW YORK, January 16 (Fitch) The Goldman Sachs Group, Inc. (Goldman) reported  relatively weaker net revenue in 4Q'14, with declines in fixed income,  currencies and commodities (FICC) and underwriting outpacing strong performance  in financial advisory and equity sales and trading, according to Fitch Ratings.  While Goldman's overall financial performance was down quarter-over-quarter  (QoQ), consistent with its U.S. global trading andGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.     Goldman need not advance ex-programmer's legal fees - U.S. judgeFitch: FICC, Underwriting Weigh on Goldman's 4Q'14 ResultsGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   Goldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  (The following statement was released by the rating agency) NEW YORK, January 16 (Fitch) The Goldman Sachs Group, Inc. (Goldman) reported  relatively weaker net revenue in 4Q'14, with declines in fixed income,  currencies and commodities (FICC) and underwriting outpacing strong performance  in financial advisory and equity sales and trading, according to Fitch Ratings.  While Goldman's overall financial performance was down quarter-over-quarter  (QoQ), consistent with its U.S. global trading andGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.    Fitch: FICC, Underwriting Weigh on Goldman's 4Q'14 ResultsGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   Goldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  (The following statement was released by the rating agency) NEW YORK, January 16 (Fitch) The Goldman Sachs Group, Inc. (Goldman) reported  relatively weaker net revenue in 4Q'14, with declines in fixed income,  currencies and commodities (FICC) and underwriting outpacing strong performance  in financial advisory and equity sales and trading, according to Fitch Ratings.  While Goldman's overall financial performance was down quarter-over-quarter  (QoQ), consistent with its U.S. global trading andGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   A U.S. federal judge on Friday said computer programmer Sergey Aleynikov is not entitled to have former employer Goldman Sachs Group Inc cover his legal fees to defend against criminal charges that he stole secret code from the bank's computers.Fitch: FICC, Underwriting Weigh on Goldman's 4Q'14 ResultsGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   Goldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  (The following statement was released by the rating agency) NEW YORK, January 16 (Fitch) The Goldman Sachs Group, Inc. (Goldman) reported  relatively weaker net revenue in 4Q'14, with declines in fixed income,  currencies and commodities (FICC) and underwriting outpacing strong performance  in financial advisory and equity sales and trading, according to Fitch Ratings.  While Goldman's overall financial performance was down quarter-over-quarter  (QoQ), consistent with its U.S. global trading andGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.    A U.S. federal judge on Friday said computer programmer Sergey Aleynikov is not entitled to have former employer Goldman Sachs Group Inc cover his legal fees to defend against criminal charges that he stole secret code from the bank's computers.Goldman need not advance ex-programmer's legal fees - U.S. judgeFitch: FICC, Underwriting Weigh on Goldman's 4Q'14 ResultsGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   Goldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  (The following statement was released by the rating agency) NEW YORK, January 16 (Fitch) The Goldman Sachs Group, Inc. (Goldman) reported  relatively weaker net revenue in 4Q'14, with declines in fixed income,  currencies and commodities (FICC) and underwriting outpacing strong performance  in financial advisory and equity sales and trading, according to Fitch Ratings.  While Goldman's overall financial performance was down quarter-over-quarter  (QoQ), consistent with its U.S. global trading andGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.    Fitch: FICC, Underwriting Weigh on Goldman's 4Q'14 ResultsGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   Goldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  (The following statement was released by the rating agency) NEW YORK, January 16 (Fitch) The Goldman Sachs Group, Inc. (Goldman) reported  relatively weaker net revenue in 4Q'14, with declines in fixed income,  currencies and commodities (FICC) and underwriting outpacing strong performance  in financial advisory and equity sales and trading, according to Fitch Ratings.  While Goldman's overall financial performance was down quarter-over-quarter  (QoQ), consistent with its U.S. global trading andGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   A U.S. federal judge on Friday said computer programmer Sergey Aleynikov is not entitled to have former employer Goldman Sachs Group Inc cover his legal fees to defend against criminal charges that he stole secret code from the bank's computers.Fitch: FICC, Underwriting Weigh on Goldman's 4Q'14 ResultsGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   Goldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  (The following statement was released by the rating agency) NEW YORK, January 16 (Fitch) The Goldman Sachs Group, Inc. (Goldman) reported  relatively weaker net revenue in 4Q'14, with declines in fixed income,  currencies and commodities (FICC) and underwriting outpacing strong performance  in financial advisory and equity sales and trading, according to Fitch Ratings.  While Goldman's overall financial performance was down quarter-over-quarter  (QoQ), consistent with its U.S. global trading andGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.      Goldman need not advance ex-programmer's legal fees - U.S. judgeGoldman need not advance ex-programmer's legal fees - U.S. judgeFitch: FICC, Underwriting Weigh on Goldman's 4Q'14 ResultsGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   Goldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  (The following statement was released by the rating agency) NEW YORK, January 16 (Fitch) The Goldman Sachs Group, Inc. (Goldman) reported  relatively weaker net revenue in 4Q'14, with declines in fixed income,  currencies and commodities (FICC) and underwriting outpacing strong performance  in financial advisory and equity sales and trading, according to Fitch Ratings.  While Goldman's overall financial performance was down quarter-over-quarter  (QoQ), consistent with its U.S. global trading andGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.    Fitch: FICC, Underwriting Weigh on Goldman's 4Q'14 ResultsGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   Goldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  (The following statement was released by the rating agency) NEW YORK, January 16 (Fitch) The Goldman Sachs Group, Inc. (Goldman) reported  relatively weaker net revenue in 4Q'14, with declines in fixed income,  currencies and commodities (FICC) and underwriting outpacing strong performance  in financial advisory and equity sales and trading, according to Fitch Ratings.  While Goldman's overall financial performance was down quarter-over-quarter  (QoQ), consistent with its U.S. global trading andGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   A U.S. federal judge on Friday said computer programmer Sergey Aleynikov is not entitled to have former employer Goldman Sachs Group Inc cover his legal fees to defend against criminal charges that he stole secret code from the bank's computers.Fitch: FICC, Underwriting Weigh on Goldman's 4Q'14 ResultsGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   Goldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  (The following statement was released by the rating agency) NEW YORK, January 16 (Fitch) The Goldman Sachs Group, Inc. (Goldman) reported  relatively weaker net revenue in 4Q'14, with declines in fixed income,  currencies and commodities (FICC) and underwriting outpacing strong performance  in financial advisory and equity sales and trading, according to Fitch Ratings.  While Goldman's overall financial performance was down quarter-over-quarter  (QoQ), consistent with its U.S. global trading andGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.     Goldman need not advance ex-programmer's legal fees - U.S. judgeFitch: FICC, Underwriting Weigh on Goldman's 4Q'14 ResultsGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   Goldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  (The following statement was released by the rating agency) NEW YORK, January 16 (Fitch) The Goldman Sachs Group, Inc. (Goldman) reported  relatively weaker net revenue in 4Q'14, with declines in fixed income,  currencies and commodities (FICC) and underwriting outpacing strong performance  in financial advisory and equity sales and trading, according to Fitch Ratings.  While Goldman's overall financial performance was down quarter-over-quarter  (QoQ), consistent with its U.S. global trading andGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.    Fitch: FICC, Underwriting Weigh on Goldman's 4Q'14 ResultsGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   Goldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  (The following statement was released by the rating agency) NEW YORK, January 16 (Fitch) The Goldman Sachs Group, Inc. (Goldman) reported  relatively weaker net revenue in 4Q'14, with declines in fixed income,  currencies and commodities (FICC) and underwriting outpacing strong performance  in financial advisory and equity sales and trading, according to Fitch Ratings.  While Goldman's overall financial performance was down quarter-over-quarter  (QoQ), consistent with its U.S. global trading andGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   A U.S. federal judge on Friday said computer programmer Sergey Aleynikov is not entitled to have former employer Goldman Sachs Group Inc cover his legal fees to defend against criminal charges that he stole secret code from the bank's computers.Fitch: FICC, Underwriting Weigh on Goldman's 4Q'14 ResultsGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   Goldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  (The following statement was released by the rating agency) NEW YORK, January 16 (Fitch) The Goldman Sachs Group, Inc. (Goldman) reported  relatively weaker net revenue in 4Q'14, with declines in fixed income,  currencies and commodities (FICC) and underwriting outpacing strong performance  in financial advisory and equity sales and trading, according to Fitch Ratings.  While Goldman's overall financial performance was down quarter-over-quarter  (QoQ), consistent with its U.S. global trading andGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.    A U.S. federal judge on Friday said computer programmer Sergey Aleynikov is not entitled to have former employer Goldman Sachs Group Inc cover his legal fees to defend against criminal charges that he stole secret code from the bank's computers.Goldman need not advance ex-programmer's legal fees - U.S. judgeFitch: FICC, Underwriting Weigh on Goldman's 4Q'14 ResultsGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   Goldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  (The following statement was released by the rating agency) NEW YORK, January 16 (Fitch) The Goldman Sachs Group, Inc. (Goldman) reported  relatively weaker net revenue in 4Q'14, with declines in fixed income,  currencies and commodities (FICC) and underwriting outpacing strong performance  in financial advisory and equity sales and trading, according to Fitch Ratings.  While Goldman's overall financial performance was down quarter-over-quarter  (QoQ), consistent with its U.S. global trading andGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.    Fitch: FICC, Underwriting Weigh on Goldman's 4Q'14 ResultsGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   Goldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  (The following statement was released by the rating agency) NEW YORK, January 16 (Fitch) The Goldman Sachs Group, Inc. (Goldman) reported  relatively weaker net revenue in 4Q'14, with declines in fixed income,  currencies and commodities (FICC) and underwriting outpacing strong performance  in financial advisory and equity sales and trading, according to Fitch Ratings.  While Goldman's overall financial performance was down quarter-over-quarter  (QoQ), consistent with its U.S. global trading andGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   A U.S. federal judge on Friday said computer programmer Sergey Aleynikov is not entitled to have former employer Goldman Sachs Group Inc cover his legal fees to defend against criminal charges that he stole secret code from the bank's computers.Fitch: FICC, Underwriting Weigh on Goldman's 4Q'14 ResultsGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   Goldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  (The following statement was released by the rating agency) NEW YORK, January 16 (Fitch) The Goldman Sachs Group, Inc. (Goldman) reported  relatively weaker net revenue in 4Q'14, with declines in fixed income,  currencies and commodities (FICC) and underwriting outpacing strong performance  in financial advisory and equity sales and trading, according to Fitch Ratings.  While Goldman's overall financial performance was down quarter-over-quarter  (QoQ), consistent with its U.S. global trading andGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.     Jan 16 A U.S. federal judge on Friday said computer programmer Sergey Aleynikov is not entitled to have former employer Goldman Sachs Group Inc cover his legal fees to defend against criminal charges that he stole secret code from the bank's computers.Goldman need not advance ex-programmer's legal fees - U.S. judgeGoldman need not advance ex-programmer's legal fees - U.S. judgeFitch: FICC, Underwriting Weigh on Goldman's 4Q'14 ResultsGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   Goldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  (The following statement was released by the rating agency) NEW YORK, January 16 (Fitch) The Goldman Sachs Group, Inc. (Goldman) reported  relatively weaker net revenue in 4Q'14, with declines in fixed income,  currencies and commodities (FICC) and underwriting outpacing strong performance  in financial advisory and equity sales and trading, according to Fitch Ratings.  While Goldman's overall financial performance was down quarter-over-quarter  (QoQ), consistent with its U.S. global trading andGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.    Fitch: FICC, Underwriting Weigh on Goldman's 4Q'14 ResultsGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   Goldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  (The following statement was released by the rating agency) NEW YORK, January 16 (Fitch) The Goldman Sachs Group, Inc. (Goldman) reported  relatively weaker net revenue in 4Q'14, with declines in fixed income,  currencies and commodities (FICC) and underwriting outpacing strong performance  in financial advisory and equity sales and trading, according to Fitch Ratings.  While Goldman's overall financial performance was down quarter-over-quarter  (QoQ), consistent with its U.S. global trading andGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   A U.S. federal judge on Friday said computer programmer Sergey Aleynikov is not entitled to have former employer Goldman Sachs Group Inc cover his legal fees to defend against criminal charges that he stole secret code from the bank's computers.Fitch: FICC, Underwriting Weigh on Goldman's 4Q'14 ResultsGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   Goldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  (The following statement was released by the rating agency) NEW YORK, January 16 (Fitch) The Goldman Sachs Group, Inc. (Goldman) reported  relatively weaker net revenue in 4Q'14, with declines in fixed income,  currencies and commodities (FICC) and underwriting outpacing strong performance  in financial advisory and equity sales and trading, according to Fitch Ratings.  While Goldman's overall financial performance was down quarter-over-quarter  (QoQ), consistent with its U.S. global trading andGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.     Goldman need not advance ex-programmer's legal fees - U.S. judgeFitch: FICC, Underwriting Weigh on Goldman's 4Q'14 ResultsGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   Goldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  (The following statement was released by the rating agency) NEW YORK, January 16 (Fitch) The Goldman Sachs Group, Inc. (Goldman) reported  relatively weaker net revenue in 4Q'14, with declines in fixed income,  currencies and commodities (FICC) and underwriting outpacing strong performance  in financial advisory and equity sales and trading, according to Fitch Ratings.  While Goldman's overall financial performance was down quarter-over-quarter  (QoQ), consistent with its U.S. global trading andGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.    Fitch: FICC, Underwriting Weigh on Goldman's 4Q'14 ResultsGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   Goldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  (The following statement was released by the rating agency) NEW YORK, January 16 (Fitch) The Goldman Sachs Group, Inc. (Goldman) reported  relatively weaker net revenue in 4Q'14, with declines in fixed income,  currencies and commodities (FICC) and underwriting outpacing strong performance  in financial advisory and equity sales and trading, according to Fitch Ratings.  While Goldman's overall financial performance was down quarter-over-quarter  (QoQ), consistent with its U.S. global trading andGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   A U.S. federal judge on Friday said computer programmer Sergey Aleynikov is not entitled to have former employer Goldman Sachs Group Inc cover his legal fees to defend against criminal charges that he stole secret code from the bank's computers.Fitch: FICC, Underwriting Weigh on Goldman's 4Q'14 ResultsGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   Goldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  (The following statement was released by the rating agency) NEW YORK, January 16 (Fitch) The Goldman Sachs Group, Inc. (Goldman) reported  relatively weaker net revenue in 4Q'14, with declines in fixed income,  currencies and commodities (FICC) and underwriting outpacing strong performance  in financial advisory and equity sales and trading, according to Fitch Ratings.  While Goldman's overall financial performance was down quarter-over-quarter  (QoQ), consistent with its U.S. global trading andGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.    A U.S. federal judge on Friday said computer programmer Sergey Aleynikov is not entitled to have former employer Goldman Sachs Group Inc cover his legal fees to defend against criminal charges that he stole secret code from the bank's computers.Goldman need not advance ex-programmer's legal fees - U.S. judgeFitch: FICC, Underwriting Weigh on Goldman's 4Q'14 ResultsGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   Goldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  (The following statement was released by the rating agency) NEW YORK, January 16 (Fitch) The Goldman Sachs Group, Inc. (Goldman) reported  relatively weaker net revenue in 4Q'14, with declines in fixed income,  currencies and commodities (FICC) and underwriting outpacing strong performance  in financial advisory and equity sales and trading, according to Fitch Ratings.  While Goldman's overall financial performance was down quarter-over-quarter  (QoQ), consistent with its U.S. global trading andGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.    Fitch: FICC, Underwriting Weigh on Goldman's 4Q'14 ResultsGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   Goldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  (The following statement was released by the rating agency) NEW YORK, January 16 (Fitch) The Goldman Sachs Group, Inc. (Goldman) reported  relatively weaker net revenue in 4Q'14, with declines in fixed income,  currencies and commodities (FICC) and underwriting outpacing strong performance  in financial advisory and equity sales and trading, according to Fitch Ratings.  While Goldman's overall financial performance was down quarter-over-quarter  (QoQ), consistent with its U.S. global trading andGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   A U.S. federal judge on Friday said computer programmer Sergey Aleynikov is not entitled to have former employer Goldman Sachs Group Inc cover his legal fees to defend against criminal charges that he stole secret code from the bank's computers.Fitch: FICC, Underwriting Weigh on Goldman's 4Q'14 ResultsGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   Goldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  (The following statement was released by the rating agency) NEW YORK, January 16 (Fitch) The Goldman Sachs Group, Inc. (Goldman) reported  relatively weaker net revenue in 4Q'14, with declines in fixed income,  currencies and commodities (FICC) and underwriting outpacing strong performance  in financial advisory and equity sales and trading, according to Fitch Ratings.  While Goldman's overall financial performance was down quarter-over-quarter  (QoQ), consistent with its U.S. global trading andGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.        UPDATE 5-Goldman Sachs profit hit by weak fixed-income tradingGoldman need not advance ex-programmer's legal fees - U.S. judgeGoldman need not advance ex-programmer's legal fees - U.S. judgeGoldman need not advance ex-programmer's legal fees - U.S. judgeFitch: FICC, Underwriting Weigh on Goldman's 4Q'14 ResultsGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   Goldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  (The following statement was released by the rating agency) NEW YORK, January 16 (Fitch) The Goldman Sachs Group, Inc. (Goldman) reported  relatively weaker net revenue in 4Q'14, with declines in fixed income,  currencies and commodities (FICC) and underwriting outpacing strong performance  in financial advisory and equity sales and trading, according to Fitch Ratings.  While Goldman's overall financial performance was down quarter-over-quarter  (QoQ), consistent with its U.S. global trading andGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.    Fitch: FICC, Underwriting Weigh on Goldman's 4Q'14 ResultsGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   Goldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  (The following statement was released by the rating agency) NEW YORK, January 16 (Fitch) The Goldman Sachs Group, Inc. (Goldman) reported  relatively weaker net revenue in 4Q'14, with declines in fixed income,  currencies and commodities (FICC) and underwriting outpacing strong performance  in financial advisory and equity sales and trading, according to Fitch Ratings.  While Goldman's overall financial performance was down quarter-over-quarter  (QoQ), consistent with its U.S. global trading andGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   A U.S. federal judge on Friday said computer programmer Sergey Aleynikov is not entitled to have former employer Goldman Sachs Group Inc cover his legal fees to defend against criminal charges that he stole secret code from the bank's computers.Fitch: FICC, Underwriting Weigh on Goldman's 4Q'14 ResultsGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   Goldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  (The following statement was released by the rating agency) NEW YORK, January 16 (Fitch) The Goldman Sachs Group, Inc. (Goldman) reported  relatively weaker net revenue in 4Q'14, with declines in fixed income,  currencies and commodities (FICC) and underwriting outpacing strong performance  in financial advisory and equity sales and trading, according to Fitch Ratings.  While Goldman's overall financial performance was down quarter-over-quarter  (QoQ), consistent with its U.S. global trading andGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.     Goldman need not advance ex-programmer's legal fees - U.S. judgeFitch: FICC, Underwriting Weigh on Goldman's 4Q'14 ResultsGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   Goldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  (The following statement was released by the rating agency) NEW YORK, January 16 (Fitch) The Goldman Sachs Group, Inc. (Goldman) reported  relatively weaker net revenue in 4Q'14, with declines in fixed income,  currencies and commodities (FICC) and underwriting outpacing strong performance  in financial advisory and equity sales and trading, according to Fitch Ratings.  While Goldman's overall financial performance was down quarter-over-quarter  (QoQ), consistent with its U.S. global trading andGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.    Fitch: FICC, Underwriting Weigh on Goldman's 4Q'14 ResultsGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   Goldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  (The following statement was released by the rating agency) NEW YORK, January 16 (Fitch) The Goldman Sachs Group, Inc. (Goldman) reported  relatively weaker net revenue in 4Q'14, with declines in fixed income,  currencies and commodities (FICC) and underwriting outpacing strong performance  in financial advisory and equity sales and trading, according to Fitch Ratings.  While Goldman's overall financial performance was down quarter-over-quarter  (QoQ), consistent with its U.S. global trading andGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   A U.S. federal judge on Friday said computer programmer Sergey Aleynikov is not entitled to have former employer Goldman Sachs Group Inc cover his legal fees to defend against criminal charges that he stole secret code from the bank's computers.Fitch: FICC, Underwriting Weigh on Goldman's 4Q'14 ResultsGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   Goldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  (The following statement was released by the rating agency) NEW YORK, January 16 (Fitch) The Goldman Sachs Group, Inc. (Goldman) reported  relatively weaker net revenue in 4Q'14, with declines in fixed income,  currencies and commodities (FICC) and underwriting outpacing strong performance  in financial advisory and equity sales and trading, according to Fitch Ratings.  While Goldman's overall financial performance was down quarter-over-quarter  (QoQ), consistent with its U.S. global trading andGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.    A U.S. federal judge on Friday said computer programmer Sergey Aleynikov is not entitled to have former employer Goldman Sachs Group Inc cover his legal fees to defend against criminal charges that he stole secret code from the bank's computers.Goldman need not advance ex-programmer's legal fees - U.S. judgeFitch: FICC, Underwriting Weigh on Goldman's 4Q'14 ResultsGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   Goldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  (The following statement was released by the rating agency) NEW YORK, January 16 (Fitch) The Goldman Sachs Group, Inc. (Goldman) reported  relatively weaker net revenue in 4Q'14, with declines in fixed income,  currencies and commodities (FICC) and underwriting outpacing strong performance  in financial advisory and equity sales and trading, according to Fitch Ratings.  While Goldman's overall financial performance was down quarter-over-quarter  (QoQ), consistent with its U.S. global trading andGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.    Fitch: FICC, Underwriting Weigh on Goldman's 4Q'14 ResultsGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   Goldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  (The following statement was released by the rating agency) NEW YORK, January 16 (Fitch) The Goldman Sachs Group, Inc. (Goldman) reported  relatively weaker net revenue in 4Q'14, with declines in fixed income,  currencies and commodities (FICC) and underwriting outpacing strong performance  in financial advisory and equity sales and trading, according to Fitch Ratings.  While Goldman's overall financial performance was down quarter-over-quarter  (QoQ), consistent with its U.S. global trading andGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   A U.S. federal judge on Friday said computer programmer Sergey Aleynikov is not entitled to have former employer Goldman Sachs Group Inc cover his legal fees to defend against criminal charges that he stole secret code from the bank's computers.Fitch: FICC, Underwriting Weigh on Goldman's 4Q'14 ResultsGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   Goldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  (The following statement was released by the rating agency) NEW YORK, January 16 (Fitch) The Goldman Sachs Group, Inc. (Goldman) reported  relatively weaker net revenue in 4Q'14, with declines in fixed income,  currencies and commodities (FICC) and underwriting outpacing strong performance  in financial advisory and equity sales and trading, according to Fitch Ratings.  While Goldman's overall financial performance was down quarter-over-quarter  (QoQ), consistent with its U.S. global trading andGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.      Goldman need not advance ex-programmer's legal fees - U.S. judgeGoldman need not advance ex-programmer's legal fees - U.S. judgeFitch: FICC, Underwriting Weigh on Goldman's 4Q'14 ResultsGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   Goldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  (The following statement was released by the rating agency) NEW YORK, January 16 (Fitch) The Goldman Sachs Group, Inc. (Goldman) reported  relatively weaker net revenue in 4Q'14, with declines in fixed income,  currencies and commodities (FICC) and underwriting outpacing strong performance  in financial advisory and equity sales and trading, according to Fitch Ratings.  While Goldman's overall financial performance was down quarter-over-quarter  (QoQ), consistent with its U.S. global trading andGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.    Fitch: FICC, Underwriting Weigh on Goldman's 4Q'14 ResultsGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   Goldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  (The following statement was released by the rating agency) NEW YORK, January 16 (Fitch) The Goldman Sachs Group, Inc. (Goldman) reported  relatively weaker net revenue in 4Q'14, with declines in fixed income,  currencies and commodities (FICC) and underwriting outpacing strong performance  in financial advisory and equity sales and trading, according to Fitch Ratings.  While Goldman's overall financial performance was down quarter-over-quarter  (QoQ), consistent with its U.S. global trading andGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   A U.S. federal judge on Friday said computer programmer Sergey Aleynikov is not entitled to have former employer Goldman Sachs Group Inc cover his legal fees to defend against criminal charges that he stole secret code from the bank's computers.Fitch: FICC, Underwriting Weigh on Goldman's 4Q'14 ResultsGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   Goldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  (The following statement was released by the rating agency) NEW YORK, January 16 (Fitch) The Goldman Sachs Group, Inc. (Goldman) reported  relatively weaker net revenue in 4Q'14, with declines in fixed income,  currencies and commodities (FICC) and underwriting outpacing strong performance  in financial advisory and equity sales and trading, according to Fitch Ratings.  While Goldman's overall financial performance was down quarter-over-quarter  (QoQ), consistent with its U.S. global trading andGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.     Goldman need not advance ex-programmer's legal fees - U.S. judgeFitch: FICC, Underwriting Weigh on Goldman's 4Q'14 ResultsGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   Goldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  (The following statement was released by the rating agency) NEW YORK, January 16 (Fitch) The Goldman Sachs Group, Inc. (Goldman) reported  relatively weaker net revenue in 4Q'14, with declines in fixed income,  currencies and commodities (FICC) and underwriting outpacing strong performance  in financial advisory and equity sales and trading, according to Fitch Ratings.  While Goldman's overall financial performance was down quarter-over-quarter  (QoQ), consistent with its U.S. global trading andGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.    Fitch: FICC, Underwriting Weigh on Goldman's 4Q'14 ResultsGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   Goldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  (The following statement was released by the rating agency) NEW YORK, January 16 (Fitch) The Goldman Sachs Group, Inc. (Goldman) reported  relatively weaker net revenue in 4Q'14, with declines in fixed income,  currencies and commodities (FICC) and underwriting outpacing strong performance  in financial advisory and equity sales and trading, according to Fitch Ratings.  While Goldman's overall financial performance was down quarter-over-quarter  (QoQ), consistent with its U.S. global trading andGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   A U.S. federal judge on Friday said computer programmer Sergey Aleynikov is not entitled to have former employer Goldman Sachs Group Inc cover his legal fees to defend against criminal charges that he stole secret code from the bank's computers.Fitch: FICC, Underwriting Weigh on Goldman's 4Q'14 ResultsGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   Goldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  (The following statement was released by the rating agency) NEW YORK, January 16 (Fitch) The Goldman Sachs Group, Inc. (Goldman) reported  relatively weaker net revenue in 4Q'14, with declines in fixed income,  currencies and commodities (FICC) and underwriting outpacing strong performance  in financial advisory and equity sales and trading, according to Fitch Ratings.  While Goldman's overall financial performance was down quarter-over-quarter  (QoQ), consistent with its U.S. global trading andGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.    A U.S. federal judge on Friday said computer programmer Sergey Aleynikov is not entitled to have former employer Goldman Sachs Group Inc cover his legal fees to defend against criminal charges that he stole secret code from the bank's computers.Goldman need not advance ex-programmer's legal fees - U.S. judgeFitch: FICC, Underwriting Weigh on Goldman's 4Q'14 ResultsGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   Goldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  (The following statement was released by the rating agency) NEW YORK, January 16 (Fitch) The Goldman Sachs Group, Inc. (Goldman) reported  relatively weaker net revenue in 4Q'14, with declines in fixed income,  currencies and commodities (FICC) and underwriting outpacing strong performance  in financial advisory and equity sales and trading, according to Fitch Ratings.  While Goldman's overall financial performance was down quarter-over-quarter  (QoQ), consistent with its U.S. global trading andGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.    Fitch: FICC, Underwriting Weigh on Goldman's 4Q'14 ResultsGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   Goldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  (The following statement was released by the rating agency) NEW YORK, January 16 (Fitch) The Goldman Sachs Group, Inc. (Goldman) reported  relatively weaker net revenue in 4Q'14, with declines in fixed income,  currencies and commodities (FICC) and underwriting outpacing strong performance  in financial advisory and equity sales and trading, according to Fitch Ratings.  While Goldman's overall financial performance was down quarter-over-quarter  (QoQ), consistent with its U.S. global trading andGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   A U.S. federal judge on Friday said computer programmer Sergey Aleynikov is not entitled to have former employer Goldman Sachs Group Inc cover his legal fees to defend against criminal charges that he stole secret code from the bank's computers.Fitch: FICC, Underwriting Weigh on Goldman's 4Q'14 ResultsGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   Goldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  (The following statement was released by the rating agency) NEW YORK, January 16 (Fitch) The Goldman Sachs Group, Inc. (Goldman) reported  relatively weaker net revenue in 4Q'14, with declines in fixed income,  currencies and commodities (FICC) and underwriting outpacing strong performance  in financial advisory and equity sales and trading, according to Fitch Ratings.  While Goldman's overall financial performance was down quarter-over-quarter  (QoQ), consistent with its U.S. global trading andGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.     Jan 16 A U.S. federal judge on Friday said computer programmer Sergey Aleynikov is not entitled to have former employer Goldman Sachs Group Inc cover his legal fees to defend against criminal charges that he stole secret code from the bank's computers.Goldman need not advance ex-programmer's legal fees - U.S. judgeGoldman need not advance ex-programmer's legal fees - U.S. judgeFitch: FICC, Underwriting Weigh on Goldman's 4Q'14 ResultsGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   Goldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  (The following statement was released by the rating agency) NEW YORK, January 16 (Fitch) The Goldman Sachs Group, Inc. (Goldman) reported  relatively weaker net revenue in 4Q'14, with declines in fixed income,  currencies and commodities (FICC) and underwriting outpacing strong performance  in financial advisory and equity sales and trading, according to Fitch Ratings.  While Goldman's overall financial performance was down quarter-over-quarter  (QoQ), consistent with its U.S. global trading andGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.    Fitch: FICC, Underwriting Weigh on Goldman's 4Q'14 ResultsGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   Goldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  (The following statement was released by the rating agency) NEW YORK, January 16 (Fitch) The Goldman Sachs Group, Inc. (Goldman) reported  relatively weaker net revenue in 4Q'14, with declines in fixed income,  currencies and commodities (FICC) and underwriting outpacing strong performance  in financial advisory and equity sales and trading, according to Fitch Ratings.  While Goldman's overall financial performance was down quarter-over-quarter  (QoQ), consistent with its U.S. global trading andGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   A U.S. federal judge on Friday said computer programmer Sergey Aleynikov is not entitled to have former employer Goldman Sachs Group Inc cover his legal fees to defend against criminal charges that he stole secret code from the bank's computers.Fitch: FICC, Underwriting Weigh on Goldman's 4Q'14 ResultsGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   Goldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  (The following statement was released by the rating agency) NEW YORK, January 16 (Fitch) The Goldman Sachs Group, Inc. (Goldman) reported  relatively weaker net revenue in 4Q'14, with declines in fixed income,  currencies and commodities (FICC) and underwriting outpacing strong performance  in financial advisory and equity sales and trading, according to Fitch Ratings.  While Goldman's overall financial performance was down quarter-over-quarter  (QoQ), consistent with its U.S. global trading andGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.     Goldman need not advance ex-programmer's legal fees - U.S. judgeFitch: FICC, Underwriting Weigh on Goldman's 4Q'14 ResultsGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   Goldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  (The following statement was released by the rating agency) NEW YORK, January 16 (Fitch) The Goldman Sachs Group, Inc. (Goldman) reported  relatively weaker net revenue in 4Q'14, with declines in fixed income,  currencies and commodities (FICC) and underwriting outpacing strong performance  in financial advisory and equity sales and trading, according to Fitch Ratings.  While Goldman's overall financial performance was down quarter-over-quarter  (QoQ), consistent with its U.S. global trading andGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.    Fitch: FICC, Underwriting Weigh on Goldman's 4Q'14 ResultsGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   Goldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  (The following statement was released by the rating agency) NEW YORK, January 16 (Fitch) The Goldman Sachs Group, Inc. (Goldman) reported  relatively weaker net revenue in 4Q'14, with declines in fixed income,  currencies and commodities (FICC) and underwriting outpacing strong performance  in financial advisory and equity sales and trading, according to Fitch Ratings.  While Goldman's overall financial performance was down quarter-over-quarter  (QoQ), consistent with its U.S. global trading andGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   A U.S. federal judge on Friday said computer programmer Sergey Aleynikov is not entitled to have former employer Goldman Sachs Group Inc cover his legal fees to defend against criminal charges that he stole secret code from the bank's computers.Fitch: FICC, Underwriting Weigh on Goldman's 4Q'14 ResultsGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   Goldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  (The following statement was released by the rating agency) NEW YORK, January 16 (Fitch) The Goldman Sachs Group, Inc. (Goldman) reported  relatively weaker net revenue in 4Q'14, with declines in fixed income,  currencies and commodities (FICC) and underwriting outpacing strong performance  in financial advisory and equity sales and trading, according to Fitch Ratings.  While Goldman's overall financial performance was down quarter-over-quarter  (QoQ), consistent with its U.S. global trading andGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.    A U.S. federal judge on Friday said computer programmer Sergey Aleynikov is not entitled to have former employer Goldman Sachs Group Inc cover his legal fees to defend against criminal charges that he stole secret code from the bank's computers.Goldman need not advance ex-programmer's legal fees - U.S. judgeFitch: FICC, Underwriting Weigh on Goldman's 4Q'14 ResultsGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   Goldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  (The following statement was released by the rating agency) NEW YORK, January 16 (Fitch) The Goldman Sachs Group, Inc. (Goldman) reported  relatively weaker net revenue in 4Q'14, with declines in fixed income,  currencies and commodities (FICC) and underwriting outpacing strong performance  in financial advisory and equity sales and trading, according to Fitch Ratings.  While Goldman's overall financial performance was down quarter-over-quarter  (QoQ), consistent with its U.S. global trading andGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.    Fitch: FICC, Underwriting Weigh on Goldman's 4Q'14 ResultsGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   Goldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  (The following statement was released by the rating agency) NEW YORK, January 16 (Fitch) The Goldman Sachs Group, Inc. (Goldman) reported  relatively weaker net revenue in 4Q'14, with declines in fixed income,  currencies and commodities (FICC) and underwriting outpacing strong performance  in financial advisory and equity sales and trading, according to Fitch Ratings.  While Goldman's overall financial performance was down quarter-over-quarter  (QoQ), consistent with its U.S. global trading andGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   A U.S. federal judge on Friday said computer programmer Sergey Aleynikov is not entitled to have former employer Goldman Sachs Group Inc cover his legal fees to defend against criminal charges that he stole secret code from the bank's computers.Fitch: FICC, Underwriting Weigh on Goldman's 4Q'14 ResultsGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   Goldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  (The following statement was released by the rating agency) NEW YORK, January 16 (Fitch) The Goldman Sachs Group, Inc. (Goldman) reported  relatively weaker net revenue in 4Q'14, with declines in fixed income,  currencies and commodities (FICC) and underwriting outpacing strong performance  in financial advisory and equity sales and trading, according to Fitch Ratings.  While Goldman's overall financial performance was down quarter-over-quarter  (QoQ), consistent with its U.S. global trading andGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.       Goldman need not advance ex-programmer's legal fees - U.S. judgeGoldman need not advance ex-programmer's legal fees - U.S. judgeGoldman need not advance ex-programmer's legal fees - U.S. judgeFitch: FICC, Underwriting Weigh on Goldman's 4Q'14 ResultsGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   Goldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  (The following statement was released by the rating agency) NEW YORK, January 16 (Fitch) The Goldman Sachs Group, Inc. (Goldman) reported  relatively weaker net revenue in 4Q'14, with declines in fixed income,  currencies and commodities (FICC) and underwriting outpacing strong performance  in financial advisory and equity sales and trading, according to Fitch Ratings.  While Goldman's overall financial performance was down quarter-over-quarter  (QoQ), consistent with its U.S. global trading andGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.    Fitch: FICC, Underwriting Weigh on Goldman's 4Q'14 ResultsGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   Goldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  (The following statement was released by the rating agency) NEW YORK, January 16 (Fitch) The Goldman Sachs Group, Inc. (Goldman) reported  relatively weaker net revenue in 4Q'14, with declines in fixed income,  currencies and commodities (FICC) and underwriting outpacing strong performance  in financial advisory and equity sales and trading, according to Fitch Ratings.  While Goldman's overall financial performance was down quarter-over-quarter  (QoQ), consistent with its U.S. global trading andGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   A U.S. federal judge on Friday said computer programmer Sergey Aleynikov is not entitled to have former employer Goldman Sachs Group Inc cover his legal fees to defend against criminal charges that he stole secret code from the bank's computers.Fitch: FICC, Underwriting Weigh on Goldman's 4Q'14 ResultsGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   Goldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  (The following statement was released by the rating agency) NEW YORK, January 16 (Fitch) The Goldman Sachs Group, Inc. (Goldman) reported  relatively weaker net revenue in 4Q'14, with declines in fixed income,  currencies and commodities (FICC) and underwriting outpacing strong performance  in financial advisory and equity sales and trading, according to Fitch Ratings.  While Goldman's overall financial performance was down quarter-over-quarter  (QoQ), consistent with its U.S. global trading andGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.     Goldman need not advance ex-programmer's legal fees - U.S. judgeFitch: FICC, Underwriting Weigh on Goldman's 4Q'14 ResultsGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   Goldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  (The following statement was released by the rating agency) NEW YORK, January 16 (Fitch) The Goldman Sachs Group, Inc. (Goldman) reported  relatively weaker net revenue in 4Q'14, with declines in fixed income,  currencies and commodities (FICC) and underwriting outpacing strong performance  in financial advisory and equity sales and trading, according to Fitch Ratings.  While Goldman's overall financial performance was down quarter-over-quarter  (QoQ), consistent with its U.S. global trading andGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.    Fitch: FICC, Underwriting Weigh on Goldman's 4Q'14 ResultsGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   Goldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  (The following statement was released by the rating agency) NEW YORK, January 16 (Fitch) The Goldman Sachs Group, Inc. (Goldman) reported  relatively weaker net revenue in 4Q'14, with declines in fixed income,  currencies and commodities (FICC) and underwriting outpacing strong performance  in financial advisory and equity sales and trading, according to Fitch Ratings.  While Goldman's overall financial performance was down quarter-over-quarter  (QoQ), consistent with its U.S. global trading andGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   A U.S. federal judge on Friday said computer programmer Sergey Aleynikov is not entitled to have former employer Goldman Sachs Group Inc cover his legal fees to defend against criminal charges that he stole secret code from the bank's computers.Fitch: FICC, Underwriting Weigh on Goldman's 4Q'14 ResultsGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   Goldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  (The following statement was released by the rating agency) NEW YORK, January 16 (Fitch) The Goldman Sachs Group, Inc. (Goldman) reported  relatively weaker net revenue in 4Q'14, with declines in fixed income,  currencies and commodities (FICC) and underwriting outpacing strong performance  in financial advisory and equity sales and trading, according to Fitch Ratings.  While Goldman's overall financial performance was down quarter-over-quarter  (QoQ), consistent with its U.S. global trading andGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.    A U.S. federal judge on Friday said computer programmer Sergey Aleynikov is not entitled to have former employer Goldman Sachs Group Inc cover his legal fees to defend against criminal charges that he stole secret code from the bank's computers.Goldman need not advance ex-programmer's legal fees - U.S. judgeFitch: FICC, Underwriting Weigh on Goldman's 4Q'14 ResultsGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   Goldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  (The following statement was released by the rating agency) NEW YORK, January 16 (Fitch) The Goldman Sachs Group, Inc. (Goldman) reported  relatively weaker net revenue in 4Q'14, with declines in fixed income,  currencies and commodities (FICC) and underwriting outpacing strong performance  in financial advisory and equity sales and trading, according to Fitch Ratings.  While Goldman's overall financial performance was down quarter-over-quarter  (QoQ), consistent with its U.S. global trading andGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.    Fitch: FICC, Underwriting Weigh on Goldman's 4Q'14 ResultsGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   Goldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  (The following statement was released by the rating agency) NEW YORK, January 16 (Fitch) The Goldman Sachs Group, Inc. (Goldman) reported  relatively weaker net revenue in 4Q'14, with declines in fixed income,  currencies and commodities (FICC) and underwriting outpacing strong performance  in financial advisory and equity sales and trading, according to Fitch Ratings.  While Goldman's overall financial performance was down quarter-over-quarter  (QoQ), consistent with its U.S. global trading andGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   A U.S. federal judge on Friday said computer programmer Sergey Aleynikov is not entitled to have former employer Goldman Sachs Group Inc cover his legal fees to defend against criminal charges that he stole secret code from the bank's computers.Fitch: FICC, Underwriting Weigh on Goldman's 4Q'14 ResultsGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   Goldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  (The following statement was released by the rating agency) NEW YORK, January 16 (Fitch) The Goldman Sachs Group, Inc. (Goldman) reported  relatively weaker net revenue in 4Q'14, with declines in fixed income,  currencies and commodities (FICC) and underwriting outpacing strong performance  in financial advisory and equity sales and trading, according to Fitch Ratings.  While Goldman's overall financial performance was down quarter-over-quarter  (QoQ), consistent with its U.S. global trading andGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.      Goldman need not advance ex-programmer's legal fees - U.S. judgeGoldman need not advance ex-programmer's legal fees - U.S. judgeFitch: FICC, Underwriting Weigh on Goldman's 4Q'14 ResultsGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   Goldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  (The following statement was released by the rating agency) NEW YORK, January 16 (Fitch) The Goldman Sachs Group, Inc. (Goldman) reported  relatively weaker net revenue in 4Q'14, with declines in fixed income,  currencies and commodities (FICC) and underwriting outpacing strong performance  in financial advisory and equity sales and trading, according to Fitch Ratings.  While Goldman's overall financial performance was down quarter-over-quarter  (QoQ), consistent with its U.S. global trading andGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.    Fitch: FICC, Underwriting Weigh on Goldman's 4Q'14 ResultsGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   Goldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  (The following statement was released by the rating agency) NEW YORK, January 16 (Fitch) The Goldman Sachs Group, Inc. (Goldman) reported  relatively weaker net revenue in 4Q'14, with declines in fixed income,  currencies and commodities (FICC) and underwriting outpacing strong performance  in financial advisory and equity sales and trading, according to Fitch Ratings.  While Goldman's overall financial performance was down quarter-over-quarter  (QoQ), consistent with its U.S. global trading andGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   A U.S. federal judge on Friday said computer programmer Sergey Aleynikov is not entitled to have former employer Goldman Sachs Group Inc cover his legal fees to defend against criminal charges that he stole secret code from the bank's computers.Fitch: FICC, Underwriting Weigh on Goldman's 4Q'14 ResultsGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   Goldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  (The following statement was released by the rating agency) NEW YORK, January 16 (Fitch) The Goldman Sachs Group, Inc. (Goldman) reported  relatively weaker net revenue in 4Q'14, with declines in fixed income,  currencies and commodities (FICC) and underwriting outpacing strong performance  in financial advisory and equity sales and trading, according to Fitch Ratings.  While Goldman's overall financial performance was down quarter-over-quarter  (QoQ), consistent with its U.S. global trading andGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.     Goldman need not advance ex-programmer's legal fees - U.S. judgeFitch: FICC, Underwriting Weigh on Goldman's 4Q'14 ResultsGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   Goldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  (The following statement was released by the rating agency) NEW YORK, January 16 (Fitch) The Goldman Sachs Group, Inc. (Goldman) reported  relatively weaker net revenue in 4Q'14, with declines in fixed income,  currencies and commodities (FICC) and underwriting outpacing strong performance  in financial advisory and equity sales and trading, according to Fitch Ratings.  While Goldman's overall financial performance was down quarter-over-quarter  (QoQ), consistent with its U.S. global trading andGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.    Fitch: FICC, Underwriting Weigh on Goldman's 4Q'14 ResultsGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   Goldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  (The following statement was released by the rating agency) NEW YORK, January 16 (Fitch) The Goldman Sachs Group, Inc. (Goldman) reported  relatively weaker net revenue in 4Q'14, with declines in fixed income,  currencies and commodities (FICC) and underwriting outpacing strong performance  in financial advisory and equity sales and trading, according to Fitch Ratings.  While Goldman's overall financial performance was down quarter-over-quarter  (QoQ), consistent with its U.S. global trading andGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   A U.S. federal judge on Friday said computer programmer Sergey Aleynikov is not entitled to have former employer Goldman Sachs Group Inc cover his legal fees to defend against criminal charges that he stole secret code from the bank's computers.Fitch: FICC, Underwriting Weigh on Goldman's 4Q'14 ResultsGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   Goldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  (The following statement was released by the rating agency) NEW YORK, January 16 (Fitch) The Goldman Sachs Group, Inc. (Goldman) reported  relatively weaker net revenue in 4Q'14, with declines in fixed income,  currencies and commodities (FICC) and underwriting outpacing strong performance  in financial advisory and equity sales and trading, according to Fitch Ratings.  While Goldman's overall financial performance was down quarter-over-quarter  (QoQ), consistent with its U.S. global trading andGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.    A U.S. federal judge on Friday said computer programmer Sergey Aleynikov is not entitled to have former employer Goldman Sachs Group Inc cover his legal fees to defend against criminal charges that he stole secret code from the bank's computers.Goldman need not advance ex-programmer's legal fees - U.S. judgeFitch: FICC, Underwriting Weigh on Goldman's 4Q'14 ResultsGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   Goldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  (The following statement was released by the rating agency) NEW YORK, January 16 (Fitch) The Goldman Sachs Group, Inc. (Goldman) reported  relatively weaker net revenue in 4Q'14, with declines in fixed income,  currencies and commodities (FICC) and underwriting outpacing strong performance  in financial advisory and equity sales and trading, according to Fitch Ratings.  While Goldman's overall financial performance was down quarter-over-quarter  (QoQ), consistent with its U.S. global trading andGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.    Fitch: FICC, Underwriting Weigh on Goldman's 4Q'14 ResultsGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   Goldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  (The following statement was released by the rating agency) NEW YORK, January 16 (Fitch) The Goldman Sachs Group, Inc. (Goldman) reported  relatively weaker net revenue in 4Q'14, with declines in fixed income,  currencies and commodities (FICC) and underwriting outpacing strong performance  in financial advisory and equity sales and trading, according to Fitch Ratings.  While Goldman's overall financial performance was down quarter-over-quarter  (QoQ), consistent with its U.S. global trading andGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   A U.S. federal judge on Friday said computer programmer Sergey Aleynikov is not entitled to have former employer Goldman Sachs Group Inc cover his legal fees to defend against criminal charges that he stole secret code from the bank's computers.Fitch: FICC, Underwriting Weigh on Goldman's 4Q'14 ResultsGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   Goldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  (The following statement was released by the rating agency) NEW YORK, January 16 (Fitch) The Goldman Sachs Group, Inc. (Goldman) reported  relatively weaker net revenue in 4Q'14, with declines in fixed income,  currencies and commodities (FICC) and underwriting outpacing strong performance  in financial advisory and equity sales and trading, according to Fitch Ratings.  While Goldman's overall financial performance was down quarter-over-quarter  (QoQ), consistent with its U.S. global trading andGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.     Jan 16 A U.S. federal judge on Friday said computer programmer Sergey Aleynikov is not entitled to have former employer Goldman Sachs Group Inc cover his legal fees to defend against criminal charges that he stole secret code from the bank's computers.Goldman need not advance ex-programmer's legal fees - U.S. judgeGoldman need not advance ex-programmer's legal fees - U.S. judgeFitch: FICC, Underwriting Weigh on Goldman's 4Q'14 ResultsGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   Goldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  (The following statement was released by the rating agency) NEW YORK, January 16 (Fitch) The Goldman Sachs Group, Inc. (Goldman) reported  relatively weaker net revenue in 4Q'14, with declines in fixed income,  currencies and commodities (FICC) and underwriting outpacing strong performance  in financial advisory and equity sales and trading, according to Fitch Ratings.  While Goldman's overall financial performance was down quarter-over-quarter  (QoQ), consistent with its U.S. global trading andGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.    Fitch: FICC, Underwriting Weigh on Goldman's 4Q'14 ResultsGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   Goldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  (The following statement was released by the rating agency) NEW YORK, January 16 (Fitch) The Goldman Sachs Group, Inc. (Goldman) reported  relatively weaker net revenue in 4Q'14, with declines in fixed income,  currencies and commodities (FICC) and underwriting outpacing strong performance  in financial advisory and equity sales and trading, according to Fitch Ratings.  While Goldman's overall financial performance was down quarter-over-quarter  (QoQ), consistent with its U.S. global trading andGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   A U.S. federal judge on Friday said computer programmer Sergey Aleynikov is not entitled to have former employer Goldman Sachs Group Inc cover his legal fees to defend against criminal charges that he stole secret code from the bank's computers.Fitch: FICC, Underwriting Weigh on Goldman's 4Q'14 ResultsGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   Goldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  (The following statement was released by the rating agency) NEW YORK, January 16 (Fitch) The Goldman Sachs Group, Inc. (Goldman) reported  relatively weaker net revenue in 4Q'14, with declines in fixed income,  currencies and commodities (FICC) and underwriting outpacing strong performance  in financial advisory and equity sales and trading, according to Fitch Ratings.  While Goldman's overall financial performance was down quarter-over-quarter  (QoQ), consistent with its U.S. global trading andGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.     Goldman need not advance ex-programmer's legal fees - U.S. judgeFitch: FICC, Underwriting Weigh on Goldman's 4Q'14 ResultsGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   Goldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  (The following statement was released by the rating agency) NEW YORK, January 16 (Fitch) The Goldman Sachs Group, Inc. (Goldman) reported  relatively weaker net revenue in 4Q'14, with declines in fixed income,  currencies and commodities (FICC) and underwriting outpacing strong performance  in financial advisory and equity sales and trading, according to Fitch Ratings.  While Goldman's overall financial performance was down quarter-over-quarter  (QoQ), consistent with its U.S. global trading andGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.    Fitch: FICC, Underwriting Weigh on Goldman's 4Q'14 ResultsGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   Goldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  (The following statement was released by the rating agency) NEW YORK, January 16 (Fitch) The Goldman Sachs Group, Inc. (Goldman) reported  relatively weaker net revenue in 4Q'14, with declines in fixed income,  currencies and commodities (FICC) and underwriting outpacing strong performance  in financial advisory and equity sales and trading, according to Fitch Ratings.  While Goldman's overall financial performance was down quarter-over-quarter  (QoQ), consistent with its U.S. global trading andGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   A U.S. federal judge on Friday said computer programmer Sergey Aleynikov is not entitled to have former employer Goldman Sachs Group Inc cover his legal fees to defend against criminal charges that he stole secret code from the bank's computers.Fitch: FICC, Underwriting Weigh on Goldman's 4Q'14 ResultsGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   Goldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  (The following statement was released by the rating agency) NEW YORK, January 16 (Fitch) The Goldman Sachs Group, Inc. (Goldman) reported  relatively weaker net revenue in 4Q'14, with declines in fixed income,  currencies and commodities (FICC) and underwriting outpacing strong performance  in financial advisory and equity sales and trading, according to Fitch Ratings.  While Goldman's overall financial performance was down quarter-over-quarter  (QoQ), consistent with its U.S. global trading andGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.    A U.S. federal judge on Friday said computer programmer Sergey Aleynikov is not entitled to have former employer Goldman Sachs Group Inc cover his legal fees to defend against criminal charges that he stole secret code from the bank's computers.Goldman need not advance ex-programmer's legal fees - U.S. judgeFitch: FICC, Underwriting Weigh on Goldman's 4Q'14 ResultsGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   Goldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  (The following statement was released by the rating agency) NEW YORK, January 16 (Fitch) The Goldman Sachs Group, Inc. (Goldman) reported  relatively weaker net revenue in 4Q'14, with declines in fixed income,  currencies and commodities (FICC) and underwriting outpacing strong performance  in financial advisory and equity sales and trading, according to Fitch Ratings.  While Goldman's overall financial performance was down quarter-over-quarter  (QoQ), consistent with its U.S. global trading andGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.    Fitch: FICC, Underwriting Weigh on Goldman's 4Q'14 ResultsGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   Goldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  (The following statement was released by the rating agency) NEW YORK, January 16 (Fitch) The Goldman Sachs Group, Inc. (Goldman) reported  relatively weaker net revenue in 4Q'14, with declines in fixed income,  currencies and commodities (FICC) and underwriting outpacing strong performance  in financial advisory and equity sales and trading, according to Fitch Ratings.  While Goldman's overall financial performance was down quarter-over-quarter  (QoQ), consistent with its U.S. global trading andGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   A U.S. federal judge on Friday said computer programmer Sergey Aleynikov is not entitled to have former employer Goldman Sachs Group Inc cover his legal fees to defend against criminal charges that he stole secret code from the bank's computers.Fitch: FICC, Underwriting Weigh on Goldman's 4Q'14 ResultsGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   Goldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  (The following statement was released by the rating agency) NEW YORK, January 16 (Fitch) The Goldman Sachs Group, Inc. (Goldman) reported  relatively weaker net revenue in 4Q'14, with declines in fixed income,  currencies and commodities (FICC) and underwriting outpacing strong performance  in financial advisory and equity sales and trading, according to Fitch Ratings.  While Goldman's overall financial performance was down quarter-over-quarter  (QoQ), consistent with its U.S. global trading andGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.      * Shares down less than 1 pct in midday trading   (Adds details from conference call; updates share move)Goldman need not advance ex-programmer's legal fees - U.S. judgeGoldman need not advance ex-programmer's legal fees - U.S. judgeGoldman need not advance ex-programmer's legal fees - U.S. judgeFitch: FICC, Underwriting Weigh on Goldman's 4Q'14 ResultsGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   Goldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  (The following statement was released by the rating agency) NEW YORK, January 16 (Fitch) The Goldman Sachs Group, Inc. (Goldman) reported  relatively weaker net revenue in 4Q'14, with declines in fixed income,  currencies and commodities (FICC) and underwriting outpacing strong performance  in financial advisory and equity sales and trading, according to Fitch Ratings.  While Goldman's overall financial performance was down quarter-over-quarter  (QoQ), consistent with its U.S. global trading andGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.    Fitch: FICC, Underwriting Weigh on Goldman's 4Q'14 ResultsGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   Goldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  (The following statement was released by the rating agency) NEW YORK, January 16 (Fitch) The Goldman Sachs Group, Inc. (Goldman) reported  relatively weaker net revenue in 4Q'14, with declines in fixed income,  currencies and commodities (FICC) and underwriting outpacing strong performance  in financial advisory and equity sales and trading, according to Fitch Ratings.  While Goldman's overall financial performance was down quarter-over-quarter  (QoQ), consistent with its U.S. global trading andGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   A U.S. federal judge on Friday said computer programmer Sergey Aleynikov is not entitled to have former employer Goldman Sachs Group Inc cover his legal fees to defend against criminal charges that he stole secret code from the bank's computers.Fitch: FICC, Underwriting Weigh on Goldman's 4Q'14 ResultsGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   Goldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  (The following statement was released by the rating agency) NEW YORK, January 16 (Fitch) The Goldman Sachs Group, Inc. (Goldman) reported  relatively weaker net revenue in 4Q'14, with declines in fixed income,  currencies and commodities (FICC) and underwriting outpacing strong performance  in financial advisory and equity sales and trading, according to Fitch Ratings.  While Goldman's overall financial performance was down quarter-over-quarter  (QoQ), consistent with its U.S. global trading andGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.     Goldman need not advance ex-programmer's legal fees - U.S. judgeFitch: FICC, Underwriting Weigh on Goldman's 4Q'14 ResultsGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   Goldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  (The following statement was released by the rating agency) NEW YORK, January 16 (Fitch) The Goldman Sachs Group, Inc. (Goldman) reported  relatively weaker net revenue in 4Q'14, with declines in fixed income,  currencies and commodities (FICC) and underwriting outpacing strong performance  in financial advisory and equity sales and trading, according to Fitch Ratings.  While Goldman's overall financial performance was down quarter-over-quarter  (QoQ), consistent with its U.S. global trading andGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.    Fitch: FICC, Underwriting Weigh on Goldman's 4Q'14 ResultsGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   Goldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  (The following statement was released by the rating agency) NEW YORK, January 16 (Fitch) The Goldman Sachs Group, Inc. (Goldman) reported  relatively weaker net revenue in 4Q'14, with declines in fixed income,  currencies and commodities (FICC) and underwriting outpacing strong performance  in financial advisory and equity sales and trading, according to Fitch Ratings.  While Goldman's overall financial performance was down quarter-over-quarter  (QoQ), consistent with its U.S. global trading andGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   A U.S. federal judge on Friday said computer programmer Sergey Aleynikov is not entitled to have former employer Goldman Sachs Group Inc cover his legal fees to defend against criminal charges that he stole secret code from the bank's computers.Fitch: FICC, Underwriting Weigh on Goldman's 4Q'14 ResultsGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   Goldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  (The following statement was released by the rating agency) NEW YORK, January 16 (Fitch) The Goldman Sachs Group, Inc. (Goldman) reported  relatively weaker net revenue in 4Q'14, with declines in fixed income,  currencies and commodities (FICC) and underwriting outpacing strong performance  in financial advisory and equity sales and trading, according to Fitch Ratings.  While Goldman's overall financial performance was down quarter-over-quarter  (QoQ), consistent with its U.S. global trading andGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.    A U.S. federal judge on Friday said computer programmer Sergey Aleynikov is not entitled to have former employer Goldman Sachs Group Inc cover his legal fees to defend against criminal charges that he stole secret code from the bank's computers.Goldman need not advance ex-programmer's legal fees - U.S. judgeFitch: FICC, Underwriting Weigh on Goldman's 4Q'14 ResultsGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   Goldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  (The following statement was released by the rating agency) NEW YORK, January 16 (Fitch) The Goldman Sachs Group, Inc. (Goldman) reported  relatively weaker net revenue in 4Q'14, with declines in fixed income,  currencies and commodities (FICC) and underwriting outpacing strong performance  in financial advisory and equity sales and trading, according to Fitch Ratings.  While Goldman's overall financial performance was down quarter-over-quarter  (QoQ), consistent with its U.S. global trading andGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.    Fitch: FICC, Underwriting Weigh on Goldman's 4Q'14 ResultsGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   Goldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  (The following statement was released by the rating agency) NEW YORK, January 16 (Fitch) The Goldman Sachs Group, Inc. (Goldman) reported  relatively weaker net revenue in 4Q'14, with declines in fixed income,  currencies and commodities (FICC) and underwriting outpacing strong performance  in financial advisory and equity sales and trading, according to Fitch Ratings.  While Goldman's overall financial performance was down quarter-over-quarter  (QoQ), consistent with its U.S. global trading andGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   A U.S. federal judge on Friday said computer programmer Sergey Aleynikov is not entitled to have former employer Goldman Sachs Group Inc cover his legal fees to defend against criminal charges that he stole secret code from the bank's computers.Fitch: FICC, Underwriting Weigh on Goldman's 4Q'14 ResultsGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   Goldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  (The following statement was released by the rating agency) NEW YORK, January 16 (Fitch) The Goldman Sachs Group, Inc. (Goldman) reported  relatively weaker net revenue in 4Q'14, with declines in fixed income,  currencies and commodities (FICC) and underwriting outpacing strong performance  in financial advisory and equity sales and trading, according to Fitch Ratings.  While Goldman's overall financial performance was down quarter-over-quarter  (QoQ), consistent with its U.S. global trading andGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.      Goldman need not advance ex-programmer's legal fees - U.S. judgeGoldman need not advance ex-programmer's legal fees - U.S. judgeFitch: FICC, Underwriting Weigh on Goldman's 4Q'14 ResultsGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   Goldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  (The following statement was released by the rating agency) NEW YORK, January 16 (Fitch) The Goldman Sachs Group, Inc. (Goldman) reported  relatively weaker net revenue in 4Q'14, with declines in fixed income,  currencies and commodities (FICC) and underwriting outpacing strong performance  in financial advisory and equity sales and trading, according to Fitch Ratings.  While Goldman's overall financial performance was down quarter-over-quarter  (QoQ), consistent with its U.S. global trading andGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.    Fitch: FICC, Underwriting Weigh on Goldman's 4Q'14 ResultsGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   Goldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  (The following statement was released by the rating agency) NEW YORK, January 16 (Fitch) The Goldman Sachs Group, Inc. (Goldman) reported  relatively weaker net revenue in 4Q'14, with declines in fixed income,  currencies and commodities (FICC) and underwriting outpacing strong performance  in financial advisory and equity sales and trading, according to Fitch Ratings.  While Goldman's overall financial performance was down quarter-over-quarter  (QoQ), consistent with its U.S. global trading andGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   A U.S. federal judge on Friday said computer programmer Sergey Aleynikov is not entitled to have former employer Goldman Sachs Group Inc cover his legal fees to defend against criminal charges that he stole secret code from the bank's computers.Fitch: FICC, Underwriting Weigh on Goldman's 4Q'14 ResultsGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   Goldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  (The following statement was released by the rating agency) NEW YORK, January 16 (Fitch) The Goldman Sachs Group, Inc. (Goldman) reported  relatively weaker net revenue in 4Q'14, with declines in fixed income,  currencies and commodities (FICC) and underwriting outpacing strong performance  in financial advisory and equity sales and trading, according to Fitch Ratings.  While Goldman's overall financial performance was down quarter-over-quarter  (QoQ), consistent with its U.S. global trading andGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.     Goldman need not advance ex-programmer's legal fees - U.S. judgeFitch: FICC, Underwriting Weigh on Goldman's 4Q'14 ResultsGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   Goldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  (The following statement was released by the rating agency) NEW YORK, January 16 (Fitch) The Goldman Sachs Group, Inc. (Goldman) reported  relatively weaker net revenue in 4Q'14, with declines in fixed income,  currencies and commodities (FICC) and underwriting outpacing strong performance  in financial advisory and equity sales and trading, according to Fitch Ratings.  While Goldman's overall financial performance was down quarter-over-quarter  (QoQ), consistent with its U.S. global trading andGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.    Fitch: FICC, Underwriting Weigh on Goldman's 4Q'14 ResultsGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   Goldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  (The following statement was released by the rating agency) NEW YORK, January 16 (Fitch) The Goldman Sachs Group, Inc. (Goldman) reported  relatively weaker net revenue in 4Q'14, with declines in fixed income,  currencies and commodities (FICC) and underwriting outpacing strong performance  in financial advisory and equity sales and trading, according to Fitch Ratings.  While Goldman's overall financial performance was down quarter-over-quarter  (QoQ), consistent with its U.S. global trading andGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   A U.S. federal judge on Friday said computer programmer Sergey Aleynikov is not entitled to have former employer Goldman Sachs Group Inc cover his legal fees to defend against criminal charges that he stole secret code from the bank's computers.Fitch: FICC, Underwriting Weigh on Goldman's 4Q'14 ResultsGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   Goldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  (The following statement was released by the rating agency) NEW YORK, January 16 (Fitch) The Goldman Sachs Group, Inc. (Goldman) reported  relatively weaker net revenue in 4Q'14, with declines in fixed income,  currencies and commodities (FICC) and underwriting outpacing strong performance  in financial advisory and equity sales and trading, according to Fitch Ratings.  While Goldman's overall financial performance was down quarter-over-quarter  (QoQ), consistent with its U.S. global trading andGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.    A U.S. federal judge on Friday said computer programmer Sergey Aleynikov is not entitled to have former employer Goldman Sachs Group Inc cover his legal fees to defend against criminal charges that he stole secret code from the bank's computers.Goldman need not advance ex-programmer's legal fees - U.S. judgeFitch: FICC, Underwriting Weigh on Goldman's 4Q'14 ResultsGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   Goldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  (The following statement was released by the rating agency) NEW YORK, January 16 (Fitch) The Goldman Sachs Group, Inc. (Goldman) reported  relatively weaker net revenue in 4Q'14, with declines in fixed income,  currencies and commodities (FICC) and underwriting outpacing strong performance  in financial advisory and equity sales and trading, according to Fitch Ratings.  While Goldman's overall financial performance was down quarter-over-quarter  (QoQ), consistent with its U.S. global trading andGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.    Fitch: FICC, Underwriting Weigh on Goldman's 4Q'14 ResultsGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   Goldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  (The following statement was released by the rating agency) NEW YORK, January 16 (Fitch) The Goldman Sachs Group, Inc. (Goldman) reported  relatively weaker net revenue in 4Q'14, with declines in fixed income,  currencies and commodities (FICC) and underwriting outpacing strong performance  in financial advisory and equity sales and trading, according to Fitch Ratings.  While Goldman's overall financial performance was down quarter-over-quarter  (QoQ), consistent with its U.S. global trading andGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   A U.S. federal judge on Friday said computer programmer Sergey Aleynikov is not entitled to have former employer Goldman Sachs Group Inc cover his legal fees to defend against criminal charges that he stole secret code from the bank's computers.Fitch: FICC, Underwriting Weigh on Goldman's 4Q'14 ResultsGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   Goldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  (The following statement was released by the rating agency) NEW YORK, January 16 (Fitch) The Goldman Sachs Group, Inc. (Goldman) reported  relatively weaker net revenue in 4Q'14, with declines in fixed income,  currencies and commodities (FICC) and underwriting outpacing strong performance  in financial advisory and equity sales and trading, according to Fitch Ratings.  While Goldman's overall financial performance was down quarter-over-quarter  (QoQ), consistent with its U.S. global trading andGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.     Jan 16 A U.S. federal judge on Friday said computer programmer Sergey Aleynikov is not entitled to have former employer Goldman Sachs Group Inc cover his legal fees to defend against criminal charges that he stole secret code from the bank's computers.Goldman need not advance ex-programmer's legal fees - U.S. judgeGoldman need not advance ex-programmer's legal fees - U.S. judgeFitch: FICC, Underwriting Weigh on Goldman's 4Q'14 ResultsGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   Goldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  (The following statement was released by the rating agency) NEW YORK, January 16 (Fitch) The Goldman Sachs Group, Inc. (Goldman) reported  relatively weaker net revenue in 4Q'14, with declines in fixed income,  currencies and commodities (FICC) and underwriting outpacing strong performance  in financial advisory and equity sales and trading, according to Fitch Ratings.  While Goldman's overall financial performance was down quarter-over-quarter  (QoQ), consistent with its U.S. global trading andGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.    Fitch: FICC, Underwriting Weigh on Goldman's 4Q'14 ResultsGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   Goldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  (The following statement was released by the rating agency) NEW YORK, January 16 (Fitch) The Goldman Sachs Group, Inc. (Goldman) reported  relatively weaker net revenue in 4Q'14, with declines in fixed income,  currencies and commodities (FICC) and underwriting outpacing strong performance  in financial advisory and equity sales and trading, according to Fitch Ratings.  While Goldman's overall financial performance was down quarter-over-quarter  (QoQ), consistent with its U.S. global trading andGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   A U.S. federal judge on Friday said computer programmer Sergey Aleynikov is not entitled to have former employer Goldman Sachs Group Inc cover his legal fees to defend against criminal charges that he stole secret code from the bank's computers.Fitch: FICC, Underwriting Weigh on Goldman's 4Q'14 ResultsGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   Goldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  (The following statement was released by the rating agency) NEW YORK, January 16 (Fitch) The Goldman Sachs Group, Inc. (Goldman) reported  relatively weaker net revenue in 4Q'14, with declines in fixed income,  currencies and commodities (FICC) and underwriting outpacing strong performance  in financial advisory and equity sales and trading, according to Fitch Ratings.  While Goldman's overall financial performance was down quarter-over-quarter  (QoQ), consistent with its U.S. global trading andGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.     Goldman need not advance ex-programmer's legal fees - U.S. judgeFitch: FICC, Underwriting Weigh on Goldman's 4Q'14 ResultsGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   Goldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  (The following statement was released by the rating agency) NEW YORK, January 16 (Fitch) The Goldman Sachs Group, Inc. (Goldman) reported  relatively weaker net revenue in 4Q'14, with declines in fixed income,  currencies and commodities (FICC) and underwriting outpacing strong performance  in financial advisory and equity sales and trading, according to Fitch Ratings.  While Goldman's overall financial performance was down quarter-over-quarter  (QoQ), consistent with its U.S. global trading andGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.    Fitch: FICC, Underwriting Weigh on Goldman's 4Q'14 ResultsGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   Goldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  (The following statement was released by the rating agency) NEW YORK, January 16 (Fitch) The Goldman Sachs Group, Inc. (Goldman) reported  relatively weaker net revenue in 4Q'14, with declines in fixed income,  currencies and commodities (FICC) and underwriting outpacing strong performance  in financial advisory and equity sales and trading, according to Fitch Ratings.  While Goldman's overall financial performance was down quarter-over-quarter  (QoQ), consistent with its U.S. global trading andGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   A U.S. federal judge on Friday said computer programmer Sergey Aleynikov is not entitled to have former employer Goldman Sachs Group Inc cover his legal fees to defend against criminal charges that he stole secret code from the bank's computers.Fitch: FICC, Underwriting Weigh on Goldman's 4Q'14 ResultsGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   Goldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  (The following statement was released by the rating agency) NEW YORK, January 16 (Fitch) The Goldman Sachs Group, Inc. (Goldman) reported  relatively weaker net revenue in 4Q'14, with declines in fixed income,  currencies and commodities (FICC) and underwriting outpacing strong performance  in financial advisory and equity sales and trading, according to Fitch Ratings.  While Goldman's overall financial performance was down quarter-over-quarter  (QoQ), consistent with its U.S. global trading andGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.    A U.S. federal judge on Friday said computer programmer Sergey Aleynikov is not entitled to have former employer Goldman Sachs Group Inc cover his legal fees to defend against criminal charges that he stole secret code from the bank's computers.Goldman need not advance ex-programmer's legal fees - U.S. judgeFitch: FICC, Underwriting Weigh on Goldman's 4Q'14 ResultsGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   Goldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  (The following statement was released by the rating agency) NEW YORK, January 16 (Fitch) The Goldman Sachs Group, Inc. (Goldman) reported  relatively weaker net revenue in 4Q'14, with declines in fixed income,  currencies and commodities (FICC) and underwriting outpacing strong performance  in financial advisory and equity sales and trading, according to Fitch Ratings.  While Goldman's overall financial performance was down quarter-over-quarter  (QoQ), consistent with its U.S. global trading andGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.    Fitch: FICC, Underwriting Weigh on Goldman's 4Q'14 ResultsGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   Goldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  (The following statement was released by the rating agency) NEW YORK, January 16 (Fitch) The Goldman Sachs Group, Inc. (Goldman) reported  relatively weaker net revenue in 4Q'14, with declines in fixed income,  currencies and commodities (FICC) and underwriting outpacing strong performance  in financial advisory and equity sales and trading, according to Fitch Ratings.  While Goldman's overall financial performance was down quarter-over-quarter  (QoQ), consistent with its U.S. global trading andGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   A U.S. federal judge on Friday said computer programmer Sergey Aleynikov is not entitled to have former employer Goldman Sachs Group Inc cover his legal fees to defend against criminal charges that he stole secret code from the bank's computers.Fitch: FICC, Underwriting Weigh on Goldman's 4Q'14 ResultsGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   Goldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  (The following statement was released by the rating agency) NEW YORK, January 16 (Fitch) The Goldman Sachs Group, Inc. (Goldman) reported  relatively weaker net revenue in 4Q'14, with declines in fixed income,  currencies and commodities (FICC) and underwriting outpacing strong performance  in financial advisory and equity sales and trading, according to Fitch Ratings.  While Goldman's overall financial performance was down quarter-over-quarter  (QoQ), consistent with its U.S. global trading andGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.       Jan 16 Goldman Sachs Group Inc reported a 7 percent drop in quarterly profit as investment banking revenue slid and an unexpected bout of market volatility in December hit revenue in its business that trades bonds, currencies and commodities.UPDATE 5-Goldman Sachs profit hit by weak fixed-income tradingGoldman need not advance ex-programmer's legal fees - U.S. judgeGoldman need not advance ex-programmer's legal fees - U.S. judgeGoldman need not advance ex-programmer's legal fees - U.S. judgeFitch: FICC, Underwriting Weigh on Goldman's 4Q'14 ResultsGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   Goldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  (The following statement was released by the rating agency) NEW YORK, January 16 (Fitch) The Goldman Sachs Group, Inc. (Goldman) reported  relatively weaker net revenue in 4Q'14, with declines in fixed income,  currencies and commodities (FICC) and underwriting outpacing strong performance  in financial advisory and equity sales and trading, according to Fitch Ratings.  While Goldman's overall financial performance was down quarter-over-quarter  (QoQ), consistent with its U.S. global trading andGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.    Fitch: FICC, Underwriting Weigh on Goldman's 4Q'14 ResultsGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   Goldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  (The following statement was released by the rating agency) NEW YORK, January 16 (Fitch) The Goldman Sachs Group, Inc. (Goldman) reported  relatively weaker net revenue in 4Q'14, with declines in fixed income,  currencies and commodities (FICC) and underwriting outpacing strong performance  in financial advisory and equity sales and trading, according to Fitch Ratings.  While Goldman's overall financial performance was down quarter-over-quarter  (QoQ), consistent with its U.S. global trading andGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   A U.S. federal judge on Friday said computer programmer Sergey Aleynikov is not entitled to have former employer Goldman Sachs Group Inc cover his legal fees to defend against criminal charges that he stole secret code from the bank's computers.Fitch: FICC, Underwriting Weigh on Goldman's 4Q'14 ResultsGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   Goldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  (The following statement was released by the rating agency) NEW YORK, January 16 (Fitch) The Goldman Sachs Group, Inc. (Goldman) reported  relatively weaker net revenue in 4Q'14, with declines in fixed income,  currencies and commodities (FICC) and underwriting outpacing strong performance  in financial advisory and equity sales and trading, according to Fitch Ratings.  While Goldman's overall financial performance was down quarter-over-quarter  (QoQ), consistent with its U.S. global trading andGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.     Goldman need not advance ex-programmer's legal fees - U.S. judgeFitch: FICC, Underwriting Weigh on Goldman's 4Q'14 ResultsGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   Goldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  (The following statement was released by the rating agency) NEW YORK, January 16 (Fitch) The Goldman Sachs Group, Inc. (Goldman) reported  relatively weaker net revenue in 4Q'14, with declines in fixed income,  currencies and commodities (FICC) and underwriting outpacing strong performance  in financial advisory and equity sales and trading, according to Fitch Ratings.  While Goldman's overall financial performance was down quarter-over-quarter  (QoQ), consistent with its U.S. global trading andGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.    Fitch: FICC, Underwriting Weigh on Goldman's 4Q'14 ResultsGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   Goldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  (The following statement was released by the rating agency) NEW YORK, January 16 (Fitch) The Goldman Sachs Group, Inc. (Goldman) reported  relatively weaker net revenue in 4Q'14, with declines in fixed income,  currencies and commodities (FICC) and underwriting outpacing strong performance  in financial advisory and equity sales and trading, according to Fitch Ratings.  While Goldman's overall financial performance was down quarter-over-quarter  (QoQ), consistent with its U.S. global trading andGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   A U.S. federal judge on Friday said computer programmer Sergey Aleynikov is not entitled to have former employer Goldman Sachs Group Inc cover his legal fees to defend against criminal charges that he stole secret code from the bank's computers.Fitch: FICC, Underwriting Weigh on Goldman's 4Q'14 ResultsGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   Goldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  (The following statement was released by the rating agency) NEW YORK, January 16 (Fitch) The Goldman Sachs Group, Inc. (Goldman) reported  relatively weaker net revenue in 4Q'14, with declines in fixed income,  currencies and commodities (FICC) and underwriting outpacing strong performance  in financial advisory and equity sales and trading, according to Fitch Ratings.  While Goldman's overall financial performance was down quarter-over-quarter  (QoQ), consistent with its U.S. global trading andGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.    A U.S. federal judge on Friday said computer programmer Sergey Aleynikov is not entitled to have former employer Goldman Sachs Group Inc cover his legal fees to defend against criminal charges that he stole secret code from the bank's computers.Goldman need not advance ex-programmer's legal fees - U.S. judgeFitch: FICC, Underwriting Weigh on Goldman's 4Q'14 ResultsGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   Goldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  (The following statement was released by the rating agency) NEW YORK, January 16 (Fitch) The Goldman Sachs Group, Inc. (Goldman) reported  relatively weaker net revenue in 4Q'14, with declines in fixed income,  currencies and commodities (FICC) and underwriting outpacing strong performance  in financial advisory and equity sales and trading, according to Fitch Ratings.  While Goldman's overall financial performance was down quarter-over-quarter  (QoQ), consistent with its U.S. global trading andGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.    Fitch: FICC, Underwriting Weigh on Goldman's 4Q'14 ResultsGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   Goldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  (The following statement was released by the rating agency) NEW YORK, January 16 (Fitch) The Goldman Sachs Group, Inc. (Goldman) reported  relatively weaker net revenue in 4Q'14, with declines in fixed income,  currencies and commodities (FICC) and underwriting outpacing strong performance  in financial advisory and equity sales and trading, according to Fitch Ratings.  While Goldman's overall financial performance was down quarter-over-quarter  (QoQ), consistent with its U.S. global trading andGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   A U.S. federal judge on Friday said computer programmer Sergey Aleynikov is not entitled to have former employer Goldman Sachs Group Inc cover his legal fees to defend against criminal charges that he stole secret code from the bank's computers.Fitch: FICC, Underwriting Weigh on Goldman's 4Q'14 ResultsGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   Goldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  (The following statement was released by the rating agency) NEW YORK, January 16 (Fitch) The Goldman Sachs Group, Inc. (Goldman) reported  relatively weaker net revenue in 4Q'14, with declines in fixed income,  currencies and commodities (FICC) and underwriting outpacing strong performance  in financial advisory and equity sales and trading, according to Fitch Ratings.  While Goldman's overall financial performance was down quarter-over-quarter  (QoQ), consistent with its U.S. global trading andGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.      Goldman need not advance ex-programmer's legal fees - U.S. judgeGoldman need not advance ex-programmer's legal fees - U.S. judgeFitch: FICC, Underwriting Weigh on Goldman's 4Q'14 ResultsGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   Goldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  (The following statement was released by the rating agency) NEW YORK, January 16 (Fitch) The Goldman Sachs Group, Inc. (Goldman) reported  relatively weaker net revenue in 4Q'14, with declines in fixed income,  currencies and commodities (FICC) and underwriting outpacing strong performance  in financial advisory and equity sales and trading, according to Fitch Ratings.  While Goldman's overall financial performance was down quarter-over-quarter  (QoQ), consistent with its U.S. global trading andGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.    Fitch: FICC, Underwriting Weigh on Goldman's 4Q'14 ResultsGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   Goldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  (The following statement was released by the rating agency) NEW YORK, January 16 (Fitch) The Goldman Sachs Group, Inc. (Goldman) reported  relatively weaker net revenue in 4Q'14, with declines in fixed income,  currencies and commodities (FICC) and underwriting outpacing strong performance  in financial advisory and equity sales and trading, according to Fitch Ratings.  While Goldman's overall financial performance was down quarter-over-quarter  (QoQ), consistent with its U.S. global trading andGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   A U.S. federal judge on Friday said computer programmer Sergey Aleynikov is not entitled to have former employer Goldman Sachs Group Inc cover his legal fees to defend against criminal charges that he stole secret code from the bank's computers.Fitch: FICC, Underwriting Weigh on Goldman's 4Q'14 ResultsGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   Goldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  (The following statement was released by the rating agency) NEW YORK, January 16 (Fitch) The Goldman Sachs Group, Inc. (Goldman) reported  relatively weaker net revenue in 4Q'14, with declines in fixed income,  currencies and commodities (FICC) and underwriting outpacing strong performance  in financial advisory and equity sales and trading, according to Fitch Ratings.  While Goldman's overall financial performance was down quarter-over-quarter  (QoQ), consistent with its U.S. global trading andGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.     Goldman need not advance ex-programmer's legal fees - U.S. judgeFitch: FICC, Underwriting Weigh on Goldman's 4Q'14 ResultsGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   Goldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  (The following statement was released by the rating agency) NEW YORK, January 16 (Fitch) The Goldman Sachs Group, Inc. (Goldman) reported  relatively weaker net revenue in 4Q'14, with declines in fixed income,  currencies and commodities (FICC) and underwriting outpacing strong performance  in financial advisory and equity sales and trading, according to Fitch Ratings.  While Goldman's overall financial performance was down quarter-over-quarter  (QoQ), consistent with its U.S. global trading andGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.    Fitch: FICC, Underwriting Weigh on Goldman's 4Q'14 ResultsGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   Goldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  (The following statement was released by the rating agency) NEW YORK, January 16 (Fitch) The Goldman Sachs Group, Inc. (Goldman) reported  relatively weaker net revenue in 4Q'14, with declines in fixed income,  currencies and commodities (FICC) and underwriting outpacing strong performance  in financial advisory and equity sales and trading, according to Fitch Ratings.  While Goldman's overall financial performance was down quarter-over-quarter  (QoQ), consistent with its U.S. global trading andGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   A U.S. federal judge on Friday said computer programmer Sergey Aleynikov is not entitled to have former employer Goldman Sachs Group Inc cover his legal fees to defend against criminal charges that he stole secret code from the bank's computers.Fitch: FICC, Underwriting Weigh on Goldman's 4Q'14 ResultsGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   Goldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  (The following statement was released by the rating agency) NEW YORK, January 16 (Fitch) The Goldman Sachs Group, Inc. (Goldman) reported  relatively weaker net revenue in 4Q'14, with declines in fixed income,  currencies and commodities (FICC) and underwriting outpacing strong performance  in financial advisory and equity sales and trading, according to Fitch Ratings.  While Goldman's overall financial performance was down quarter-over-quarter  (QoQ), consistent with its U.S. global trading andGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.    A U.S. federal judge on Friday said computer programmer Sergey Aleynikov is not entitled to have former employer Goldman Sachs Group Inc cover his legal fees to defend against criminal charges that he stole secret code from the bank's computers.Goldman need not advance ex-programmer's legal fees - U.S. judgeFitch: FICC, Underwriting Weigh on Goldman's 4Q'14 ResultsGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   Goldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  (The following statement was released by the rating agency) NEW YORK, January 16 (Fitch) The Goldman Sachs Group, Inc. (Goldman) reported  relatively weaker net revenue in 4Q'14, with declines in fixed income,  currencies and commodities (FICC) and underwriting outpacing strong performance  in financial advisory and equity sales and trading, according to Fitch Ratings.  While Goldman's overall financial performance was down quarter-over-quarter  (QoQ), consistent with its U.S. global trading andGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.    Fitch: FICC, Underwriting Weigh on Goldman's 4Q'14 ResultsGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   Goldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  (The following statement was released by the rating agency) NEW YORK, January 16 (Fitch) The Goldman Sachs Group, Inc. (Goldman) reported  relatively weaker net revenue in 4Q'14, with declines in fixed income,  currencies and commodities (FICC) and underwriting outpacing strong performance  in financial advisory and equity sales and trading, according to Fitch Ratings.  While Goldman's overall financial performance was down quarter-over-quarter  (QoQ), consistent with its U.S. global trading andGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   A U.S. federal judge on Friday said computer programmer Sergey Aleynikov is not entitled to have former employer Goldman Sachs Group Inc cover his legal fees to defend against criminal charges that he stole secret code from the bank's computers.Fitch: FICC, Underwriting Weigh on Goldman's 4Q'14 ResultsGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   Goldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  (The following statement was released by the rating agency) NEW YORK, January 16 (Fitch) The Goldman Sachs Group, Inc. (Goldman) reported  relatively weaker net revenue in 4Q'14, with declines in fixed income,  currencies and commodities (FICC) and underwriting outpacing strong performance  in financial advisory and equity sales and trading, according to Fitch Ratings.  While Goldman's overall financial performance was down quarter-over-quarter  (QoQ), consistent with its U.S. global trading andGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.     Jan 16 A U.S. federal judge on Friday said computer programmer Sergey Aleynikov is not entitled to have former employer Goldman Sachs Group Inc cover his legal fees to defend against criminal charges that he stole secret code from the bank's computers.Goldman need not advance ex-programmer's legal fees - U.S. judgeGoldman need not advance ex-programmer's legal fees - U.S. judgeFitch: FICC, Underwriting Weigh on Goldman's 4Q'14 ResultsGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   Goldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  (The following statement was released by the rating agency) NEW YORK, January 16 (Fitch) The Goldman Sachs Group, Inc. (Goldman) reported  relatively weaker net revenue in 4Q'14, with declines in fixed income,  currencies and commodities (FICC) and underwriting outpacing strong performance  in financial advisory and equity sales and trading, according to Fitch Ratings.  While Goldman's overall financial performance was down quarter-over-quarter  (QoQ), consistent with its U.S. global trading andGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.    Fitch: FICC, Underwriting Weigh on Goldman's 4Q'14 ResultsGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   Goldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  (The following statement was released by the rating agency) NEW YORK, January 16 (Fitch) The Goldman Sachs Group, Inc. (Goldman) reported  relatively weaker net revenue in 4Q'14, with declines in fixed income,  currencies and commodities (FICC) and underwriting outpacing strong performance  in financial advisory and equity sales and trading, according to Fitch Ratings.  While Goldman's overall financial performance was down quarter-over-quarter  (QoQ), consistent with its U.S. global trading andGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   A U.S. federal judge on Friday said computer programmer Sergey Aleynikov is not entitled to have former employer Goldman Sachs Group Inc cover his legal fees to defend against criminal charges that he stole secret code from the bank's computers.Fitch: FICC, Underwriting Weigh on Goldman's 4Q'14 ResultsGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   Goldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  (The following statement was released by the rating agency) NEW YORK, January 16 (Fitch) The Goldman Sachs Group, Inc. (Goldman) reported  relatively weaker net revenue in 4Q'14, with declines in fixed income,  currencies and commodities (FICC) and underwriting outpacing strong performance  in financial advisory and equity sales and trading, according to Fitch Ratings.  While Goldman's overall financial performance was down quarter-over-quarter  (QoQ), consistent with its U.S. global trading andGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.     Goldman need not advance ex-programmer's legal fees - U.S. judgeFitch: FICC, Underwriting Weigh on Goldman's 4Q'14 ResultsGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   Goldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  (The following statement was released by the rating agency) NEW YORK, January 16 (Fitch) The Goldman Sachs Group, Inc. (Goldman) reported  relatively weaker net revenue in 4Q'14, with declines in fixed income,  currencies and commodities (FICC) and underwriting outpacing strong performance  in financial advisory and equity sales and trading, according to Fitch Ratings.  While Goldman's overall financial performance was down quarter-over-quarter  (QoQ), consistent with its U.S. global trading andGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.    Fitch: FICC, Underwriting Weigh on Goldman's 4Q'14 ResultsGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   Goldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  (The following statement was released by the rating agency) NEW YORK, January 16 (Fitch) The Goldman Sachs Group, Inc. (Goldman) reported  relatively weaker net revenue in 4Q'14, with declines in fixed income,  currencies and commodities (FICC) and underwriting outpacing strong performance  in financial advisory and equity sales and trading, according to Fitch Ratings.  While Goldman's overall financial performance was down quarter-over-quarter  (QoQ), consistent with its U.S. global trading andGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   A U.S. federal judge on Friday said computer programmer Sergey Aleynikov is not entitled to have former employer Goldman Sachs Group Inc cover his legal fees to defend against criminal charges that he stole secret code from the bank's computers.Fitch: FICC, Underwriting Weigh on Goldman's 4Q'14 ResultsGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   Goldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  (The following statement was released by the rating agency) NEW YORK, January 16 (Fitch) The Goldman Sachs Group, Inc. (Goldman) reported  relatively weaker net revenue in 4Q'14, with declines in fixed income,  currencies and commodities (FICC) and underwriting outpacing strong performance  in financial advisory and equity sales and trading, according to Fitch Ratings.  While Goldman's overall financial performance was down quarter-over-quarter  (QoQ), consistent with its U.S. global trading andGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.    A U.S. federal judge on Friday said computer programmer Sergey Aleynikov is not entitled to have former employer Goldman Sachs Group Inc cover his legal fees to defend against criminal charges that he stole secret code from the bank's computers.Goldman need not advance ex-programmer's legal fees - U.S. judgeFitch: FICC, Underwriting Weigh on Goldman's 4Q'14 ResultsGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   Goldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  (The following statement was released by the rating agency) NEW YORK, January 16 (Fitch) The Goldman Sachs Group, Inc. (Goldman) reported  relatively weaker net revenue in 4Q'14, with declines in fixed income,  currencies and commodities (FICC) and underwriting outpacing strong performance  in financial advisory and equity sales and trading, according to Fitch Ratings.  While Goldman's overall financial performance was down quarter-over-quarter  (QoQ), consistent with its U.S. global trading andGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.    Fitch: FICC, Underwriting Weigh on Goldman's 4Q'14 ResultsGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   Goldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  (The following statement was released by the rating agency) NEW YORK, January 16 (Fitch) The Goldman Sachs Group, Inc. (Goldman) reported  relatively weaker net revenue in 4Q'14, with declines in fixed income,  currencies and commodities (FICC) and underwriting outpacing strong performance  in financial advisory and equity sales and trading, according to Fitch Ratings.  While Goldman's overall financial performance was down quarter-over-quarter  (QoQ), consistent with its U.S. global trading andGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   A U.S. federal judge on Friday said computer programmer Sergey Aleynikov is not entitled to have former employer Goldman Sachs Group Inc cover his legal fees to defend against criminal charges that he stole secret code from the bank's computers.Fitch: FICC, Underwriting Weigh on Goldman's 4Q'14 ResultsGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   Goldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  (The following statement was released by the rating agency) NEW YORK, January 16 (Fitch) The Goldman Sachs Group, Inc. (Goldman) reported  relatively weaker net revenue in 4Q'14, with declines in fixed income,  currencies and commodities (FICC) and underwriting outpacing strong performance  in financial advisory and equity sales and trading, according to Fitch Ratings.  While Goldman's overall financial performance was down quarter-over-quarter  (QoQ), consistent with its U.S. global trading andGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.       Goldman need not advance ex-programmer's legal fees - U.S. judgeGoldman need not advance ex-programmer's legal fees - U.S. judgeGoldman need not advance ex-programmer's legal fees - U.S. judgeFitch: FICC, Underwriting Weigh on Goldman's 4Q'14 ResultsGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   Goldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  (The following statement was released by the rating agency) NEW YORK, January 16 (Fitch) The Goldman Sachs Group, Inc. (Goldman) reported  relatively weaker net revenue in 4Q'14, with declines in fixed income,  currencies and commodities (FICC) and underwriting outpacing strong performance  in financial advisory and equity sales and trading, according to Fitch Ratings.  While Goldman's overall financial performance was down quarter-over-quarter  (QoQ), consistent with its U.S. global trading andGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.    Fitch: FICC, Underwriting Weigh on Goldman's 4Q'14 ResultsGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   Goldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  (The following statement was released by the rating agency) NEW YORK, January 16 (Fitch) The Goldman Sachs Group, Inc. (Goldman) reported  relatively weaker net revenue in 4Q'14, with declines in fixed income,  currencies and commodities (FICC) and underwriting outpacing strong performance  in financial advisory and equity sales and trading, according to Fitch Ratings.  While Goldman's overall financial performance was down quarter-over-quarter  (QoQ), consistent with its U.S. global trading andGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   A U.S. federal judge on Friday said computer programmer Sergey Aleynikov is not entitled to have former employer Goldman Sachs Group Inc cover his legal fees to defend against criminal charges that he stole secret code from the bank's computers.Fitch: FICC, Underwriting Weigh on Goldman's 4Q'14 ResultsGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   Goldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  (The following statement was released by the rating agency) NEW YORK, January 16 (Fitch) The Goldman Sachs Group, Inc. (Goldman) reported  relatively weaker net revenue in 4Q'14, with declines in fixed income,  currencies and commodities (FICC) and underwriting outpacing strong performance  in financial advisory and equity sales and trading, according to Fitch Ratings.  While Goldman's overall financial performance was down quarter-over-quarter  (QoQ), consistent with its U.S. global trading andGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.     Goldman need not advance ex-programmer's legal fees - U.S. judgeFitch: FICC, Underwriting Weigh on Goldman's 4Q'14 ResultsGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   Goldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  (The following statement was released by the rating agency) NEW YORK, January 16 (Fitch) The Goldman Sachs Group, Inc. (Goldman) reported  relatively weaker net revenue in 4Q'14, with declines in fixed income,  currencies and commodities (FICC) and underwriting outpacing strong performance  in financial advisory and equity sales and trading, according to Fitch Ratings.  While Goldman's overall financial performance was down quarter-over-quarter  (QoQ), consistent with its U.S. global trading andGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.    Fitch: FICC, Underwriting Weigh on Goldman's 4Q'14 ResultsGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   Goldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  (The following statement was released by the rating agency) NEW YORK, January 16 (Fitch) The Goldman Sachs Group, Inc. (Goldman) reported  relatively weaker net revenue in 4Q'14, with declines in fixed income,  currencies and commodities (FICC) and underwriting outpacing strong performance  in financial advisory and equity sales and trading, according to Fitch Ratings.  While Goldman's overall financial performance was down quarter-over-quarter  (QoQ), consistent with its U.S. global trading andGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   A U.S. federal judge on Friday said computer programmer Sergey Aleynikov is not entitled to have former employer Goldman Sachs Group Inc cover his legal fees to defend against criminal charges that he stole secret code from the bank's computers.Fitch: FICC, Underwriting Weigh on Goldman's 4Q'14 ResultsGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   Goldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  (The following statement was released by the rating agency) NEW YORK, January 16 (Fitch) The Goldman Sachs Group, Inc. (Goldman) reported  relatively weaker net revenue in 4Q'14, with declines in fixed income,  currencies and commodities (FICC) and underwriting outpacing strong performance  in financial advisory and equity sales and trading, according to Fitch Ratings.  While Goldman's overall financial performance was down quarter-over-quarter  (QoQ), consistent with its U.S. global trading andGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.    A U.S. federal judge on Friday said computer programmer Sergey Aleynikov is not entitled to have former employer Goldman Sachs Group Inc cover his legal fees to defend against criminal charges that he stole secret code from the bank's computers.Goldman need not advance ex-programmer's legal fees - U.S. judgeFitch: FICC, Underwriting Weigh on Goldman's 4Q'14 ResultsGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   Goldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  (The following statement was released by the rating agency) NEW YORK, January 16 (Fitch) The Goldman Sachs Group, Inc. (Goldman) reported  relatively weaker net revenue in 4Q'14, with declines in fixed income,  currencies and commodities (FICC) and underwriting outpacing strong performance  in financial advisory and equity sales and trading, according to Fitch Ratings.  While Goldman's overall financial performance was down quarter-over-quarter  (QoQ), consistent with its U.S. global trading andGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.    Fitch: FICC, Underwriting Weigh on Goldman's 4Q'14 ResultsGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   Goldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  (The following statement was released by the rating agency) NEW YORK, January 16 (Fitch) The Goldman Sachs Group, Inc. (Goldman) reported  relatively weaker net revenue in 4Q'14, with declines in fixed income,  currencies and commodities (FICC) and underwriting outpacing strong performance  in financial advisory and equity sales and trading, according to Fitch Ratings.  While Goldman's overall financial performance was down quarter-over-quarter  (QoQ), consistent with its U.S. global trading andGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   A U.S. federal judge on Friday said computer programmer Sergey Aleynikov is not entitled to have former employer Goldman Sachs Group Inc cover his legal fees to defend against criminal charges that he stole secret code from the bank's computers.Fitch: FICC, Underwriting Weigh on Goldman's 4Q'14 ResultsGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   Goldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  (The following statement was released by the rating agency) NEW YORK, January 16 (Fitch) The Goldman Sachs Group, Inc. (Goldman) reported  relatively weaker net revenue in 4Q'14, with declines in fixed income,  currencies and commodities (FICC) and underwriting outpacing strong performance  in financial advisory and equity sales and trading, according to Fitch Ratings.  While Goldman's overall financial performance was down quarter-over-quarter  (QoQ), consistent with its U.S. global trading andGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.      Goldman need not advance ex-programmer's legal fees - U.S. judgeGoldman need not advance ex-programmer's legal fees - U.S. judgeFitch: FICC, Underwriting Weigh on Goldman's 4Q'14 ResultsGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   Goldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  (The following statement was released by the rating agency) NEW YORK, January 16 (Fitch) The Goldman Sachs Group, Inc. (Goldman) reported  relatively weaker net revenue in 4Q'14, with declines in fixed income,  currencies and commodities (FICC) and underwriting outpacing strong performance  in financial advisory and equity sales and trading, according to Fitch Ratings.  While Goldman's overall financial performance was down quarter-over-quarter  (QoQ), consistent with its U.S. global trading andGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.    Fitch: FICC, Underwriting Weigh on Goldman's 4Q'14 ResultsGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   Goldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  (The following statement was released by the rating agency) NEW YORK, January 16 (Fitch) The Goldman Sachs Group, Inc. (Goldman) reported  relatively weaker net revenue in 4Q'14, with declines in fixed income,  currencies and commodities (FICC) and underwriting outpacing strong performance  in financial advisory and equity sales and trading, according to Fitch Ratings.  While Goldman's overall financial performance was down quarter-over-quarter  (QoQ), consistent with its U.S. global trading andGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   A U.S. federal judge on Friday said computer programmer Sergey Aleynikov is not entitled to have former employer Goldman Sachs Group Inc cover his legal fees to defend against criminal charges that he stole secret code from the bank's computers.Fitch: FICC, Underwriting Weigh on Goldman's 4Q'14 ResultsGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   Goldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  (The following statement was released by the rating agency) NEW YORK, January 16 (Fitch) The Goldman Sachs Group, Inc. (Goldman) reported  relatively weaker net revenue in 4Q'14, with declines in fixed income,  currencies and commodities (FICC) and underwriting outpacing strong performance  in financial advisory and equity sales and trading, according to Fitch Ratings.  While Goldman's overall financial performance was down quarter-over-quarter  (QoQ), consistent with its U.S. global trading andGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.     Goldman need not advance ex-programmer's legal fees - U.S. judgeFitch: FICC, Underwriting Weigh on Goldman's 4Q'14 ResultsGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   Goldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  (The following statement was released by the rating agency) NEW YORK, January 16 (Fitch) The Goldman Sachs Group, Inc. (Goldman) reported  relatively weaker net revenue in 4Q'14, with declines in fixed income,  currencies and commodities (FICC) and underwriting outpacing strong performance  in financial advisory and equity sales and trading, according to Fitch Ratings.  While Goldman's overall financial performance was down quarter-over-quarter  (QoQ), consistent with its U.S. global trading andGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.    Fitch: FICC, Underwriting Weigh on Goldman's 4Q'14 ResultsGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   Goldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  (The following statement was released by the rating agency) NEW YORK, January 16 (Fitch) The Goldman Sachs Group, Inc. (Goldman) reported  relatively weaker net revenue in 4Q'14, with declines in fixed income,  currencies and commodities (FICC) and underwriting outpacing strong performance  in financial advisory and equity sales and trading, according to Fitch Ratings.  While Goldman's overall financial performance was down quarter-over-quarter  (QoQ), consistent with its U.S. global trading andGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   A U.S. federal judge on Friday said computer programmer Sergey Aleynikov is not entitled to have former employer Goldman Sachs Group Inc cover his legal fees to defend against criminal charges that he stole secret code from the bank's computers.Fitch: FICC, Underwriting Weigh on Goldman's 4Q'14 ResultsGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   Goldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  (The following statement was released by the rating agency) NEW YORK, January 16 (Fitch) The Goldman Sachs Group, Inc. (Goldman) reported  relatively weaker net revenue in 4Q'14, with declines in fixed income,  currencies and commodities (FICC) and underwriting outpacing strong performance  in financial advisory and equity sales and trading, according to Fitch Ratings.  While Goldman's overall financial performance was down quarter-over-quarter  (QoQ), consistent with its U.S. global trading andGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.    A U.S. federal judge on Friday said computer programmer Sergey Aleynikov is not entitled to have former employer Goldman Sachs Group Inc cover his legal fees to defend against criminal charges that he stole secret code from the bank's computers.Goldman need not advance ex-programmer's legal fees - U.S. judgeFitch: FICC, Underwriting Weigh on Goldman's 4Q'14 ResultsGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   Goldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  (The following statement was released by the rating agency) NEW YORK, January 16 (Fitch) The Goldman Sachs Group, Inc. (Goldman) reported  relatively weaker net revenue in 4Q'14, with declines in fixed income,  currencies and commodities (FICC) and underwriting outpacing strong performance  in financial advisory and equity sales and trading, according to Fitch Ratings.  While Goldman's overall financial performance was down quarter-over-quarter  (QoQ), consistent with its U.S. global trading andGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.    Fitch: FICC, Underwriting Weigh on Goldman's 4Q'14 ResultsGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   Goldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  (The following statement was released by the rating agency) NEW YORK, January 16 (Fitch) The Goldman Sachs Group, Inc. (Goldman) reported  relatively weaker net revenue in 4Q'14, with declines in fixed income,  currencies and commodities (FICC) and underwriting outpacing strong performance  in financial advisory and equity sales and trading, according to Fitch Ratings.  While Goldman's overall financial performance was down quarter-over-quarter  (QoQ), consistent with its U.S. global trading andGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   A U.S. federal judge on Friday said computer programmer Sergey Aleynikov is not entitled to have former employer Goldman Sachs Group Inc cover his legal fees to defend against criminal charges that he stole secret code from the bank's computers.Fitch: FICC, Underwriting Weigh on Goldman's 4Q'14 ResultsGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   Goldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  (The following statement was released by the rating agency) NEW YORK, January 16 (Fitch) The Goldman Sachs Group, Inc. (Goldman) reported  relatively weaker net revenue in 4Q'14, with declines in fixed income,  currencies and commodities (FICC) and underwriting outpacing strong performance  in financial advisory and equity sales and trading, according to Fitch Ratings.  While Goldman's overall financial performance was down quarter-over-quarter  (QoQ), consistent with its U.S. global trading andGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.     Jan 16 A U.S. federal judge on Friday said computer programmer Sergey Aleynikov is not entitled to have former employer Goldman Sachs Group Inc cover his legal fees to defend against criminal charges that he stole secret code from the bank's computers.Goldman need not advance ex-programmer's legal fees - U.S. judgeGoldman need not advance ex-programmer's legal fees - U.S. judgeFitch: FICC, Underwriting Weigh on Goldman's 4Q'14 ResultsGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   Goldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  (The following statement was released by the rating agency) NEW YORK, January 16 (Fitch) The Goldman Sachs Group, Inc. (Goldman) reported  relatively weaker net revenue in 4Q'14, with declines in fixed income,  currencies and commodities (FICC) and underwriting outpacing strong performance  in financial advisory and equity sales and trading, according to Fitch Ratings.  While Goldman's overall financial performance was down quarter-over-quarter  (QoQ), consistent with its U.S. global trading andGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.    Fitch: FICC, Underwriting Weigh on Goldman's 4Q'14 ResultsGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   Goldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  (The following statement was released by the rating agency) NEW YORK, January 16 (Fitch) The Goldman Sachs Group, Inc. (Goldman) reported  relatively weaker net revenue in 4Q'14, with declines in fixed income,  currencies and commodities (FICC) and underwriting outpacing strong performance  in financial advisory and equity sales and trading, according to Fitch Ratings.  While Goldman's overall financial performance was down quarter-over-quarter  (QoQ), consistent with its U.S. global trading andGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   A U.S. federal judge on Friday said computer programmer Sergey Aleynikov is not entitled to have former employer Goldman Sachs Group Inc cover his legal fees to defend against criminal charges that he stole secret code from the bank's computers.Fitch: FICC, Underwriting Weigh on Goldman's 4Q'14 ResultsGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   Goldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  (The following statement was released by the rating agency) NEW YORK, January 16 (Fitch) The Goldman Sachs Group, Inc. (Goldman) reported  relatively weaker net revenue in 4Q'14, with declines in fixed income,  currencies and commodities (FICC) and underwriting outpacing strong performance  in financial advisory and equity sales and trading, according to Fitch Ratings.  While Goldman's overall financial performance was down quarter-over-quarter  (QoQ), consistent with its U.S. global trading andGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.     Goldman need not advance ex-programmer's legal fees - U.S. judgeFitch: FICC, Underwriting Weigh on Goldman's 4Q'14 ResultsGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   Goldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  (The following statement was released by the rating agency) NEW YORK, January 16 (Fitch) The Goldman Sachs Group, Inc. (Goldman) reported  relatively weaker net revenue in 4Q'14, with declines in fixed income,  currencies and commodities (FICC) and underwriting outpacing strong performance  in financial advisory and equity sales and trading, according to Fitch Ratings.  While Goldman's overall financial performance was down quarter-over-quarter  (QoQ), consistent with its U.S. global trading andGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.    Fitch: FICC, Underwriting Weigh on Goldman's 4Q'14 ResultsGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   Goldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  (The following statement was released by the rating agency) NEW YORK, January 16 (Fitch) The Goldman Sachs Group, Inc. (Goldman) reported  relatively weaker net revenue in 4Q'14, with declines in fixed income,  currencies and commodities (FICC) and underwriting outpacing strong performance  in financial advisory and equity sales and trading, according to Fitch Ratings.  While Goldman's overall financial performance was down quarter-over-quarter  (QoQ), consistent with its U.S. global trading andGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   A U.S. federal judge on Friday said computer programmer Sergey Aleynikov is not entitled to have former employer Goldman Sachs Group Inc cover his legal fees to defend against criminal charges that he stole secret code from the bank's computers.Fitch: FICC, Underwriting Weigh on Goldman's 4Q'14 ResultsGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   Goldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  (The following statement was released by the rating agency) NEW YORK, January 16 (Fitch) The Goldman Sachs Group, Inc. (Goldman) reported  relatively weaker net revenue in 4Q'14, with declines in fixed income,  currencies and commodities (FICC) and underwriting outpacing strong performance  in financial advisory and equity sales and trading, according to Fitch Ratings.  While Goldman's overall financial performance was down quarter-over-quarter  (QoQ), consistent with its U.S. global trading andGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.    A U.S. federal judge on Friday said computer programmer Sergey Aleynikov is not entitled to have former employer Goldman Sachs Group Inc cover his legal fees to defend against criminal charges that he stole secret code from the bank's computers.Goldman need not advance ex-programmer's legal fees - U.S. judgeFitch: FICC, Underwriting Weigh on Goldman's 4Q'14 ResultsGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   Goldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  (The following statement was released by the rating agency) NEW YORK, January 16 (Fitch) The Goldman Sachs Group, Inc. (Goldman) reported  relatively weaker net revenue in 4Q'14, with declines in fixed income,  currencies and commodities (FICC) and underwriting outpacing strong performance  in financial advisory and equity sales and trading, according to Fitch Ratings.  While Goldman's overall financial performance was down quarter-over-quarter  (QoQ), consistent with its U.S. global trading andGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.    Fitch: FICC, Underwriting Weigh on Goldman's 4Q'14 ResultsGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   Goldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  (The following statement was released by the rating agency) NEW YORK, January 16 (Fitch) The Goldman Sachs Group, Inc. (Goldman) reported  relatively weaker net revenue in 4Q'14, with declines in fixed income,  currencies and commodities (FICC) and underwriting outpacing strong performance  in financial advisory and equity sales and trading, according to Fitch Ratings.  While Goldman's overall financial performance was down quarter-over-quarter  (QoQ), consistent with its U.S. global trading andGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   A U.S. federal judge on Friday said computer programmer Sergey Aleynikov is not entitled to have former employer Goldman Sachs Group Inc cover his legal fees to defend against criminal charges that he stole secret code from the bank's computers.Fitch: FICC, Underwriting Weigh on Goldman's 4Q'14 ResultsGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   Goldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  (The following statement was released by the rating agency) NEW YORK, January 16 (Fitch) The Goldman Sachs Group, Inc. (Goldman) reported  relatively weaker net revenue in 4Q'14, with declines in fixed income,  currencies and commodities (FICC) and underwriting outpacing strong performance  in financial advisory and equity sales and trading, according to Fitch Ratings.  While Goldman's overall financial performance was down quarter-over-quarter  (QoQ), consistent with its U.S. global trading andGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.      * Shares down less than 1 pct in midday trading   (Adds details from conference call; updates share move)Goldman need not advance ex-programmer's legal fees - U.S. judgeGoldman need not advance ex-programmer's legal fees - U.S. judgeGoldman need not advance ex-programmer's legal fees - U.S. judgeFitch: FICC, Underwriting Weigh on Goldman's 4Q'14 ResultsGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   Goldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  (The following statement was released by the rating agency) NEW YORK, January 16 (Fitch) The Goldman Sachs Group, Inc. (Goldman) reported  relatively weaker net revenue in 4Q'14, with declines in fixed income,  currencies and commodities (FICC) and underwriting outpacing strong performance  in financial advisory and equity sales and trading, according to Fitch Ratings.  While Goldman's overall financial performance was down quarter-over-quarter  (QoQ), consistent with its U.S. global trading andGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.    Fitch: FICC, Underwriting Weigh on Goldman's 4Q'14 ResultsGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   Goldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  (The following statement was released by the rating agency) NEW YORK, January 16 (Fitch) The Goldman Sachs Group, Inc. (Goldman) reported  relatively weaker net revenue in 4Q'14, with declines in fixed income,  currencies and commodities (FICC) and underwriting outpacing strong performance  in financial advisory and equity sales and trading, according to Fitch Ratings.  While Goldman's overall financial performance was down quarter-over-quarter  (QoQ), consistent with its U.S. global trading andGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   A U.S. federal judge on Friday said computer programmer Sergey Aleynikov is not entitled to have former employer Goldman Sachs Group Inc cover his legal fees to defend against criminal charges that he stole secret code from the bank's computers.Fitch: FICC, Underwriting Weigh on Goldman's 4Q'14 ResultsGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   Goldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  (The following statement was released by the rating agency) NEW YORK, January 16 (Fitch) The Goldman Sachs Group, Inc. (Goldman) reported  relatively weaker net revenue in 4Q'14, with declines in fixed income,  currencies and commodities (FICC) and underwriting outpacing strong performance  in financial advisory and equity sales and trading, according to Fitch Ratings.  While Goldman's overall financial performance was down quarter-over-quarter  (QoQ), consistent with its U.S. global trading andGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.     Goldman need not advance ex-programmer's legal fees - U.S. judgeFitch: FICC, Underwriting Weigh on Goldman's 4Q'14 ResultsGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   Goldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  (The following statement was released by the rating agency) NEW YORK, January 16 (Fitch) The Goldman Sachs Group, Inc. (Goldman) reported  relatively weaker net revenue in 4Q'14, with declines in fixed income,  currencies and commodities (FICC) and underwriting outpacing strong performance  in financial advisory and equity sales and trading, according to Fitch Ratings.  While Goldman's overall financial performance was down quarter-over-quarter  (QoQ), consistent with its U.S. global trading andGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.    Fitch: FICC, Underwriting Weigh on Goldman's 4Q'14 ResultsGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   Goldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  (The following statement was released by the rating agency) NEW YORK, January 16 (Fitch) The Goldman Sachs Group, Inc. (Goldman) reported  relatively weaker net revenue in 4Q'14, with declines in fixed income,  currencies and commodities (FICC) and underwriting outpacing strong performance  in financial advisory and equity sales and trading, according to Fitch Ratings.  While Goldman's overall financial performance was down quarter-over-quarter  (QoQ), consistent with its U.S. global trading andGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   A U.S. federal judge on Friday said computer programmer Sergey Aleynikov is not entitled to have former employer Goldman Sachs Group Inc cover his legal fees to defend against criminal charges that he stole secret code from the bank's computers.Fitch: FICC, Underwriting Weigh on Goldman's 4Q'14 ResultsGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   Goldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  (The following statement was released by the rating agency) NEW YORK, January 16 (Fitch) The Goldman Sachs Group, Inc. (Goldman) reported  relatively weaker net revenue in 4Q'14, with declines in fixed income,  currencies and commodities (FICC) and underwriting outpacing strong performance  in financial advisory and equity sales and trading, according to Fitch Ratings.  While Goldman's overall financial performance was down quarter-over-quarter  (QoQ), consistent with its U.S. global trading andGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.    A U.S. federal judge on Friday said computer programmer Sergey Aleynikov is not entitled to have former employer Goldman Sachs Group Inc cover his legal fees to defend against criminal charges that he stole secret code from the bank's computers.Goldman need not advance ex-programmer's legal fees - U.S. judgeFitch: FICC, Underwriting Weigh on Goldman's 4Q'14 ResultsGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   Goldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  (The following statement was released by the rating agency) NEW YORK, January 16 (Fitch) The Goldman Sachs Group, Inc. (Goldman) reported  relatively weaker net revenue in 4Q'14, with declines in fixed income,  currencies and commodities (FICC) and underwriting outpacing strong performance  in financial advisory and equity sales and trading, according to Fitch Ratings.  While Goldman's overall financial performance was down quarter-over-quarter  (QoQ), consistent with its U.S. global trading andGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.    Fitch: FICC, Underwriting Weigh on Goldman's 4Q'14 ResultsGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   Goldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  (The following statement was released by the rating agency) NEW YORK, January 16 (Fitch) The Goldman Sachs Group, Inc. (Goldman) reported  relatively weaker net revenue in 4Q'14, with declines in fixed income,  currencies and commodities (FICC) and underwriting outpacing strong performance  in financial advisory and equity sales and trading, according to Fitch Ratings.  While Goldman's overall financial performance was down quarter-over-quarter  (QoQ), consistent with its U.S. global trading andGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   A U.S. federal judge on Friday said computer programmer Sergey Aleynikov is not entitled to have former employer Goldman Sachs Group Inc cover his legal fees to defend against criminal charges that he stole secret code from the bank's computers.Fitch: FICC, Underwriting Weigh on Goldman's 4Q'14 ResultsGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   Goldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  (The following statement was released by the rating agency) NEW YORK, January 16 (Fitch) The Goldman Sachs Group, Inc. (Goldman) reported  relatively weaker net revenue in 4Q'14, with declines in fixed income,  currencies and commodities (FICC) and underwriting outpacing strong performance  in financial advisory and equity sales and trading, according to Fitch Ratings.  While Goldman's overall financial performance was down quarter-over-quarter  (QoQ), consistent with its U.S. global trading andGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.      Goldman need not advance ex-programmer's legal fees - U.S. judgeGoldman need not advance ex-programmer's legal fees - U.S. judgeFitch: FICC, Underwriting Weigh on Goldman's 4Q'14 ResultsGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   Goldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  (The following statement was released by the rating agency) NEW YORK, January 16 (Fitch) The Goldman Sachs Group, Inc. (Goldman) reported  relatively weaker net revenue in 4Q'14, with declines in fixed income,  currencies and commodities (FICC) and underwriting outpacing strong performance  in financial advisory and equity sales and trading, according to Fitch Ratings.  While Goldman's overall financial performance was down quarter-over-quarter  (QoQ), consistent with its U.S. global trading andGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.    Fitch: FICC, Underwriting Weigh on Goldman's 4Q'14 ResultsGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   Goldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  (The following statement was released by the rating agency) NEW YORK, January 16 (Fitch) The Goldman Sachs Group, Inc. (Goldman) reported  relatively weaker net revenue in 4Q'14, with declines in fixed income,  currencies and commodities (FICC) and underwriting outpacing strong performance  in financial advisory and equity sales and trading, according to Fitch Ratings.  While Goldman's overall financial performance was down quarter-over-quarter  (QoQ), consistent with its U.S. global trading andGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   A U.S. federal judge on Friday said computer programmer Sergey Aleynikov is not entitled to have former employer Goldman Sachs Group Inc cover his legal fees to defend against criminal charges that he stole secret code from the bank's computers.Fitch: FICC, Underwriting Weigh on Goldman's 4Q'14 ResultsGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   Goldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  (The following statement was released by the rating agency) NEW YORK, January 16 (Fitch) The Goldman Sachs Group, Inc. (Goldman) reported  relatively weaker net revenue in 4Q'14, with declines in fixed income,  currencies and commodities (FICC) and underwriting outpacing strong performance  in financial advisory and equity sales and trading, according to Fitch Ratings.  While Goldman's overall financial performance was down quarter-over-quarter  (QoQ), consistent with its U.S. global trading andGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.     Goldman need not advance ex-programmer's legal fees - U.S. judgeFitch: FICC, Underwriting Weigh on Goldman's 4Q'14 ResultsGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   Goldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  (The following statement was released by the rating agency) NEW YORK, January 16 (Fitch) The Goldman Sachs Group, Inc. (Goldman) reported  relatively weaker net revenue in 4Q'14, with declines in fixed income,  currencies and commodities (FICC) and underwriting outpacing strong performance  in financial advisory and equity sales and trading, according to Fitch Ratings.  While Goldman's overall financial performance was down quarter-over-quarter  (QoQ), consistent with its U.S. global trading andGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.    Fitch: FICC, Underwriting Weigh on Goldman's 4Q'14 ResultsGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   Goldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  (The following statement was released by the rating agency) NEW YORK, January 16 (Fitch) The Goldman Sachs Group, Inc. (Goldman) reported  relatively weaker net revenue in 4Q'14, with declines in fixed income,  currencies and commodities (FICC) and underwriting outpacing strong performance  in financial advisory and equity sales and trading, according to Fitch Ratings.  While Goldman's overall financial performance was down quarter-over-quarter  (QoQ), consistent with its U.S. global trading andGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   A U.S. federal judge on Friday said computer programmer Sergey Aleynikov is not entitled to have former employer Goldman Sachs Group Inc cover his legal fees to defend against criminal charges that he stole secret code from the bank's computers.Fitch: FICC, Underwriting Weigh on Goldman's 4Q'14 ResultsGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   Goldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  (The following statement was released by the rating agency) NEW YORK, January 16 (Fitch) The Goldman Sachs Group, Inc. (Goldman) reported  relatively weaker net revenue in 4Q'14, with declines in fixed income,  currencies and commodities (FICC) and underwriting outpacing strong performance  in financial advisory and equity sales and trading, according to Fitch Ratings.  While Goldman's overall financial performance was down quarter-over-quarter  (QoQ), consistent with its U.S. global trading andGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.    A U.S. federal judge on Friday said computer programmer Sergey Aleynikov is not entitled to have former employer Goldman Sachs Group Inc cover his legal fees to defend against criminal charges that he stole secret code from the bank's computers.Goldman need not advance ex-programmer's legal fees - U.S. judgeFitch: FICC, Underwriting Weigh on Goldman's 4Q'14 ResultsGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   Goldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  (The following statement was released by the rating agency) NEW YORK, January 16 (Fitch) The Goldman Sachs Group, Inc. (Goldman) reported  relatively weaker net revenue in 4Q'14, with declines in fixed income,  currencies and commodities (FICC) and underwriting outpacing strong performance  in financial advisory and equity sales and trading, according to Fitch Ratings.  While Goldman's overall financial performance was down quarter-over-quarter  (QoQ), consistent with its U.S. global trading andGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.    Fitch: FICC, Underwriting Weigh on Goldman's 4Q'14 ResultsGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   Goldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  (The following statement was released by the rating agency) NEW YORK, January 16 (Fitch) The Goldman Sachs Group, Inc. (Goldman) reported  relatively weaker net revenue in 4Q'14, with declines in fixed income,  currencies and commodities (FICC) and underwriting outpacing strong performance  in financial advisory and equity sales and trading, according to Fitch Ratings.  While Goldman's overall financial performance was down quarter-over-quarter  (QoQ), consistent with its U.S. global trading andGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   A U.S. federal judge on Friday said computer programmer Sergey Aleynikov is not entitled to have former employer Goldman Sachs Group Inc cover his legal fees to defend against criminal charges that he stole secret code from the bank's computers.Fitch: FICC, Underwriting Weigh on Goldman's 4Q'14 ResultsGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   Goldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  (The following statement was released by the rating agency) NEW YORK, January 16 (Fitch) The Goldman Sachs Group, Inc. (Goldman) reported  relatively weaker net revenue in 4Q'14, with declines in fixed income,  currencies and commodities (FICC) and underwriting outpacing strong performance  in financial advisory and equity sales and trading, according to Fitch Ratings.  While Goldman's overall financial performance was down quarter-over-quarter  (QoQ), consistent with its U.S. global trading andGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.     Jan 16 A U.S. federal judge on Friday said computer programmer Sergey Aleynikov is not entitled to have former employer Goldman Sachs Group Inc cover his legal fees to defend against criminal charges that he stole secret code from the bank's computers.Goldman need not advance ex-programmer's legal fees - U.S. judgeGoldman need not advance ex-programmer's legal fees - U.S. judgeFitch: FICC, Underwriting Weigh on Goldman's 4Q'14 ResultsGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   Goldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  (The following statement was released by the rating agency) NEW YORK, January 16 (Fitch) The Goldman Sachs Group, Inc. (Goldman) reported  relatively weaker net revenue in 4Q'14, with declines in fixed income,  currencies and commodities (FICC) and underwriting outpacing strong performance  in financial advisory and equity sales and trading, according to Fitch Ratings.  While Goldman's overall financial performance was down quarter-over-quarter  (QoQ), consistent with its U.S. global trading andGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.    Fitch: FICC, Underwriting Weigh on Goldman's 4Q'14 ResultsGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   Goldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  (The following statement was released by the rating agency) NEW YORK, January 16 (Fitch) The Goldman Sachs Group, Inc. (Goldman) reported  relatively weaker net revenue in 4Q'14, with declines in fixed income,  currencies and commodities (FICC) and underwriting outpacing strong performance  in financial advisory and equity sales and trading, according to Fitch Ratings.  While Goldman's overall financial performance was down quarter-over-quarter  (QoQ), consistent with its U.S. global trading andGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   A U.S. federal judge on Friday said computer programmer Sergey Aleynikov is not entitled to have former employer Goldman Sachs Group Inc cover his legal fees to defend against criminal charges that he stole secret code from the bank's computers.Fitch: FICC, Underwriting Weigh on Goldman's 4Q'14 ResultsGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   Goldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  (The following statement was released by the rating agency) NEW YORK, January 16 (Fitch) The Goldman Sachs Group, Inc. (Goldman) reported  relatively weaker net revenue in 4Q'14, with declines in fixed income,  currencies and commodities (FICC) and underwriting outpacing strong performance  in financial advisory and equity sales and trading, according to Fitch Ratings.  While Goldman's overall financial performance was down quarter-over-quarter  (QoQ), consistent with its U.S. global trading andGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.     Goldman need not advance ex-programmer's legal fees - U.S. judgeFitch: FICC, Underwriting Weigh on Goldman's 4Q'14 ResultsGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   Goldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  (The following statement was released by the rating agency) NEW YORK, January 16 (Fitch) The Goldman Sachs Group, Inc. (Goldman) reported  relatively weaker net revenue in 4Q'14, with declines in fixed income,  currencies and commodities (FICC) and underwriting outpacing strong performance  in financial advisory and equity sales and trading, according to Fitch Ratings.  While Goldman's overall financial performance was down quarter-over-quarter  (QoQ), consistent with its U.S. global trading andGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.    Fitch: FICC, Underwriting Weigh on Goldman's 4Q'14 ResultsGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   Goldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  (The following statement was released by the rating agency) NEW YORK, January 16 (Fitch) The Goldman Sachs Group, Inc. (Goldman) reported  relatively weaker net revenue in 4Q'14, with declines in fixed income,  currencies and commodities (FICC) and underwriting outpacing strong performance  in financial advisory and equity sales and trading, according to Fitch Ratings.  While Goldman's overall financial performance was down quarter-over-quarter  (QoQ), consistent with its U.S. global trading andGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   A U.S. federal judge on Friday said computer programmer Sergey Aleynikov is not entitled to have former employer Goldman Sachs Group Inc cover his legal fees to defend against criminal charges that he stole secret code from the bank's computers.Fitch: FICC, Underwriting Weigh on Goldman's 4Q'14 ResultsGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   Goldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  (The following statement was released by the rating agency) NEW YORK, January 16 (Fitch) The Goldman Sachs Group, Inc. (Goldman) reported  relatively weaker net revenue in 4Q'14, with declines in fixed income,  currencies and commodities (FICC) and underwriting outpacing strong performance  in financial advisory and equity sales and trading, according to Fitch Ratings.  While Goldman's overall financial performance was down quarter-over-quarter  (QoQ), consistent with its U.S. global trading andGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.    A U.S. federal judge on Friday said computer programmer Sergey Aleynikov is not entitled to have former employer Goldman Sachs Group Inc cover his legal fees to defend against criminal charges that he stole secret code from the bank's computers.Goldman need not advance ex-programmer's legal fees - U.S. judgeFitch: FICC, Underwriting Weigh on Goldman's 4Q'14 ResultsGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   Goldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  (The following statement was released by the rating agency) NEW YORK, January 16 (Fitch) The Goldman Sachs Group, Inc. (Goldman) reported  relatively weaker net revenue in 4Q'14, with declines in fixed income,  currencies and commodities (FICC) and underwriting outpacing strong performance  in financial advisory and equity sales and trading, according to Fitch Ratings.  While Goldman's overall financial performance was down quarter-over-quarter  (QoQ), consistent with its U.S. global trading andGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.    Fitch: FICC, Underwriting Weigh on Goldman's 4Q'14 ResultsGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   Goldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  (The following statement was released by the rating agency) NEW YORK, January 16 (Fitch) The Goldman Sachs Group, Inc. (Goldman) reported  relatively weaker net revenue in 4Q'14, with declines in fixed income,  currencies and commodities (FICC) and underwriting outpacing strong performance  in financial advisory and equity sales and trading, according to Fitch Ratings.  While Goldman's overall financial performance was down quarter-over-quarter  (QoQ), consistent with its U.S. global trading andGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   A U.S. federal judge on Friday said computer programmer Sergey Aleynikov is not entitled to have former employer Goldman Sachs Group Inc cover his legal fees to defend against criminal charges that he stole secret code from the bank's computers.Fitch: FICC, Underwriting Weigh on Goldman's 4Q'14 ResultsGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.   Goldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  (The following statement was released by the rating agency) NEW YORK, January 16 (Fitch) The Goldman Sachs Group, Inc. (Goldman) reported  relatively weaker net revenue in 4Q'14, with declines in fixed income,  currencies and commodities (FICC) and underwriting outpacing strong performance  in financial advisory and equity sales and trading, according to Fitch Ratings.  While Goldman's overall financial performance was down quarter-over-quarter  (QoQ), consistent with its U.S. global trading andGoldman Sachs touts commodities muscle as rivals shrinkGoldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.  Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated. NEW YORK, Jan 16 Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.Goldman Sachs touts commodities muscle as rivals shrink NEW YORK Goldman Sachs Group Inc  stuck with commodities trading while rivals have pulled back, and on Friday the bank felt vindicated.        
HAL,ValueAct buys 5.1 pct stake in Baker Hughes Jan 16 Activist hedge fund ValueAct Capital disclosed a 5.1 percent stake in Baker Hughes Inc, the world's No. 3 oilfield services company that has agreed to be bought by bigger rival Halliburton Co for $35 billion in cash and stock. 
INTC,UPDATE 3-Intel forecasts disappointing revenue; shares fallUS STOCKS-Futures fall, Wall Street set to post weekly declineUS STOCKS-Futures fall in wake of Swiss move; Wall St to drop for weekKynikos' Chanos says he is short Intel Corp - CNBCUPDATE 1-Hedge fund founder Chanos says shorting Intel shares - CNBCHedge fund founder Chanos says shorting Intel shares: CNBCUS STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data) NEW YORK Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)   Hedge fund founder Chanos says shorting Intel shares: CNBCUS STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data) NEW YORK Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  NEW YORK, Jan 16 Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.Hedge fund founder Chanos says shorting Intel shares: CNBCUS STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data) NEW YORK Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)    UPDATE 1-Hedge fund founder Chanos says shorting Intel shares - CNBCHedge fund founder Chanos says shorting Intel shares: CNBCUS STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data) NEW YORK Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)   Hedge fund founder Chanos says shorting Intel shares: CNBCUS STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data) NEW YORK Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  NEW YORK, Jan 16 Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.Hedge fund founder Chanos says shorting Intel shares: CNBCUS STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data) NEW YORK Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)   NEW YORK, Jan 16 Jim Chanos, founder of hedge fund firm Kynikos Associates, said Friday that he is betting against the shares of Intel Corp.UPDATE 1-Hedge fund founder Chanos says shorting Intel shares - CNBCHedge fund founder Chanos says shorting Intel shares: CNBCUS STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data) NEW YORK Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)   Hedge fund founder Chanos says shorting Intel shares: CNBCUS STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data) NEW YORK Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  NEW YORK, Jan 16 Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.Hedge fund founder Chanos says shorting Intel shares: CNBCUS STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data) NEW YORK Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)     Kynikos' Chanos says he is short Intel Corp - CNBCUPDATE 1-Hedge fund founder Chanos says shorting Intel shares - CNBCHedge fund founder Chanos says shorting Intel shares: CNBCUS STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data) NEW YORK Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)   Hedge fund founder Chanos says shorting Intel shares: CNBCUS STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data) NEW YORK Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  NEW YORK, Jan 16 Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.Hedge fund founder Chanos says shorting Intel shares: CNBCUS STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data) NEW YORK Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)    UPDATE 1-Hedge fund founder Chanos says shorting Intel shares - CNBCHedge fund founder Chanos says shorting Intel shares: CNBCUS STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data) NEW YORK Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)   Hedge fund founder Chanos says shorting Intel shares: CNBCUS STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data) NEW YORK Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  NEW YORK, Jan 16 Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.Hedge fund founder Chanos says shorting Intel shares: CNBCUS STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data) NEW YORK Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)   NEW YORK, Jan 16 Jim Chanos, founder of hedge fund firm Kynikos Associates, said Friday that he is betting against the shares of Intel Corp.UPDATE 1-Hedge fund founder Chanos says shorting Intel shares - CNBCHedge fund founder Chanos says shorting Intel shares: CNBCUS STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data) NEW YORK Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)   Hedge fund founder Chanos says shorting Intel shares: CNBCUS STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data) NEW YORK Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  NEW YORK, Jan 16 Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.Hedge fund founder Chanos says shorting Intel shares: CNBCUS STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data) NEW YORK Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)    * Futures off: Dow 68 pts, S&P; 7.5 pts, Nasdaq 29 pts   (Adds FXCM, Interactive Brokers)Kynikos' Chanos says he is short Intel Corp - CNBCUPDATE 1-Hedge fund founder Chanos says shorting Intel shares - CNBCHedge fund founder Chanos says shorting Intel shares: CNBCUS STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data) NEW YORK Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)   Hedge fund founder Chanos says shorting Intel shares: CNBCUS STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data) NEW YORK Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  NEW YORK, Jan 16 Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.Hedge fund founder Chanos says shorting Intel shares: CNBCUS STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data) NEW YORK Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)    UPDATE 1-Hedge fund founder Chanos says shorting Intel shares - CNBCHedge fund founder Chanos says shorting Intel shares: CNBCUS STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data) NEW YORK Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)   Hedge fund founder Chanos says shorting Intel shares: CNBCUS STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data) NEW YORK Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  NEW YORK, Jan 16 Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.Hedge fund founder Chanos says shorting Intel shares: CNBCUS STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data) NEW YORK Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)   NEW YORK, Jan 16 Jim Chanos, founder of hedge fund firm Kynikos Associates, said Friday that he is betting against the shares of Intel Corp.UPDATE 1-Hedge fund founder Chanos says shorting Intel shares - CNBCHedge fund founder Chanos says shorting Intel shares: CNBCUS STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data) NEW YORK Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)   Hedge fund founder Chanos says shorting Intel shares: CNBCUS STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data) NEW YORK Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  NEW YORK, Jan 16 Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.Hedge fund founder Chanos says shorting Intel shares: CNBCUS STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data) NEW YORK Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)      US STOCKS-Futures fall in wake of Swiss move; Wall St to drop for weekKynikos' Chanos says he is short Intel Corp - CNBCUPDATE 1-Hedge fund founder Chanos says shorting Intel shares - CNBCHedge fund founder Chanos says shorting Intel shares: CNBCUS STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data) NEW YORK Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)   Hedge fund founder Chanos says shorting Intel shares: CNBCUS STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data) NEW YORK Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  NEW YORK, Jan 16 Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.Hedge fund founder Chanos says shorting Intel shares: CNBCUS STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data) NEW YORK Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)    UPDATE 1-Hedge fund founder Chanos says shorting Intel shares - CNBCHedge fund founder Chanos says shorting Intel shares: CNBCUS STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data) NEW YORK Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)   Hedge fund founder Chanos says shorting Intel shares: CNBCUS STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data) NEW YORK Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  NEW YORK, Jan 16 Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.Hedge fund founder Chanos says shorting Intel shares: CNBCUS STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data) NEW YORK Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)   NEW YORK, Jan 16 Jim Chanos, founder of hedge fund firm Kynikos Associates, said Friday that he is betting against the shares of Intel Corp.UPDATE 1-Hedge fund founder Chanos says shorting Intel shares - CNBCHedge fund founder Chanos says shorting Intel shares: CNBCUS STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data) NEW YORK Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)   Hedge fund founder Chanos says shorting Intel shares: CNBCUS STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data) NEW YORK Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  NEW YORK, Jan 16 Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.Hedge fund founder Chanos says shorting Intel shares: CNBCUS STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data) NEW YORK Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)     Kynikos' Chanos says he is short Intel Corp - CNBCUPDATE 1-Hedge fund founder Chanos says shorting Intel shares - CNBCHedge fund founder Chanos says shorting Intel shares: CNBCUS STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data) NEW YORK Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)   Hedge fund founder Chanos says shorting Intel shares: CNBCUS STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data) NEW YORK Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  NEW YORK, Jan 16 Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.Hedge fund founder Chanos says shorting Intel shares: CNBCUS STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data) NEW YORK Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)    UPDATE 1-Hedge fund founder Chanos says shorting Intel shares - CNBCHedge fund founder Chanos says shorting Intel shares: CNBCUS STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data) NEW YORK Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)   Hedge fund founder Chanos says shorting Intel shares: CNBCUS STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data) NEW YORK Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  NEW YORK, Jan 16 Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.Hedge fund founder Chanos says shorting Intel shares: CNBCUS STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data) NEW YORK Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)   NEW YORK, Jan 16 Jim Chanos, founder of hedge fund firm Kynikos Associates, said Friday that he is betting against the shares of Intel Corp.UPDATE 1-Hedge fund founder Chanos says shorting Intel shares - CNBCHedge fund founder Chanos says shorting Intel shares: CNBCUS STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data) NEW YORK Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)   Hedge fund founder Chanos says shorting Intel shares: CNBCUS STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data) NEW YORK Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  NEW YORK, Jan 16 Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.Hedge fund founder Chanos says shorting Intel shares: CNBCUS STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data) NEW YORK Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)    * Futures off: Dow 68 pts, S&P; 7.5 pts, Nasdaq 29 pts   (Adds FXCM, Interactive Brokers)Kynikos' Chanos says he is short Intel Corp - CNBCUPDATE 1-Hedge fund founder Chanos says shorting Intel shares - CNBCHedge fund founder Chanos says shorting Intel shares: CNBCUS STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data) NEW YORK Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)   Hedge fund founder Chanos says shorting Intel shares: CNBCUS STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data) NEW YORK Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  NEW YORK, Jan 16 Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.Hedge fund founder Chanos says shorting Intel shares: CNBCUS STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data) NEW YORK Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)    UPDATE 1-Hedge fund founder Chanos says shorting Intel shares - CNBCHedge fund founder Chanos says shorting Intel shares: CNBCUS STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data) NEW YORK Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)   Hedge fund founder Chanos says shorting Intel shares: CNBCUS STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data) NEW YORK Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  NEW YORK, Jan 16 Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.Hedge fund founder Chanos says shorting Intel shares: CNBCUS STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data) NEW YORK Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)   NEW YORK, Jan 16 Jim Chanos, founder of hedge fund firm Kynikos Associates, said Friday that he is betting against the shares of Intel Corp.UPDATE 1-Hedge fund founder Chanos says shorting Intel shares - CNBCHedge fund founder Chanos says shorting Intel shares: CNBCUS STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data) NEW YORK Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)   Hedge fund founder Chanos says shorting Intel shares: CNBCUS STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data) NEW YORK Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  NEW YORK, Jan 16 Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.Hedge fund founder Chanos says shorting Intel shares: CNBCUS STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data) NEW YORK Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)     NEW YORK, Jan 16 U.S. stock index futures edged lower on Friday, following five straight days of losses for major indexes, setting Wall Street up for its fourth negative week out of the past six.US STOCKS-Futures fall in wake of Swiss move; Wall St to drop for weekKynikos' Chanos says he is short Intel Corp - CNBCUPDATE 1-Hedge fund founder Chanos says shorting Intel shares - CNBCHedge fund founder Chanos says shorting Intel shares: CNBCUS STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data) NEW YORK Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)   Hedge fund founder Chanos says shorting Intel shares: CNBCUS STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data) NEW YORK Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  NEW YORK, Jan 16 Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.Hedge fund founder Chanos says shorting Intel shares: CNBCUS STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data) NEW YORK Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)    UPDATE 1-Hedge fund founder Chanos says shorting Intel shares - CNBCHedge fund founder Chanos says shorting Intel shares: CNBCUS STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data) NEW YORK Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)   Hedge fund founder Chanos says shorting Intel shares: CNBCUS STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data) NEW YORK Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  NEW YORK, Jan 16 Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.Hedge fund founder Chanos says shorting Intel shares: CNBCUS STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data) NEW YORK Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)   NEW YORK, Jan 16 Jim Chanos, founder of hedge fund firm Kynikos Associates, said Friday that he is betting against the shares of Intel Corp.UPDATE 1-Hedge fund founder Chanos says shorting Intel shares - CNBCHedge fund founder Chanos says shorting Intel shares: CNBCUS STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data) NEW YORK Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)   Hedge fund founder Chanos says shorting Intel shares: CNBCUS STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data) NEW YORK Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  NEW YORK, Jan 16 Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.Hedge fund founder Chanos says shorting Intel shares: CNBCUS STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data) NEW YORK Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)     Kynikos' Chanos says he is short Intel Corp - CNBCUPDATE 1-Hedge fund founder Chanos says shorting Intel shares - CNBCHedge fund founder Chanos says shorting Intel shares: CNBCUS STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data) NEW YORK Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)   Hedge fund founder Chanos says shorting Intel shares: CNBCUS STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data) NEW YORK Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  NEW YORK, Jan 16 Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.Hedge fund founder Chanos says shorting Intel shares: CNBCUS STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data) NEW YORK Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)    UPDATE 1-Hedge fund founder Chanos says shorting Intel shares - CNBCHedge fund founder Chanos says shorting Intel shares: CNBCUS STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data) NEW YORK Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)   Hedge fund founder Chanos says shorting Intel shares: CNBCUS STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data) NEW YORK Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  NEW YORK, Jan 16 Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.Hedge fund founder Chanos says shorting Intel shares: CNBCUS STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data) NEW YORK Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)   NEW YORK, Jan 16 Jim Chanos, founder of hedge fund firm Kynikos Associates, said Friday that he is betting against the shares of Intel Corp.UPDATE 1-Hedge fund founder Chanos says shorting Intel shares - CNBCHedge fund founder Chanos says shorting Intel shares: CNBCUS STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data) NEW YORK Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)   Hedge fund founder Chanos says shorting Intel shares: CNBCUS STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data) NEW YORK Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  NEW YORK, Jan 16 Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.Hedge fund founder Chanos says shorting Intel shares: CNBCUS STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data) NEW YORK Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)    * Futures off: Dow 68 pts, S&P; 7.5 pts, Nasdaq 29 pts   (Adds FXCM, Interactive Brokers)Kynikos' Chanos says he is short Intel Corp - CNBCUPDATE 1-Hedge fund founder Chanos says shorting Intel shares - CNBCHedge fund founder Chanos says shorting Intel shares: CNBCUS STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data) NEW YORK Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)   Hedge fund founder Chanos says shorting Intel shares: CNBCUS STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data) NEW YORK Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  NEW YORK, Jan 16 Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.Hedge fund founder Chanos says shorting Intel shares: CNBCUS STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data) NEW YORK Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)    UPDATE 1-Hedge fund founder Chanos says shorting Intel shares - CNBCHedge fund founder Chanos says shorting Intel shares: CNBCUS STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data) NEW YORK Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)   Hedge fund founder Chanos says shorting Intel shares: CNBCUS STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data) NEW YORK Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  NEW YORK, Jan 16 Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.Hedge fund founder Chanos says shorting Intel shares: CNBCUS STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data) NEW YORK Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)   NEW YORK, Jan 16 Jim Chanos, founder of hedge fund firm Kynikos Associates, said Friday that he is betting against the shares of Intel Corp.UPDATE 1-Hedge fund founder Chanos says shorting Intel shares - CNBCHedge fund founder Chanos says shorting Intel shares: CNBCUS STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data) NEW YORK Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)   Hedge fund founder Chanos says shorting Intel shares: CNBCUS STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data) NEW YORK Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  NEW YORK, Jan 16 Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.Hedge fund founder Chanos says shorting Intel shares: CNBCUS STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data) NEW YORK Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)       US STOCKS-Futures fall, Wall Street set to post weekly declineUS STOCKS-Futures fall in wake of Swiss move; Wall St to drop for weekKynikos' Chanos says he is short Intel Corp - CNBCUPDATE 1-Hedge fund founder Chanos says shorting Intel shares - CNBCHedge fund founder Chanos says shorting Intel shares: CNBCUS STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data) NEW YORK Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)   Hedge fund founder Chanos says shorting Intel shares: CNBCUS STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data) NEW YORK Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  NEW YORK, Jan 16 Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.Hedge fund founder Chanos says shorting Intel shares: CNBCUS STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data) NEW YORK Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)    UPDATE 1-Hedge fund founder Chanos says shorting Intel shares - CNBCHedge fund founder Chanos says shorting Intel shares: CNBCUS STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data) NEW YORK Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)   Hedge fund founder Chanos says shorting Intel shares: CNBCUS STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data) NEW YORK Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  NEW YORK, Jan 16 Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.Hedge fund founder Chanos says shorting Intel shares: CNBCUS STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data) NEW YORK Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)   NEW YORK, Jan 16 Jim Chanos, founder of hedge fund firm Kynikos Associates, said Friday that he is betting against the shares of Intel Corp.UPDATE 1-Hedge fund founder Chanos says shorting Intel shares - CNBCHedge fund founder Chanos says shorting Intel shares: CNBCUS STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data) NEW YORK Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)   Hedge fund founder Chanos says shorting Intel shares: CNBCUS STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data) NEW YORK Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  NEW YORK, Jan 16 Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.Hedge fund founder Chanos says shorting Intel shares: CNBCUS STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data) NEW YORK Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)     Kynikos' Chanos says he is short Intel Corp - CNBCUPDATE 1-Hedge fund founder Chanos says shorting Intel shares - CNBCHedge fund founder Chanos says shorting Intel shares: CNBCUS STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data) NEW YORK Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)   Hedge fund founder Chanos says shorting Intel shares: CNBCUS STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data) NEW YORK Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  NEW YORK, Jan 16 Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.Hedge fund founder Chanos says shorting Intel shares: CNBCUS STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data) NEW YORK Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)    UPDATE 1-Hedge fund founder Chanos says shorting Intel shares - CNBCHedge fund founder Chanos says shorting Intel shares: CNBCUS STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data) NEW YORK Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)   Hedge fund founder Chanos says shorting Intel shares: CNBCUS STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data) NEW YORK Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  NEW YORK, Jan 16 Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.Hedge fund founder Chanos says shorting Intel shares: CNBCUS STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data) NEW YORK Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)   NEW YORK, Jan 16 Jim Chanos, founder of hedge fund firm Kynikos Associates, said Friday that he is betting against the shares of Intel Corp.UPDATE 1-Hedge fund founder Chanos says shorting Intel shares - CNBCHedge fund founder Chanos says shorting Intel shares: CNBCUS STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data) NEW YORK Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)   Hedge fund founder Chanos says shorting Intel shares: CNBCUS STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data) NEW YORK Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  NEW YORK, Jan 16 Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.Hedge fund founder Chanos says shorting Intel shares: CNBCUS STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data) NEW YORK Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)    * Futures off: Dow 68 pts, S&P; 7.5 pts, Nasdaq 29 pts   (Adds FXCM, Interactive Brokers)Kynikos' Chanos says he is short Intel Corp - CNBCUPDATE 1-Hedge fund founder Chanos says shorting Intel shares - CNBCHedge fund founder Chanos says shorting Intel shares: CNBCUS STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data) NEW YORK Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)   Hedge fund founder Chanos says shorting Intel shares: CNBCUS STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data) NEW YORK Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  NEW YORK, Jan 16 Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.Hedge fund founder Chanos says shorting Intel shares: CNBCUS STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data) NEW YORK Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)    UPDATE 1-Hedge fund founder Chanos says shorting Intel shares - CNBCHedge fund founder Chanos says shorting Intel shares: CNBCUS STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data) NEW YORK Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)   Hedge fund founder Chanos says shorting Intel shares: CNBCUS STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data) NEW YORK Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  NEW YORK, Jan 16 Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.Hedge fund founder Chanos says shorting Intel shares: CNBCUS STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data) NEW YORK Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)   NEW YORK, Jan 16 Jim Chanos, founder of hedge fund firm Kynikos Associates, said Friday that he is betting against the shares of Intel Corp.UPDATE 1-Hedge fund founder Chanos says shorting Intel shares - CNBCHedge fund founder Chanos says shorting Intel shares: CNBCUS STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data) NEW YORK Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)   Hedge fund founder Chanos says shorting Intel shares: CNBCUS STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data) NEW YORK Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  NEW YORK, Jan 16 Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.Hedge fund founder Chanos says shorting Intel shares: CNBCUS STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data) NEW YORK Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)      US STOCKS-Futures fall in wake of Swiss move; Wall St to drop for weekKynikos' Chanos says he is short Intel Corp - CNBCUPDATE 1-Hedge fund founder Chanos says shorting Intel shares - CNBCHedge fund founder Chanos says shorting Intel shares: CNBCUS STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data) NEW YORK Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)   Hedge fund founder Chanos says shorting Intel shares: CNBCUS STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data) NEW YORK Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  NEW YORK, Jan 16 Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.Hedge fund founder Chanos says shorting Intel shares: CNBCUS STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data) NEW YORK Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)    UPDATE 1-Hedge fund founder Chanos says shorting Intel shares - CNBCHedge fund founder Chanos says shorting Intel shares: CNBCUS STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data) NEW YORK Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)   Hedge fund founder Chanos says shorting Intel shares: CNBCUS STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data) NEW YORK Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  NEW YORK, Jan 16 Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.Hedge fund founder Chanos says shorting Intel shares: CNBCUS STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data) NEW YORK Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)   NEW YORK, Jan 16 Jim Chanos, founder of hedge fund firm Kynikos Associates, said Friday that he is betting against the shares of Intel Corp.UPDATE 1-Hedge fund founder Chanos says shorting Intel shares - CNBCHedge fund founder Chanos says shorting Intel shares: CNBCUS STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data) NEW YORK Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)   Hedge fund founder Chanos says shorting Intel shares: CNBCUS STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data) NEW YORK Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  NEW YORK, Jan 16 Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.Hedge fund founder Chanos says shorting Intel shares: CNBCUS STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data) NEW YORK Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)     Kynikos' Chanos says he is short Intel Corp - CNBCUPDATE 1-Hedge fund founder Chanos says shorting Intel shares - CNBCHedge fund founder Chanos says shorting Intel shares: CNBCUS STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data) NEW YORK Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)   Hedge fund founder Chanos says shorting Intel shares: CNBCUS STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data) NEW YORK Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  NEW YORK, Jan 16 Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.Hedge fund founder Chanos says shorting Intel shares: CNBCUS STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data) NEW YORK Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)    UPDATE 1-Hedge fund founder Chanos says shorting Intel shares - CNBCHedge fund founder Chanos says shorting Intel shares: CNBCUS STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data) NEW YORK Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)   Hedge fund founder Chanos says shorting Intel shares: CNBCUS STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data) NEW YORK Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  NEW YORK, Jan 16 Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.Hedge fund founder Chanos says shorting Intel shares: CNBCUS STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data) NEW YORK Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)   NEW YORK, Jan 16 Jim Chanos, founder of hedge fund firm Kynikos Associates, said Friday that he is betting against the shares of Intel Corp.UPDATE 1-Hedge fund founder Chanos says shorting Intel shares - CNBCHedge fund founder Chanos says shorting Intel shares: CNBCUS STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data) NEW YORK Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)   Hedge fund founder Chanos says shorting Intel shares: CNBCUS STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data) NEW YORK Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  NEW YORK, Jan 16 Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.Hedge fund founder Chanos says shorting Intel shares: CNBCUS STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data) NEW YORK Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)    * Futures off: Dow 68 pts, S&P; 7.5 pts, Nasdaq 29 pts   (Adds FXCM, Interactive Brokers)Kynikos' Chanos says he is short Intel Corp - CNBCUPDATE 1-Hedge fund founder Chanos says shorting Intel shares - CNBCHedge fund founder Chanos says shorting Intel shares: CNBCUS STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data) NEW YORK Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)   Hedge fund founder Chanos says shorting Intel shares: CNBCUS STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data) NEW YORK Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  NEW YORK, Jan 16 Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.Hedge fund founder Chanos says shorting Intel shares: CNBCUS STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data) NEW YORK Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)    UPDATE 1-Hedge fund founder Chanos says shorting Intel shares - CNBCHedge fund founder Chanos says shorting Intel shares: CNBCUS STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data) NEW YORK Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)   Hedge fund founder Chanos says shorting Intel shares: CNBCUS STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data) NEW YORK Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  NEW YORK, Jan 16 Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.Hedge fund founder Chanos says shorting Intel shares: CNBCUS STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data) NEW YORK Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)   NEW YORK, Jan 16 Jim Chanos, founder of hedge fund firm Kynikos Associates, said Friday that he is betting against the shares of Intel Corp.UPDATE 1-Hedge fund founder Chanos says shorting Intel shares - CNBCHedge fund founder Chanos says shorting Intel shares: CNBCUS STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data) NEW YORK Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)   Hedge fund founder Chanos says shorting Intel shares: CNBCUS STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data) NEW YORK Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  NEW YORK, Jan 16 Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.Hedge fund founder Chanos says shorting Intel shares: CNBCUS STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data) NEW YORK Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)     NEW YORK, Jan 16 U.S. stock index futures edged lower on Friday, following five straight days of losses for major indexes, setting Wall Street up for its fourth negative week out of the past six.US STOCKS-Futures fall in wake of Swiss move; Wall St to drop for weekKynikos' Chanos says he is short Intel Corp - CNBCUPDATE 1-Hedge fund founder Chanos says shorting Intel shares - CNBCHedge fund founder Chanos says shorting Intel shares: CNBCUS STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data) NEW YORK Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)   Hedge fund founder Chanos says shorting Intel shares: CNBCUS STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data) NEW YORK Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  NEW YORK, Jan 16 Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.Hedge fund founder Chanos says shorting Intel shares: CNBCUS STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data) NEW YORK Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)    UPDATE 1-Hedge fund founder Chanos says shorting Intel shares - CNBCHedge fund founder Chanos says shorting Intel shares: CNBCUS STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data) NEW YORK Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)   Hedge fund founder Chanos says shorting Intel shares: CNBCUS STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data) NEW YORK Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  NEW YORK, Jan 16 Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.Hedge fund founder Chanos says shorting Intel shares: CNBCUS STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data) NEW YORK Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)   NEW YORK, Jan 16 Jim Chanos, founder of hedge fund firm Kynikos Associates, said Friday that he is betting against the shares of Intel Corp.UPDATE 1-Hedge fund founder Chanos says shorting Intel shares - CNBCHedge fund founder Chanos says shorting Intel shares: CNBCUS STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data) NEW YORK Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)   Hedge fund founder Chanos says shorting Intel shares: CNBCUS STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data) NEW YORK Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  NEW YORK, Jan 16 Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.Hedge fund founder Chanos says shorting Intel shares: CNBCUS STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data) NEW YORK Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)     Kynikos' Chanos says he is short Intel Corp - CNBCUPDATE 1-Hedge fund founder Chanos says shorting Intel shares - CNBCHedge fund founder Chanos says shorting Intel shares: CNBCUS STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data) NEW YORK Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)   Hedge fund founder Chanos says shorting Intel shares: CNBCUS STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data) NEW YORK Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  NEW YORK, Jan 16 Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.Hedge fund founder Chanos says shorting Intel shares: CNBCUS STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data) NEW YORK Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)    UPDATE 1-Hedge fund founder Chanos says shorting Intel shares - CNBCHedge fund founder Chanos says shorting Intel shares: CNBCUS STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data) NEW YORK Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)   Hedge fund founder Chanos says shorting Intel shares: CNBCUS STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data) NEW YORK Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  NEW YORK, Jan 16 Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.Hedge fund founder Chanos says shorting Intel shares: CNBCUS STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data) NEW YORK Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)   NEW YORK, Jan 16 Jim Chanos, founder of hedge fund firm Kynikos Associates, said Friday that he is betting against the shares of Intel Corp.UPDATE 1-Hedge fund founder Chanos says shorting Intel shares - CNBCHedge fund founder Chanos says shorting Intel shares: CNBCUS STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data) NEW YORK Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)   Hedge fund founder Chanos says shorting Intel shares: CNBCUS STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data) NEW YORK Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  NEW YORK, Jan 16 Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.Hedge fund founder Chanos says shorting Intel shares: CNBCUS STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data) NEW YORK Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)    * Futures off: Dow 68 pts, S&P; 7.5 pts, Nasdaq 29 pts   (Adds FXCM, Interactive Brokers)Kynikos' Chanos says he is short Intel Corp - CNBCUPDATE 1-Hedge fund founder Chanos says shorting Intel shares - CNBCHedge fund founder Chanos says shorting Intel shares: CNBCUS STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data) NEW YORK Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)   Hedge fund founder Chanos says shorting Intel shares: CNBCUS STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data) NEW YORK Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  NEW YORK, Jan 16 Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.Hedge fund founder Chanos says shorting Intel shares: CNBCUS STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data) NEW YORK Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)    UPDATE 1-Hedge fund founder Chanos says shorting Intel shares - CNBCHedge fund founder Chanos says shorting Intel shares: CNBCUS STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data) NEW YORK Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)   Hedge fund founder Chanos says shorting Intel shares: CNBCUS STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data) NEW YORK Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  NEW YORK, Jan 16 Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.Hedge fund founder Chanos says shorting Intel shares: CNBCUS STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data) NEW YORK Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)   NEW YORK, Jan 16 Jim Chanos, founder of hedge fund firm Kynikos Associates, said Friday that he is betting against the shares of Intel Corp.UPDATE 1-Hedge fund founder Chanos says shorting Intel shares - CNBCHedge fund founder Chanos says shorting Intel shares: CNBCUS STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data) NEW YORK Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)   Hedge fund founder Chanos says shorting Intel shares: CNBCUS STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data) NEW YORK Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  NEW YORK, Jan 16 Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.Hedge fund founder Chanos says shorting Intel shares: CNBCUS STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data) NEW YORK Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)      Jan 15 Chipmaker Intel Corp forecast revenue and gross margins for this quarter that disappointed investors, sending its shares down 2.7 percent in extended trading.US STOCKS-Futures fall, Wall Street set to post weekly declineUS STOCKS-Futures fall in wake of Swiss move; Wall St to drop for weekKynikos' Chanos says he is short Intel Corp - CNBCUPDATE 1-Hedge fund founder Chanos says shorting Intel shares - CNBCHedge fund founder Chanos says shorting Intel shares: CNBCUS STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data) NEW YORK Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)   Hedge fund founder Chanos says shorting Intel shares: CNBCUS STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data) NEW YORK Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  NEW YORK, Jan 16 Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.Hedge fund founder Chanos says shorting Intel shares: CNBCUS STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data) NEW YORK Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)    UPDATE 1-Hedge fund founder Chanos says shorting Intel shares - CNBCHedge fund founder Chanos says shorting Intel shares: CNBCUS STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data) NEW YORK Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)   Hedge fund founder Chanos says shorting Intel shares: CNBCUS STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data) NEW YORK Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  NEW YORK, Jan 16 Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.Hedge fund founder Chanos says shorting Intel shares: CNBCUS STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data) NEW YORK Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)   NEW YORK, Jan 16 Jim Chanos, founder of hedge fund firm Kynikos Associates, said Friday that he is betting against the shares of Intel Corp.UPDATE 1-Hedge fund founder Chanos says shorting Intel shares - CNBCHedge fund founder Chanos says shorting Intel shares: CNBCUS STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data) NEW YORK Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)   Hedge fund founder Chanos says shorting Intel shares: CNBCUS STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data) NEW YORK Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  NEW YORK, Jan 16 Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.Hedge fund founder Chanos says shorting Intel shares: CNBCUS STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data) NEW YORK Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)     Kynikos' Chanos says he is short Intel Corp - CNBCUPDATE 1-Hedge fund founder Chanos says shorting Intel shares - CNBCHedge fund founder Chanos says shorting Intel shares: CNBCUS STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data) NEW YORK Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)   Hedge fund founder Chanos says shorting Intel shares: CNBCUS STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data) NEW YORK Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  NEW YORK, Jan 16 Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.Hedge fund founder Chanos says shorting Intel shares: CNBCUS STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data) NEW YORK Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)    UPDATE 1-Hedge fund founder Chanos says shorting Intel shares - CNBCHedge fund founder Chanos says shorting Intel shares: CNBCUS STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data) NEW YORK Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)   Hedge fund founder Chanos says shorting Intel shares: CNBCUS STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data) NEW YORK Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  NEW YORK, Jan 16 Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.Hedge fund founder Chanos says shorting Intel shares: CNBCUS STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data) NEW YORK Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)   NEW YORK, Jan 16 Jim Chanos, founder of hedge fund firm Kynikos Associates, said Friday that he is betting against the shares of Intel Corp.UPDATE 1-Hedge fund founder Chanos says shorting Intel shares - CNBCHedge fund founder Chanos says shorting Intel shares: CNBCUS STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data) NEW YORK Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)   Hedge fund founder Chanos says shorting Intel shares: CNBCUS STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data) NEW YORK Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  NEW YORK, Jan 16 Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.Hedge fund founder Chanos says shorting Intel shares: CNBCUS STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data) NEW YORK Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)    * Futures off: Dow 68 pts, S&P; 7.5 pts, Nasdaq 29 pts   (Adds FXCM, Interactive Brokers)Kynikos' Chanos says he is short Intel Corp - CNBCUPDATE 1-Hedge fund founder Chanos says shorting Intel shares - CNBCHedge fund founder Chanos says shorting Intel shares: CNBCUS STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data) NEW YORK Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)   Hedge fund founder Chanos says shorting Intel shares: CNBCUS STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data) NEW YORK Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  NEW YORK, Jan 16 Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.Hedge fund founder Chanos says shorting Intel shares: CNBCUS STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data) NEW YORK Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)    UPDATE 1-Hedge fund founder Chanos says shorting Intel shares - CNBCHedge fund founder Chanos says shorting Intel shares: CNBCUS STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data) NEW YORK Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)   Hedge fund founder Chanos says shorting Intel shares: CNBCUS STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data) NEW YORK Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  NEW YORK, Jan 16 Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.Hedge fund founder Chanos says shorting Intel shares: CNBCUS STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data) NEW YORK Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)   NEW YORK, Jan 16 Jim Chanos, founder of hedge fund firm Kynikos Associates, said Friday that he is betting against the shares of Intel Corp.UPDATE 1-Hedge fund founder Chanos says shorting Intel shares - CNBCHedge fund founder Chanos says shorting Intel shares: CNBCUS STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data) NEW YORK Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)   Hedge fund founder Chanos says shorting Intel shares: CNBCUS STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data) NEW YORK Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  NEW YORK, Jan 16 Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.Hedge fund founder Chanos says shorting Intel shares: CNBCUS STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data) NEW YORK Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)      US STOCKS-Futures fall in wake of Swiss move; Wall St to drop for weekKynikos' Chanos says he is short Intel Corp - CNBCUPDATE 1-Hedge fund founder Chanos says shorting Intel shares - CNBCHedge fund founder Chanos says shorting Intel shares: CNBCUS STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data) NEW YORK Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)   Hedge fund founder Chanos says shorting Intel shares: CNBCUS STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data) NEW YORK Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  NEW YORK, Jan 16 Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.Hedge fund founder Chanos says shorting Intel shares: CNBCUS STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data) NEW YORK Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)    UPDATE 1-Hedge fund founder Chanos says shorting Intel shares - CNBCHedge fund founder Chanos says shorting Intel shares: CNBCUS STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data) NEW YORK Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)   Hedge fund founder Chanos says shorting Intel shares: CNBCUS STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data) NEW YORK Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  NEW YORK, Jan 16 Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.Hedge fund founder Chanos says shorting Intel shares: CNBCUS STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data) NEW YORK Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)   NEW YORK, Jan 16 Jim Chanos, founder of hedge fund firm Kynikos Associates, said Friday that he is betting against the shares of Intel Corp.UPDATE 1-Hedge fund founder Chanos says shorting Intel shares - CNBCHedge fund founder Chanos says shorting Intel shares: CNBCUS STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data) NEW YORK Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)   Hedge fund founder Chanos says shorting Intel shares: CNBCUS STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data) NEW YORK Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  NEW YORK, Jan 16 Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.Hedge fund founder Chanos says shorting Intel shares: CNBCUS STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data) NEW YORK Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)     Kynikos' Chanos says he is short Intel Corp - CNBCUPDATE 1-Hedge fund founder Chanos says shorting Intel shares - CNBCHedge fund founder Chanos says shorting Intel shares: CNBCUS STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data) NEW YORK Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)   Hedge fund founder Chanos says shorting Intel shares: CNBCUS STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data) NEW YORK Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  NEW YORK, Jan 16 Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.Hedge fund founder Chanos says shorting Intel shares: CNBCUS STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data) NEW YORK Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)    UPDATE 1-Hedge fund founder Chanos says shorting Intel shares - CNBCHedge fund founder Chanos says shorting Intel shares: CNBCUS STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data) NEW YORK Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)   Hedge fund founder Chanos says shorting Intel shares: CNBCUS STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data) NEW YORK Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  NEW YORK, Jan 16 Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.Hedge fund founder Chanos says shorting Intel shares: CNBCUS STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data) NEW YORK Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)   NEW YORK, Jan 16 Jim Chanos, founder of hedge fund firm Kynikos Associates, said Friday that he is betting against the shares of Intel Corp.UPDATE 1-Hedge fund founder Chanos says shorting Intel shares - CNBCHedge fund founder Chanos says shorting Intel shares: CNBCUS STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data) NEW YORK Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)   Hedge fund founder Chanos says shorting Intel shares: CNBCUS STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data) NEW YORK Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  NEW YORK, Jan 16 Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.Hedge fund founder Chanos says shorting Intel shares: CNBCUS STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data) NEW YORK Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)    * Futures off: Dow 68 pts, S&P; 7.5 pts, Nasdaq 29 pts   (Adds FXCM, Interactive Brokers)Kynikos' Chanos says he is short Intel Corp - CNBCUPDATE 1-Hedge fund founder Chanos says shorting Intel shares - CNBCHedge fund founder Chanos says shorting Intel shares: CNBCUS STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data) NEW YORK Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)   Hedge fund founder Chanos says shorting Intel shares: CNBCUS STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data) NEW YORK Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  NEW YORK, Jan 16 Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.Hedge fund founder Chanos says shorting Intel shares: CNBCUS STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data) NEW YORK Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)    UPDATE 1-Hedge fund founder Chanos says shorting Intel shares - CNBCHedge fund founder Chanos says shorting Intel shares: CNBCUS STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data) NEW YORK Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)   Hedge fund founder Chanos says shorting Intel shares: CNBCUS STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data) NEW YORK Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  NEW YORK, Jan 16 Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.Hedge fund founder Chanos says shorting Intel shares: CNBCUS STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data) NEW YORK Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)   NEW YORK, Jan 16 Jim Chanos, founder of hedge fund firm Kynikos Associates, said Friday that he is betting against the shares of Intel Corp.UPDATE 1-Hedge fund founder Chanos says shorting Intel shares - CNBCHedge fund founder Chanos says shorting Intel shares: CNBCUS STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data) NEW YORK Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)   Hedge fund founder Chanos says shorting Intel shares: CNBCUS STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data) NEW YORK Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  NEW YORK, Jan 16 Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.Hedge fund founder Chanos says shorting Intel shares: CNBCUS STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data) NEW YORK Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)     NEW YORK, Jan 16 U.S. stock index futures edged lower on Friday, following five straight days of losses for major indexes, setting Wall Street up for its fourth negative week out of the past six.US STOCKS-Futures fall in wake of Swiss move; Wall St to drop for weekKynikos' Chanos says he is short Intel Corp - CNBCUPDATE 1-Hedge fund founder Chanos says shorting Intel shares - CNBCHedge fund founder Chanos says shorting Intel shares: CNBCUS STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data) NEW YORK Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)   Hedge fund founder Chanos says shorting Intel shares: CNBCUS STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data) NEW YORK Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  NEW YORK, Jan 16 Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.Hedge fund founder Chanos says shorting Intel shares: CNBCUS STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data) NEW YORK Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)    UPDATE 1-Hedge fund founder Chanos says shorting Intel shares - CNBCHedge fund founder Chanos says shorting Intel shares: CNBCUS STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data) NEW YORK Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)   Hedge fund founder Chanos says shorting Intel shares: CNBCUS STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data) NEW YORK Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  NEW YORK, Jan 16 Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.Hedge fund founder Chanos says shorting Intel shares: CNBCUS STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data) NEW YORK Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)   NEW YORK, Jan 16 Jim Chanos, founder of hedge fund firm Kynikos Associates, said Friday that he is betting against the shares of Intel Corp.UPDATE 1-Hedge fund founder Chanos says shorting Intel shares - CNBCHedge fund founder Chanos says shorting Intel shares: CNBCUS STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data) NEW YORK Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)   Hedge fund founder Chanos says shorting Intel shares: CNBCUS STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data) NEW YORK Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  NEW YORK, Jan 16 Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.Hedge fund founder Chanos says shorting Intel shares: CNBCUS STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data) NEW YORK Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)     Kynikos' Chanos says he is short Intel Corp - CNBCUPDATE 1-Hedge fund founder Chanos says shorting Intel shares - CNBCHedge fund founder Chanos says shorting Intel shares: CNBCUS STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data) NEW YORK Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)   Hedge fund founder Chanos says shorting Intel shares: CNBCUS STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data) NEW YORK Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  NEW YORK, Jan 16 Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.Hedge fund founder Chanos says shorting Intel shares: CNBCUS STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data) NEW YORK Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)    UPDATE 1-Hedge fund founder Chanos says shorting Intel shares - CNBCHedge fund founder Chanos says shorting Intel shares: CNBCUS STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data) NEW YORK Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)   Hedge fund founder Chanos says shorting Intel shares: CNBCUS STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data) NEW YORK Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  NEW YORK, Jan 16 Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.Hedge fund founder Chanos says shorting Intel shares: CNBCUS STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data) NEW YORK Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)   NEW YORK, Jan 16 Jim Chanos, founder of hedge fund firm Kynikos Associates, said Friday that he is betting against the shares of Intel Corp.UPDATE 1-Hedge fund founder Chanos says shorting Intel shares - CNBCHedge fund founder Chanos says shorting Intel shares: CNBCUS STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data) NEW YORK Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)   Hedge fund founder Chanos says shorting Intel shares: CNBCUS STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data) NEW YORK Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  NEW YORK, Jan 16 Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.Hedge fund founder Chanos says shorting Intel shares: CNBCUS STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data) NEW YORK Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)    * Futures off: Dow 68 pts, S&P; 7.5 pts, Nasdaq 29 pts   (Adds FXCM, Interactive Brokers)Kynikos' Chanos says he is short Intel Corp - CNBCUPDATE 1-Hedge fund founder Chanos says shorting Intel shares - CNBCHedge fund founder Chanos says shorting Intel shares: CNBCUS STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data) NEW YORK Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)   Hedge fund founder Chanos says shorting Intel shares: CNBCUS STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data) NEW YORK Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  NEW YORK, Jan 16 Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.Hedge fund founder Chanos says shorting Intel shares: CNBCUS STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data) NEW YORK Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)    UPDATE 1-Hedge fund founder Chanos says shorting Intel shares - CNBCHedge fund founder Chanos says shorting Intel shares: CNBCUS STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data) NEW YORK Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)   Hedge fund founder Chanos says shorting Intel shares: CNBCUS STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data) NEW YORK Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  NEW YORK, Jan 16 Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.Hedge fund founder Chanos says shorting Intel shares: CNBCUS STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data) NEW YORK Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)   NEW YORK, Jan 16 Jim Chanos, founder of hedge fund firm Kynikos Associates, said Friday that he is betting against the shares of Intel Corp.UPDATE 1-Hedge fund founder Chanos says shorting Intel shares - CNBCHedge fund founder Chanos says shorting Intel shares: CNBCUS STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data) NEW YORK Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)   Hedge fund founder Chanos says shorting Intel shares: CNBCUS STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data) NEW YORK Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  NEW YORK, Jan 16 Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.Hedge fund founder Chanos says shorting Intel shares: CNBCUS STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)  US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data) NEW YORK Jim Chanos, founder of hedge fund firm Kynikos Associates, said on Friday he is betting against the shares of chipmaker Intel Corp.US STOCKS-Wall St to dip at open on heels of Swiss move, data * Futures off: Dow 58 pts, S&P; 5 pts, Nasdaq 16 pts   (Adds quote, data)       
JNJ,J&J; Ebola vaccine gets 100 mln euros to speed development LONDON, Jan 16 Johnson & Johnson said on Friday that newly formed groups supporting work on its experimental Ebola vaccine would receive 100 million euros ($115 million) from Europe's Innovative Medicines Initiative to speed development. 
LUK,Leucadia National to provide FXCM with $300 million in financing: CNBCLeucadia to give FXCM $300 mln to continue operationsLeucadia to give FXCM $300 million to continue operationsWRAPUP 5-Swiss franc shock shuts some FX brokers; regulators move inUPDATE 5-FX broker FXCM gets rescue from Jefferies parent Leucadia NEW YORK, Jan 16 Retail foreign exchange broker FXCM Inc, reeling after customers lost more than $200 million from the surging Swiss franc, will get a $300 million loan from Leucadia National Corp to keep operating, the companies said in a statement Friday.  UPDATE 5-FX broker FXCM gets rescue from Jefferies parent Leucadia NEW YORK, Jan 16 Retail foreign exchange broker FXCM Inc, reeling after customers lost more than $200 million from the surging Swiss franc, will get a $300 million loan from Leucadia National Corp to keep operating, the companies said in a statement Friday. LONDON, Jan 16 The Swiss franc shock reverberated through currency trading firms around the world on Friday, wiping out many small-scale investors and the brokerages that cater to them and forcing regulators to take a closer look at the sector.UPDATE 5-FX broker FXCM gets rescue from Jefferies parent Leucadia NEW YORK, Jan 16 Retail foreign exchange broker FXCM Inc, reeling after customers lost more than $200 million from the surging Swiss franc, will get a $300 million loan from Leucadia National Corp to keep operating, the companies said in a statement Friday.   WRAPUP 5-Swiss franc shock shuts some FX brokers; regulators move inUPDATE 5-FX broker FXCM gets rescue from Jefferies parent Leucadia NEW YORK, Jan 16 Retail foreign exchange broker FXCM Inc, reeling after customers lost more than $200 million from the surging Swiss franc, will get a $300 million loan from Leucadia National Corp to keep operating, the companies said in a statement Friday.  UPDATE 5-FX broker FXCM gets rescue from Jefferies parent Leucadia NEW YORK, Jan 16 Retail foreign exchange broker FXCM Inc, reeling after customers lost more than $200 million from the surging Swiss franc, will get a $300 million loan from Leucadia National Corp to keep operating, the companies said in a statement Friday. LONDON, Jan 16 The Swiss franc shock reverberated through currency trading firms around the world on Friday, wiping out many small-scale investors and the brokerages that cater to them and forcing regulators to take a closer look at the sector.UPDATE 5-FX broker FXCM gets rescue from Jefferies parent Leucadia NEW YORK, Jan 16 Retail foreign exchange broker FXCM Inc, reeling after customers lost more than $200 million from the surging Swiss franc, will get a $300 million loan from Leucadia National Corp to keep operating, the companies said in a statement Friday.  Leucadia National Corp  will give $300 million to retail foreign exchange broker FXCM Inc  to meet regulatory capital requirements, the two companies said on Friday.WRAPUP 5-Swiss franc shock shuts some FX brokers; regulators move inUPDATE 5-FX broker FXCM gets rescue from Jefferies parent Leucadia NEW YORK, Jan 16 Retail foreign exchange broker FXCM Inc, reeling after customers lost more than $200 million from the surging Swiss franc, will get a $300 million loan from Leucadia National Corp to keep operating, the companies said in a statement Friday.  UPDATE 5-FX broker FXCM gets rescue from Jefferies parent Leucadia NEW YORK, Jan 16 Retail foreign exchange broker FXCM Inc, reeling after customers lost more than $200 million from the surging Swiss franc, will get a $300 million loan from Leucadia National Corp to keep operating, the companies said in a statement Friday. LONDON, Jan 16 The Swiss franc shock reverberated through currency trading firms around the world on Friday, wiping out many small-scale investors and the brokerages that cater to them and forcing regulators to take a closer look at the sector.UPDATE 5-FX broker FXCM gets rescue from Jefferies parent Leucadia NEW YORK, Jan 16 Retail foreign exchange broker FXCM Inc, reeling after customers lost more than $200 million from the surging Swiss franc, will get a $300 million loan from Leucadia National Corp to keep operating, the companies said in a statement Friday.    Leucadia to give FXCM $300 million to continue operationsWRAPUP 5-Swiss franc shock shuts some FX brokers; regulators move inUPDATE 5-FX broker FXCM gets rescue from Jefferies parent Leucadia NEW YORK, Jan 16 Retail foreign exchange broker FXCM Inc, reeling after customers lost more than $200 million from the surging Swiss franc, will get a $300 million loan from Leucadia National Corp to keep operating, the companies said in a statement Friday.  UPDATE 5-FX broker FXCM gets rescue from Jefferies parent Leucadia NEW YORK, Jan 16 Retail foreign exchange broker FXCM Inc, reeling after customers lost more than $200 million from the surging Swiss franc, will get a $300 million loan from Leucadia National Corp to keep operating, the companies said in a statement Friday. LONDON, Jan 16 The Swiss franc shock reverberated through currency trading firms around the world on Friday, wiping out many small-scale investors and the brokerages that cater to them and forcing regulators to take a closer look at the sector.UPDATE 5-FX broker FXCM gets rescue from Jefferies parent Leucadia NEW YORK, Jan 16 Retail foreign exchange broker FXCM Inc, reeling after customers lost more than $200 million from the surging Swiss franc, will get a $300 million loan from Leucadia National Corp to keep operating, the companies said in a statement Friday.   WRAPUP 5-Swiss franc shock shuts some FX brokers; regulators move inUPDATE 5-FX broker FXCM gets rescue from Jefferies parent Leucadia NEW YORK, Jan 16 Retail foreign exchange broker FXCM Inc, reeling after customers lost more than $200 million from the surging Swiss franc, will get a $300 million loan from Leucadia National Corp to keep operating, the companies said in a statement Friday.  UPDATE 5-FX broker FXCM gets rescue from Jefferies parent Leucadia NEW YORK, Jan 16 Retail foreign exchange broker FXCM Inc, reeling after customers lost more than $200 million from the surging Swiss franc, will get a $300 million loan from Leucadia National Corp to keep operating, the companies said in a statement Friday. LONDON, Jan 16 The Swiss franc shock reverberated through currency trading firms around the world on Friday, wiping out many small-scale investors and the brokerages that cater to them and forcing regulators to take a closer look at the sector.UPDATE 5-FX broker FXCM gets rescue from Jefferies parent Leucadia NEW YORK, Jan 16 Retail foreign exchange broker FXCM Inc, reeling after customers lost more than $200 million from the surging Swiss franc, will get a $300 million loan from Leucadia National Corp to keep operating, the companies said in a statement Friday.  Leucadia National Corp  will give $300 million to retail foreign exchange broker FXCM Inc  to meet regulatory capital requirements, the two companies said on Friday.WRAPUP 5-Swiss franc shock shuts some FX brokers; regulators move inUPDATE 5-FX broker FXCM gets rescue from Jefferies parent Leucadia NEW YORK, Jan 16 Retail foreign exchange broker FXCM Inc, reeling after customers lost more than $200 million from the surging Swiss franc, will get a $300 million loan from Leucadia National Corp to keep operating, the companies said in a statement Friday.  UPDATE 5-FX broker FXCM gets rescue from Jefferies parent Leucadia NEW YORK, Jan 16 Retail foreign exchange broker FXCM Inc, reeling after customers lost more than $200 million from the surging Swiss franc, will get a $300 million loan from Leucadia National Corp to keep operating, the companies said in a statement Friday. LONDON, Jan 16 The Swiss franc shock reverberated through currency trading firms around the world on Friday, wiping out many small-scale investors and the brokerages that cater to them and forcing regulators to take a closer look at the sector.UPDATE 5-FX broker FXCM gets rescue from Jefferies parent Leucadia NEW YORK, Jan 16 Retail foreign exchange broker FXCM Inc, reeling after customers lost more than $200 million from the surging Swiss franc, will get a $300 million loan from Leucadia National Corp to keep operating, the companies said in a statement Friday.   Jan 16 Leucadia National Corp will give $300 million to retail foreign exchange broker FXCM Inc  to meet regulatory capital requirements, the two companies said on Friday.Leucadia to give FXCM $300 million to continue operationsWRAPUP 5-Swiss franc shock shuts some FX brokers; regulators move inUPDATE 5-FX broker FXCM gets rescue from Jefferies parent Leucadia NEW YORK, Jan 16 Retail foreign exchange broker FXCM Inc, reeling after customers lost more than $200 million from the surging Swiss franc, will get a $300 million loan from Leucadia National Corp to keep operating, the companies said in a statement Friday.  UPDATE 5-FX broker FXCM gets rescue from Jefferies parent Leucadia NEW YORK, Jan 16 Retail foreign exchange broker FXCM Inc, reeling after customers lost more than $200 million from the surging Swiss franc, will get a $300 million loan from Leucadia National Corp to keep operating, the companies said in a statement Friday. LONDON, Jan 16 The Swiss franc shock reverberated through currency trading firms around the world on Friday, wiping out many small-scale investors and the brokerages that cater to them and forcing regulators to take a closer look at the sector.UPDATE 5-FX broker FXCM gets rescue from Jefferies parent Leucadia NEW YORK, Jan 16 Retail foreign exchange broker FXCM Inc, reeling after customers lost more than $200 million from the surging Swiss franc, will get a $300 million loan from Leucadia National Corp to keep operating, the companies said in a statement Friday.   WRAPUP 5-Swiss franc shock shuts some FX brokers; regulators move inUPDATE 5-FX broker FXCM gets rescue from Jefferies parent Leucadia NEW YORK, Jan 16 Retail foreign exchange broker FXCM Inc, reeling after customers lost more than $200 million from the surging Swiss franc, will get a $300 million loan from Leucadia National Corp to keep operating, the companies said in a statement Friday.  UPDATE 5-FX broker FXCM gets rescue from Jefferies parent Leucadia NEW YORK, Jan 16 Retail foreign exchange broker FXCM Inc, reeling after customers lost more than $200 million from the surging Swiss franc, will get a $300 million loan from Leucadia National Corp to keep operating, the companies said in a statement Friday. LONDON, Jan 16 The Swiss franc shock reverberated through currency trading firms around the world on Friday, wiping out many small-scale investors and the brokerages that cater to them and forcing regulators to take a closer look at the sector.UPDATE 5-FX broker FXCM gets rescue from Jefferies parent Leucadia NEW YORK, Jan 16 Retail foreign exchange broker FXCM Inc, reeling after customers lost more than $200 million from the surging Swiss franc, will get a $300 million loan from Leucadia National Corp to keep operating, the companies said in a statement Friday.  Leucadia National Corp  will give $300 million to retail foreign exchange broker FXCM Inc  to meet regulatory capital requirements, the two companies said on Friday.WRAPUP 5-Swiss franc shock shuts some FX brokers; regulators move inUPDATE 5-FX broker FXCM gets rescue from Jefferies parent Leucadia NEW YORK, Jan 16 Retail foreign exchange broker FXCM Inc, reeling after customers lost more than $200 million from the surging Swiss franc, will get a $300 million loan from Leucadia National Corp to keep operating, the companies said in a statement Friday.  UPDATE 5-FX broker FXCM gets rescue from Jefferies parent Leucadia NEW YORK, Jan 16 Retail foreign exchange broker FXCM Inc, reeling after customers lost more than $200 million from the surging Swiss franc, will get a $300 million loan from Leucadia National Corp to keep operating, the companies said in a statement Friday. LONDON, Jan 16 The Swiss franc shock reverberated through currency trading firms around the world on Friday, wiping out many small-scale investors and the brokerages that cater to them and forcing regulators to take a closer look at the sector.UPDATE 5-FX broker FXCM gets rescue from Jefferies parent Leucadia NEW YORK, Jan 16 Retail foreign exchange broker FXCM Inc, reeling after customers lost more than $200 million from the surging Swiss franc, will get a $300 million loan from Leucadia National Corp to keep operating, the companies said in a statement Friday.     Leucadia to give FXCM $300 mln to continue operationsLeucadia to give FXCM $300 million to continue operationsWRAPUP 5-Swiss franc shock shuts some FX brokers; regulators move inUPDATE 5-FX broker FXCM gets rescue from Jefferies parent Leucadia NEW YORK, Jan 16 Retail foreign exchange broker FXCM Inc, reeling after customers lost more than $200 million from the surging Swiss franc, will get a $300 million loan from Leucadia National Corp to keep operating, the companies said in a statement Friday.  UPDATE 5-FX broker FXCM gets rescue from Jefferies parent Leucadia NEW YORK, Jan 16 Retail foreign exchange broker FXCM Inc, reeling after customers lost more than $200 million from the surging Swiss franc, will get a $300 million loan from Leucadia National Corp to keep operating, the companies said in a statement Friday. LONDON, Jan 16 The Swiss franc shock reverberated through currency trading firms around the world on Friday, wiping out many small-scale investors and the brokerages that cater to them and forcing regulators to take a closer look at the sector.UPDATE 5-FX broker FXCM gets rescue from Jefferies parent Leucadia NEW YORK, Jan 16 Retail foreign exchange broker FXCM Inc, reeling after customers lost more than $200 million from the surging Swiss franc, will get a $300 million loan from Leucadia National Corp to keep operating, the companies said in a statement Friday.   WRAPUP 5-Swiss franc shock shuts some FX brokers; regulators move inUPDATE 5-FX broker FXCM gets rescue from Jefferies parent Leucadia NEW YORK, Jan 16 Retail foreign exchange broker FXCM Inc, reeling after customers lost more than $200 million from the surging Swiss franc, will get a $300 million loan from Leucadia National Corp to keep operating, the companies said in a statement Friday.  UPDATE 5-FX broker FXCM gets rescue from Jefferies parent Leucadia NEW YORK, Jan 16 Retail foreign exchange broker FXCM Inc, reeling after customers lost more than $200 million from the surging Swiss franc, will get a $300 million loan from Leucadia National Corp to keep operating, the companies said in a statement Friday. LONDON, Jan 16 The Swiss franc shock reverberated through currency trading firms around the world on Friday, wiping out many small-scale investors and the brokerages that cater to them and forcing regulators to take a closer look at the sector.UPDATE 5-FX broker FXCM gets rescue from Jefferies parent Leucadia NEW YORK, Jan 16 Retail foreign exchange broker FXCM Inc, reeling after customers lost more than $200 million from the surging Swiss franc, will get a $300 million loan from Leucadia National Corp to keep operating, the companies said in a statement Friday.  Leucadia National Corp  will give $300 million to retail foreign exchange broker FXCM Inc  to meet regulatory capital requirements, the two companies said on Friday.WRAPUP 5-Swiss franc shock shuts some FX brokers; regulators move inUPDATE 5-FX broker FXCM gets rescue from Jefferies parent Leucadia NEW YORK, Jan 16 Retail foreign exchange broker FXCM Inc, reeling after customers lost more than $200 million from the surging Swiss franc, will get a $300 million loan from Leucadia National Corp to keep operating, the companies said in a statement Friday.  UPDATE 5-FX broker FXCM gets rescue from Jefferies parent Leucadia NEW YORK, Jan 16 Retail foreign exchange broker FXCM Inc, reeling after customers lost more than $200 million from the surging Swiss franc, will get a $300 million loan from Leucadia National Corp to keep operating, the companies said in a statement Friday. LONDON, Jan 16 The Swiss franc shock reverberated through currency trading firms around the world on Friday, wiping out many small-scale investors and the brokerages that cater to them and forcing regulators to take a closer look at the sector.UPDATE 5-FX broker FXCM gets rescue from Jefferies parent Leucadia NEW YORK, Jan 16 Retail foreign exchange broker FXCM Inc, reeling after customers lost more than $200 million from the surging Swiss franc, will get a $300 million loan from Leucadia National Corp to keep operating, the companies said in a statement Friday.    Leucadia to give FXCM $300 million to continue operationsWRAPUP 5-Swiss franc shock shuts some FX brokers; regulators move inUPDATE 5-FX broker FXCM gets rescue from Jefferies parent Leucadia NEW YORK, Jan 16 Retail foreign exchange broker FXCM Inc, reeling after customers lost more than $200 million from the surging Swiss franc, will get a $300 million loan from Leucadia National Corp to keep operating, the companies said in a statement Friday.  UPDATE 5-FX broker FXCM gets rescue from Jefferies parent Leucadia NEW YORK, Jan 16 Retail foreign exchange broker FXCM Inc, reeling after customers lost more than $200 million from the surging Swiss franc, will get a $300 million loan from Leucadia National Corp to keep operating, the companies said in a statement Friday. LONDON, Jan 16 The Swiss franc shock reverberated through currency trading firms around the world on Friday, wiping out many small-scale investors and the brokerages that cater to them and forcing regulators to take a closer look at the sector.UPDATE 5-FX broker FXCM gets rescue from Jefferies parent Leucadia NEW YORK, Jan 16 Retail foreign exchange broker FXCM Inc, reeling after customers lost more than $200 million from the surging Swiss franc, will get a $300 million loan from Leucadia National Corp to keep operating, the companies said in a statement Friday.   WRAPUP 5-Swiss franc shock shuts some FX brokers; regulators move inUPDATE 5-FX broker FXCM gets rescue from Jefferies parent Leucadia NEW YORK, Jan 16 Retail foreign exchange broker FXCM Inc, reeling after customers lost more than $200 million from the surging Swiss franc, will get a $300 million loan from Leucadia National Corp to keep operating, the companies said in a statement Friday.  UPDATE 5-FX broker FXCM gets rescue from Jefferies parent Leucadia NEW YORK, Jan 16 Retail foreign exchange broker FXCM Inc, reeling after customers lost more than $200 million from the surging Swiss franc, will get a $300 million loan from Leucadia National Corp to keep operating, the companies said in a statement Friday. LONDON, Jan 16 The Swiss franc shock reverberated through currency trading firms around the world on Friday, wiping out many small-scale investors and the brokerages that cater to them and forcing regulators to take a closer look at the sector.UPDATE 5-FX broker FXCM gets rescue from Jefferies parent Leucadia NEW YORK, Jan 16 Retail foreign exchange broker FXCM Inc, reeling after customers lost more than $200 million from the surging Swiss franc, will get a $300 million loan from Leucadia National Corp to keep operating, the companies said in a statement Friday.  Leucadia National Corp  will give $300 million to retail foreign exchange broker FXCM Inc  to meet regulatory capital requirements, the two companies said on Friday.WRAPUP 5-Swiss franc shock shuts some FX brokers; regulators move inUPDATE 5-FX broker FXCM gets rescue from Jefferies parent Leucadia NEW YORK, Jan 16 Retail foreign exchange broker FXCM Inc, reeling after customers lost more than $200 million from the surging Swiss franc, will get a $300 million loan from Leucadia National Corp to keep operating, the companies said in a statement Friday.  UPDATE 5-FX broker FXCM gets rescue from Jefferies parent Leucadia NEW YORK, Jan 16 Retail foreign exchange broker FXCM Inc, reeling after customers lost more than $200 million from the surging Swiss franc, will get a $300 million loan from Leucadia National Corp to keep operating, the companies said in a statement Friday. LONDON, Jan 16 The Swiss franc shock reverberated through currency trading firms around the world on Friday, wiping out many small-scale investors and the brokerages that cater to them and forcing regulators to take a closer look at the sector.UPDATE 5-FX broker FXCM gets rescue from Jefferies parent Leucadia NEW YORK, Jan 16 Retail foreign exchange broker FXCM Inc, reeling after customers lost more than $200 million from the surging Swiss franc, will get a $300 million loan from Leucadia National Corp to keep operating, the companies said in a statement Friday.   Jan 16 Leucadia National Corp will give $300 million to retail foreign exchange broker FXCM Inc  to meet regulatory capital requirements, the two companies said on Friday.Leucadia to give FXCM $300 million to continue operationsWRAPUP 5-Swiss franc shock shuts some FX brokers; regulators move inUPDATE 5-FX broker FXCM gets rescue from Jefferies parent Leucadia NEW YORK, Jan 16 Retail foreign exchange broker FXCM Inc, reeling after customers lost more than $200 million from the surging Swiss franc, will get a $300 million loan from Leucadia National Corp to keep operating, the companies said in a statement Friday.  UPDATE 5-FX broker FXCM gets rescue from Jefferies parent Leucadia NEW YORK, Jan 16 Retail foreign exchange broker FXCM Inc, reeling after customers lost more than $200 million from the surging Swiss franc, will get a $300 million loan from Leucadia National Corp to keep operating, the companies said in a statement Friday. LONDON, Jan 16 The Swiss franc shock reverberated through currency trading firms around the world on Friday, wiping out many small-scale investors and the brokerages that cater to them and forcing regulators to take a closer look at the sector.UPDATE 5-FX broker FXCM gets rescue from Jefferies parent Leucadia NEW YORK, Jan 16 Retail foreign exchange broker FXCM Inc, reeling after customers lost more than $200 million from the surging Swiss franc, will get a $300 million loan from Leucadia National Corp to keep operating, the companies said in a statement Friday.   WRAPUP 5-Swiss franc shock shuts some FX brokers; regulators move inUPDATE 5-FX broker FXCM gets rescue from Jefferies parent Leucadia NEW YORK, Jan 16 Retail foreign exchange broker FXCM Inc, reeling after customers lost more than $200 million from the surging Swiss franc, will get a $300 million loan from Leucadia National Corp to keep operating, the companies said in a statement Friday.  UPDATE 5-FX broker FXCM gets rescue from Jefferies parent Leucadia NEW YORK, Jan 16 Retail foreign exchange broker FXCM Inc, reeling after customers lost more than $200 million from the surging Swiss franc, will get a $300 million loan from Leucadia National Corp to keep operating, the companies said in a statement Friday. LONDON, Jan 16 The Swiss franc shock reverberated through currency trading firms around the world on Friday, wiping out many small-scale investors and the brokerages that cater to them and forcing regulators to take a closer look at the sector.UPDATE 5-FX broker FXCM gets rescue from Jefferies parent Leucadia NEW YORK, Jan 16 Retail foreign exchange broker FXCM Inc, reeling after customers lost more than $200 million from the surging Swiss franc, will get a $300 million loan from Leucadia National Corp to keep operating, the companies said in a statement Friday.  Leucadia National Corp  will give $300 million to retail foreign exchange broker FXCM Inc  to meet regulatory capital requirements, the two companies said on Friday.WRAPUP 5-Swiss franc shock shuts some FX brokers; regulators move inUPDATE 5-FX broker FXCM gets rescue from Jefferies parent Leucadia NEW YORK, Jan 16 Retail foreign exchange broker FXCM Inc, reeling after customers lost more than $200 million from the surging Swiss franc, will get a $300 million loan from Leucadia National Corp to keep operating, the companies said in a statement Friday.  UPDATE 5-FX broker FXCM gets rescue from Jefferies parent Leucadia NEW YORK, Jan 16 Retail foreign exchange broker FXCM Inc, reeling after customers lost more than $200 million from the surging Swiss franc, will get a $300 million loan from Leucadia National Corp to keep operating, the companies said in a statement Friday. LONDON, Jan 16 The Swiss franc shock reverberated through currency trading firms around the world on Friday, wiping out many small-scale investors and the brokerages that cater to them and forcing regulators to take a closer look at the sector.UPDATE 5-FX broker FXCM gets rescue from Jefferies parent Leucadia NEW YORK, Jan 16 Retail foreign exchange broker FXCM Inc, reeling after customers lost more than $200 million from the surging Swiss franc, will get a $300 million loan from Leucadia National Corp to keep operating, the companies said in a statement Friday.    Leucadia National Corp , the parent of investment bank Jefferies, will provide foreign exchange brokerage FXCM Inc  with $300 million in financing, CNBC said on Friday.Leucadia to give FXCM $300 mln to continue operationsLeucadia to give FXCM $300 million to continue operationsWRAPUP 5-Swiss franc shock shuts some FX brokers; regulators move inUPDATE 5-FX broker FXCM gets rescue from Jefferies parent Leucadia NEW YORK, Jan 16 Retail foreign exchange broker FXCM Inc, reeling after customers lost more than $200 million from the surging Swiss franc, will get a $300 million loan from Leucadia National Corp to keep operating, the companies said in a statement Friday.  UPDATE 5-FX broker FXCM gets rescue from Jefferies parent Leucadia NEW YORK, Jan 16 Retail foreign exchange broker FXCM Inc, reeling after customers lost more than $200 million from the surging Swiss franc, will get a $300 million loan from Leucadia National Corp to keep operating, the companies said in a statement Friday. LONDON, Jan 16 The Swiss franc shock reverberated through currency trading firms around the world on Friday, wiping out many small-scale investors and the brokerages that cater to them and forcing regulators to take a closer look at the sector.UPDATE 5-FX broker FXCM gets rescue from Jefferies parent Leucadia NEW YORK, Jan 16 Retail foreign exchange broker FXCM Inc, reeling after customers lost more than $200 million from the surging Swiss franc, will get a $300 million loan from Leucadia National Corp to keep operating, the companies said in a statement Friday.   WRAPUP 5-Swiss franc shock shuts some FX brokers; regulators move inUPDATE 5-FX broker FXCM gets rescue from Jefferies parent Leucadia NEW YORK, Jan 16 Retail foreign exchange broker FXCM Inc, reeling after customers lost more than $200 million from the surging Swiss franc, will get a $300 million loan from Leucadia National Corp to keep operating, the companies said in a statement Friday.  UPDATE 5-FX broker FXCM gets rescue from Jefferies parent Leucadia NEW YORK, Jan 16 Retail foreign exchange broker FXCM Inc, reeling after customers lost more than $200 million from the surging Swiss franc, will get a $300 million loan from Leucadia National Corp to keep operating, the companies said in a statement Friday. LONDON, Jan 16 The Swiss franc shock reverberated through currency trading firms around the world on Friday, wiping out many small-scale investors and the brokerages that cater to them and forcing regulators to take a closer look at the sector.UPDATE 5-FX broker FXCM gets rescue from Jefferies parent Leucadia NEW YORK, Jan 16 Retail foreign exchange broker FXCM Inc, reeling after customers lost more than $200 million from the surging Swiss franc, will get a $300 million loan from Leucadia National Corp to keep operating, the companies said in a statement Friday.  Leucadia National Corp  will give $300 million to retail foreign exchange broker FXCM Inc  to meet regulatory capital requirements, the two companies said on Friday.WRAPUP 5-Swiss franc shock shuts some FX brokers; regulators move inUPDATE 5-FX broker FXCM gets rescue from Jefferies parent Leucadia NEW YORK, Jan 16 Retail foreign exchange broker FXCM Inc, reeling after customers lost more than $200 million from the surging Swiss franc, will get a $300 million loan from Leucadia National Corp to keep operating, the companies said in a statement Friday.  UPDATE 5-FX broker FXCM gets rescue from Jefferies parent Leucadia NEW YORK, Jan 16 Retail foreign exchange broker FXCM Inc, reeling after customers lost more than $200 million from the surging Swiss franc, will get a $300 million loan from Leucadia National Corp to keep operating, the companies said in a statement Friday. LONDON, Jan 16 The Swiss franc shock reverberated through currency trading firms around the world on Friday, wiping out many small-scale investors and the brokerages that cater to them and forcing regulators to take a closer look at the sector.UPDATE 5-FX broker FXCM gets rescue from Jefferies parent Leucadia NEW YORK, Jan 16 Retail foreign exchange broker FXCM Inc, reeling after customers lost more than $200 million from the surging Swiss franc, will get a $300 million loan from Leucadia National Corp to keep operating, the companies said in a statement Friday.    Leucadia to give FXCM $300 million to continue operationsWRAPUP 5-Swiss franc shock shuts some FX brokers; regulators move inUPDATE 5-FX broker FXCM gets rescue from Jefferies parent Leucadia NEW YORK, Jan 16 Retail foreign exchange broker FXCM Inc, reeling after customers lost more than $200 million from the surging Swiss franc, will get a $300 million loan from Leucadia National Corp to keep operating, the companies said in a statement Friday.  UPDATE 5-FX broker FXCM gets rescue from Jefferies parent Leucadia NEW YORK, Jan 16 Retail foreign exchange broker FXCM Inc, reeling after customers lost more than $200 million from the surging Swiss franc, will get a $300 million loan from Leucadia National Corp to keep operating, the companies said in a statement Friday. LONDON, Jan 16 The Swiss franc shock reverberated through currency trading firms around the world on Friday, wiping out many small-scale investors and the brokerages that cater to them and forcing regulators to take a closer look at the sector.UPDATE 5-FX broker FXCM gets rescue from Jefferies parent Leucadia NEW YORK, Jan 16 Retail foreign exchange broker FXCM Inc, reeling after customers lost more than $200 million from the surging Swiss franc, will get a $300 million loan from Leucadia National Corp to keep operating, the companies said in a statement Friday.   WRAPUP 5-Swiss franc shock shuts some FX brokers; regulators move inUPDATE 5-FX broker FXCM gets rescue from Jefferies parent Leucadia NEW YORK, Jan 16 Retail foreign exchange broker FXCM Inc, reeling after customers lost more than $200 million from the surging Swiss franc, will get a $300 million loan from Leucadia National Corp to keep operating, the companies said in a statement Friday.  UPDATE 5-FX broker FXCM gets rescue from Jefferies parent Leucadia NEW YORK, Jan 16 Retail foreign exchange broker FXCM Inc, reeling after customers lost more than $200 million from the surging Swiss franc, will get a $300 million loan from Leucadia National Corp to keep operating, the companies said in a statement Friday. LONDON, Jan 16 The Swiss franc shock reverberated through currency trading firms around the world on Friday, wiping out many small-scale investors and the brokerages that cater to them and forcing regulators to take a closer look at the sector.UPDATE 5-FX broker FXCM gets rescue from Jefferies parent Leucadia NEW YORK, Jan 16 Retail foreign exchange broker FXCM Inc, reeling after customers lost more than $200 million from the surging Swiss franc, will get a $300 million loan from Leucadia National Corp to keep operating, the companies said in a statement Friday.  Leucadia National Corp  will give $300 million to retail foreign exchange broker FXCM Inc  to meet regulatory capital requirements, the two companies said on Friday.WRAPUP 5-Swiss franc shock shuts some FX brokers; regulators move inUPDATE 5-FX broker FXCM gets rescue from Jefferies parent Leucadia NEW YORK, Jan 16 Retail foreign exchange broker FXCM Inc, reeling after customers lost more than $200 million from the surging Swiss franc, will get a $300 million loan from Leucadia National Corp to keep operating, the companies said in a statement Friday.  UPDATE 5-FX broker FXCM gets rescue from Jefferies parent Leucadia NEW YORK, Jan 16 Retail foreign exchange broker FXCM Inc, reeling after customers lost more than $200 million from the surging Swiss franc, will get a $300 million loan from Leucadia National Corp to keep operating, the companies said in a statement Friday. LONDON, Jan 16 The Swiss franc shock reverberated through currency trading firms around the world on Friday, wiping out many small-scale investors and the brokerages that cater to them and forcing regulators to take a closer look at the sector.UPDATE 5-FX broker FXCM gets rescue from Jefferies parent Leucadia NEW YORK, Jan 16 Retail foreign exchange broker FXCM Inc, reeling after customers lost more than $200 million from the surging Swiss franc, will get a $300 million loan from Leucadia National Corp to keep operating, the companies said in a statement Friday.   Jan 16 Leucadia National Corp will give $300 million to retail foreign exchange broker FXCM Inc  to meet regulatory capital requirements, the two companies said on Friday.Leucadia to give FXCM $300 million to continue operationsWRAPUP 5-Swiss franc shock shuts some FX brokers; regulators move inUPDATE 5-FX broker FXCM gets rescue from Jefferies parent Leucadia NEW YORK, Jan 16 Retail foreign exchange broker FXCM Inc, reeling after customers lost more than $200 million from the surging Swiss franc, will get a $300 million loan from Leucadia National Corp to keep operating, the companies said in a statement Friday.  UPDATE 5-FX broker FXCM gets rescue from Jefferies parent Leucadia NEW YORK, Jan 16 Retail foreign exchange broker FXCM Inc, reeling after customers lost more than $200 million from the surging Swiss franc, will get a $300 million loan from Leucadia National Corp to keep operating, the companies said in a statement Friday. LONDON, Jan 16 The Swiss franc shock reverberated through currency trading firms around the world on Friday, wiping out many small-scale investors and the brokerages that cater to them and forcing regulators to take a closer look at the sector.UPDATE 5-FX broker FXCM gets rescue from Jefferies parent Leucadia NEW YORK, Jan 16 Retail foreign exchange broker FXCM Inc, reeling after customers lost more than $200 million from the surging Swiss franc, will get a $300 million loan from Leucadia National Corp to keep operating, the companies said in a statement Friday.   WRAPUP 5-Swiss franc shock shuts some FX brokers; regulators move inUPDATE 5-FX broker FXCM gets rescue from Jefferies parent Leucadia NEW YORK, Jan 16 Retail foreign exchange broker FXCM Inc, reeling after customers lost more than $200 million from the surging Swiss franc, will get a $300 million loan from Leucadia National Corp to keep operating, the companies said in a statement Friday.  UPDATE 5-FX broker FXCM gets rescue from Jefferies parent Leucadia NEW YORK, Jan 16 Retail foreign exchange broker FXCM Inc, reeling after customers lost more than $200 million from the surging Swiss franc, will get a $300 million loan from Leucadia National Corp to keep operating, the companies said in a statement Friday. LONDON, Jan 16 The Swiss franc shock reverberated through currency trading firms around the world on Friday, wiping out many small-scale investors and the brokerages that cater to them and forcing regulators to take a closer look at the sector.UPDATE 5-FX broker FXCM gets rescue from Jefferies parent Leucadia NEW YORK, Jan 16 Retail foreign exchange broker FXCM Inc, reeling after customers lost more than $200 million from the surging Swiss franc, will get a $300 million loan from Leucadia National Corp to keep operating, the companies said in a statement Friday.  Leucadia National Corp  will give $300 million to retail foreign exchange broker FXCM Inc  to meet regulatory capital requirements, the two companies said on Friday.WRAPUP 5-Swiss franc shock shuts some FX brokers; regulators move inUPDATE 5-FX broker FXCM gets rescue from Jefferies parent Leucadia NEW YORK, Jan 16 Retail foreign exchange broker FXCM Inc, reeling after customers lost more than $200 million from the surging Swiss franc, will get a $300 million loan from Leucadia National Corp to keep operating, the companies said in a statement Friday.  UPDATE 5-FX broker FXCM gets rescue from Jefferies parent Leucadia NEW YORK, Jan 16 Retail foreign exchange broker FXCM Inc, reeling after customers lost more than $200 million from the surging Swiss franc, will get a $300 million loan from Leucadia National Corp to keep operating, the companies said in a statement Friday. LONDON, Jan 16 The Swiss franc shock reverberated through currency trading firms around the world on Friday, wiping out many small-scale investors and the brokerages that cater to them and forcing regulators to take a closer look at the sector.UPDATE 5-FX broker FXCM gets rescue from Jefferies parent Leucadia NEW YORK, Jan 16 Retail foreign exchange broker FXCM Inc, reeling after customers lost more than $200 million from the surging Swiss franc, will get a $300 million loan from Leucadia National Corp to keep operating, the companies said in a statement Friday.     
MSFT,British police arrest man over Christmas Xbox, Playstation hacks LONDON, Jan 16 British police said on Friday they had arrested a man in northwest England following the 2014 cyber attacks on Sony PlayStation and Microsoft Xbox systems. 
PEP,PepsiCo elects Trian Fund's nominee to boardUPDATE 1-PepsiCo elects Trian Fund advisory partner to board Jan 16 PepsiCo Inc said it had elected William Johnson, an advisory partner at Trian Fund Management, to its board, following a recent push by Trian to split the company.  UPDATE 1-PepsiCo elects Trian Fund advisory partner to board Jan 16 PepsiCo Inc said it had elected William Johnson, an advisory partner at Trian Fund Management, to its board, following a recent push by Trian to split the company. Jan 16 PepsiCo Inc said it had elected William Johnson, an advisory partner at Nelson Peltz-led Trian Fund Management to its board.UPDATE 1-PepsiCo elects Trian Fund advisory partner to board Jan 16 PepsiCo Inc said it had elected William Johnson, an advisory partner at Trian Fund Management, to its board, following a recent push by Trian to split the company.  
PG,P&G;'s Gillette sues former employees for divulging trade secretsUPDATE 2-P&G;'s Gillette sues former employees for divulging trade secretsP&G;'s Gillette sues former employees for divulging trade secrets Procter & Gamble Co unit Gillette filed a lawsuit against four former employees for disclosing trade secrets to ShaveLogic Inc, their current employer.  P&G;'s Gillette sues former employees for divulging trade secrets Procter & Gamble Co unit Gillette filed a lawsuit against four former employees for disclosing trade secrets to ShaveLogic Inc, their current employer. Jan 16 Procter & Gamble Co unit Gillette filed a lawsuit against four former employees for disclosing trade secrets to ShaveLogic Inc, their current employer.P&G;'s Gillette sues former employees for divulging trade secrets Procter & Gamble Co unit Gillette filed a lawsuit against four former employees for disclosing trade secrets to ShaveLogic Inc, their current employer.   UPDATE 2-P&G;'s Gillette sues former employees for divulging trade secretsP&G;'s Gillette sues former employees for divulging trade secrets Procter & Gamble Co unit Gillette filed a lawsuit against four former employees for disclosing trade secrets to ShaveLogic Inc, their current employer.  P&G;'s Gillette sues former employees for divulging trade secrets Procter & Gamble Co unit Gillette filed a lawsuit against four former employees for disclosing trade secrets to ShaveLogic Inc, their current employer. Jan 16 Procter & Gamble Co unit Gillette filed a lawsuit against four former employees for disclosing trade secrets to ShaveLogic Inc, their current employer.P&G;'s Gillette sues former employees for divulging trade secrets Procter & Gamble Co unit Gillette filed a lawsuit against four former employees for disclosing trade secrets to ShaveLogic Inc, their current employer.  Jan 16 Procter & Gamble Co unit Gillette filed a lawsuit against four former employees for disclosing trade secrets to ShaveLogic, their current employer.UPDATE 2-P&G;'s Gillette sues former employees for divulging trade secretsP&G;'s Gillette sues former employees for divulging trade secrets Procter & Gamble Co unit Gillette filed a lawsuit against four former employees for disclosing trade secrets to ShaveLogic Inc, their current employer.  P&G;'s Gillette sues former employees for divulging trade secrets Procter & Gamble Co unit Gillette filed a lawsuit against four former employees for disclosing trade secrets to ShaveLogic Inc, their current employer. Jan 16 Procter & Gamble Co unit Gillette filed a lawsuit against four former employees for disclosing trade secrets to ShaveLogic Inc, their current employer.P&G;'s Gillette sues former employees for divulging trade secrets Procter & Gamble Co unit Gillette filed a lawsuit against four former employees for disclosing trade secrets to ShaveLogic Inc, their current employer.   
SLB,Schlumberger says weak oil prices to impact N. America activity mostUPDATE 1-Schlumberger: International markets to fare better than N.AmericaUS STOCKS-Wall St rises after 5 down days; econ data, energy boostUS STOCKS-Wall St up after 5 down days, helped by data, energy * Indexes up: Dow 0.5 pct, S&P; 0.7 pct, Nasdaq 0.7 pct   (Updates to late afternoon)  US STOCKS-Wall St up after 5 down days, helped by data, energy * Indexes up: Dow 0.5 pct, S&P; 0.7 pct, Nasdaq 0.7 pct   (Updates to late afternoon) * Indexes up: Dow 0.27 pct, S&P; 0.5 pct, Nasdaq 0.56 pct   (Updates to early afternoon, changes byline)US STOCKS-Wall St up after 5 down days, helped by data, energy * Indexes up: Dow 0.5 pct, S&P; 0.7 pct, Nasdaq 0.7 pct   (Updates to late afternoon)   US STOCKS-Wall St rises after 5 down days; econ data, energy boostUS STOCKS-Wall St up after 5 down days, helped by data, energy * Indexes up: Dow 0.5 pct, S&P; 0.7 pct, Nasdaq 0.7 pct   (Updates to late afternoon)  US STOCKS-Wall St up after 5 down days, helped by data, energy * Indexes up: Dow 0.5 pct, S&P; 0.7 pct, Nasdaq 0.7 pct   (Updates to late afternoon) * Indexes up: Dow 0.27 pct, S&P; 0.5 pct, Nasdaq 0.56 pct   (Updates to early afternoon, changes byline)US STOCKS-Wall St up after 5 down days, helped by data, energy * Indexes up: Dow 0.5 pct, S&P; 0.7 pct, Nasdaq 0.7 pct   (Updates to late afternoon)  Jan 16 Schlumberger Ltd, the world's No.1 oilfield services provider, said the oil price drop was likely to have a "significantly more dramatic" impact on North America than on the rest of the world.US STOCKS-Wall St rises after 5 down days; econ data, energy boostUS STOCKS-Wall St up after 5 down days, helped by data, energy * Indexes up: Dow 0.5 pct, S&P; 0.7 pct, Nasdaq 0.7 pct   (Updates to late afternoon)  US STOCKS-Wall St up after 5 down days, helped by data, energy * Indexes up: Dow 0.5 pct, S&P; 0.7 pct, Nasdaq 0.7 pct   (Updates to late afternoon) * Indexes up: Dow 0.27 pct, S&P; 0.5 pct, Nasdaq 0.56 pct   (Updates to early afternoon, changes byline)US STOCKS-Wall St up after 5 down days, helped by data, energy * Indexes up: Dow 0.5 pct, S&P; 0.7 pct, Nasdaq 0.7 pct   (Updates to late afternoon)    UPDATE 1-Schlumberger: International markets to fare better than N.AmericaUS STOCKS-Wall St rises after 5 down days; econ data, energy boostUS STOCKS-Wall St up after 5 down days, helped by data, energy * Indexes up: Dow 0.5 pct, S&P; 0.7 pct, Nasdaq 0.7 pct   (Updates to late afternoon)  US STOCKS-Wall St up after 5 down days, helped by data, energy * Indexes up: Dow 0.5 pct, S&P; 0.7 pct, Nasdaq 0.7 pct   (Updates to late afternoon) * Indexes up: Dow 0.27 pct, S&P; 0.5 pct, Nasdaq 0.56 pct   (Updates to early afternoon, changes byline)US STOCKS-Wall St up after 5 down days, helped by data, energy * Indexes up: Dow 0.5 pct, S&P; 0.7 pct, Nasdaq 0.7 pct   (Updates to late afternoon)   US STOCKS-Wall St rises after 5 down days; econ data, energy boostUS STOCKS-Wall St up after 5 down days, helped by data, energy * Indexes up: Dow 0.5 pct, S&P; 0.7 pct, Nasdaq 0.7 pct   (Updates to late afternoon)  US STOCKS-Wall St up after 5 down days, helped by data, energy * Indexes up: Dow 0.5 pct, S&P; 0.7 pct, Nasdaq 0.7 pct   (Updates to late afternoon) * Indexes up: Dow 0.27 pct, S&P; 0.5 pct, Nasdaq 0.56 pct   (Updates to early afternoon, changes byline)US STOCKS-Wall St up after 5 down days, helped by data, energy * Indexes up: Dow 0.5 pct, S&P; 0.7 pct, Nasdaq 0.7 pct   (Updates to late afternoon)  Jan 16 Schlumberger Ltd, the world's No.1 oilfield services provider, said the oil price drop was likely to have a "significantly more dramatic" impact on North America than on the rest of the world.US STOCKS-Wall St rises after 5 down days; econ data, energy boostUS STOCKS-Wall St up after 5 down days, helped by data, energy * Indexes up: Dow 0.5 pct, S&P; 0.7 pct, Nasdaq 0.7 pct   (Updates to late afternoon)  US STOCKS-Wall St up after 5 down days, helped by data, energy * Indexes up: Dow 0.5 pct, S&P; 0.7 pct, Nasdaq 0.7 pct   (Updates to late afternoon) * Indexes up: Dow 0.27 pct, S&P; 0.5 pct, Nasdaq 0.56 pct   (Updates to early afternoon, changes byline)US STOCKS-Wall St up after 5 down days, helped by data, energy * Indexes up: Dow 0.5 pct, S&P; 0.7 pct, Nasdaq 0.7 pct   (Updates to late afternoon)   Jan 16 Schlumberger Ltd, the world's No.1 oilfield services provider, said the drop in oil prices was likely to have a bigger impact on activity and pricing in North America than in international markets, which is its stronghold.UPDATE 1-Schlumberger: International markets to fare better than N.AmericaUS STOCKS-Wall St rises after 5 down days; econ data, energy boostUS STOCKS-Wall St up after 5 down days, helped by data, energy * Indexes up: Dow 0.5 pct, S&P; 0.7 pct, Nasdaq 0.7 pct   (Updates to late afternoon)  US STOCKS-Wall St up after 5 down days, helped by data, energy * Indexes up: Dow 0.5 pct, S&P; 0.7 pct, Nasdaq 0.7 pct   (Updates to late afternoon) * Indexes up: Dow 0.27 pct, S&P; 0.5 pct, Nasdaq 0.56 pct   (Updates to early afternoon, changes byline)US STOCKS-Wall St up after 5 down days, helped by data, energy * Indexes up: Dow 0.5 pct, S&P; 0.7 pct, Nasdaq 0.7 pct   (Updates to late afternoon)   US STOCKS-Wall St rises after 5 down days; econ data, energy boostUS STOCKS-Wall St up after 5 down days, helped by data, energy * Indexes up: Dow 0.5 pct, S&P; 0.7 pct, Nasdaq 0.7 pct   (Updates to late afternoon)  US STOCKS-Wall St up after 5 down days, helped by data, energy * Indexes up: Dow 0.5 pct, S&P; 0.7 pct, Nasdaq 0.7 pct   (Updates to late afternoon) * Indexes up: Dow 0.27 pct, S&P; 0.5 pct, Nasdaq 0.56 pct   (Updates to early afternoon, changes byline)US STOCKS-Wall St up after 5 down days, helped by data, energy * Indexes up: Dow 0.5 pct, S&P; 0.7 pct, Nasdaq 0.7 pct   (Updates to late afternoon)  Jan 16 Schlumberger Ltd, the world's No.1 oilfield services provider, said the oil price drop was likely to have a "significantly more dramatic" impact on North America than on the rest of the world.US STOCKS-Wall St rises after 5 down days; econ data, energy boostUS STOCKS-Wall St up after 5 down days, helped by data, energy * Indexes up: Dow 0.5 pct, S&P; 0.7 pct, Nasdaq 0.7 pct   (Updates to late afternoon)  US STOCKS-Wall St up after 5 down days, helped by data, energy * Indexes up: Dow 0.5 pct, S&P; 0.7 pct, Nasdaq 0.7 pct   (Updates to late afternoon) * Indexes up: Dow 0.27 pct, S&P; 0.5 pct, Nasdaq 0.56 pct   (Updates to early afternoon, changes byline)US STOCKS-Wall St up after 5 down days, helped by data, energy * Indexes up: Dow 0.5 pct, S&P; 0.7 pct, Nasdaq 0.7 pct   (Updates to late afternoon)    
TGT,Thin crowds during CEO's visit helped seal Target Canada's demise NEW YORK/TORONTO, Jan 16 Target Corp was scrambling for ways to fix its failing Canadian expansion and considering closing just the weakest locations, but a pre-holiday visit to several stores by CEO Brian Cornell helped seal the decision for a full retreat. 
DIS,Disney hikes Bob Iger's compensation by 36 percent in 2014 Jan 16 Walt Disney Co hiked Chief Executive Robert Iger's total compensation by 36 percent in 2014, a regulatory filing showed. 
TWX,UPDATE 2-Dish reaches deal that brings back Fox news, business channels LOS ANGELES, Jan 15 The Fox News and Fox Business channels returned on Thursday to satellite TV provider Dish Network Corp's lineup after both sides agreed to a multiyear deal. 
